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O1 
MULTI-SCALE SIMULATIONS OF ASPIRATION THROMBECTOMY
M. Neidlina, M. Büsena, C. Brockmannb
aRWTH, Aachen, Germany; bUniversity Hospital, Aachen, Germany
Aim: Ischemic stroke inflicts high morbidity and mortality. Endovascular aspi-
ration of the blood clot is a common surgical technique for the recanalization 
of the occluded arteries. However, the hemodynamics in the cerebral vessel 
network (CoW) are not completely understood, which results in medical mis-
judgment and complications during surgeries. To improve treatment outcome, 
computational models derived from patient data can be used to investigate the 
blood flow conditions.
Methods: In this study, we established a multi-scale description of aspiration 
thrombectomy. Firstly, the CoW was modeled as a 1-D pipe network on the 
basis of real geometries and validated with literature values of physiological 
pressure/flow curves. Afterwards, a vascular occlusion was placed in the middle 
cerebral artery and the relevant section of the CoW was transferred to a 3-D 
computational fluid dynamic (CFD) domain. A suction catheter in different posi-
tions was included in the CFD simulations. The geometry was extracted from 
MRI scans. The boundary conditions of the 3-D domain were taken from the 1-D 
domain to ensure system coupling.
Results: The 1-D model confirms the literature data of pressure/flow curves. 
Further on, anatomical variations, like hypoplasia and aplasia of cerebral ves-
sels, can be investigated with respect to their influence on the cerebral blood 
flow. The CFD simulations can be used to calculate the optimal insertion length 
of the catheter for a successful thrombus aspiration.
Conclusions: The presented framework shows the possibility of a 1-D/3-D 
computational approach for surgical guidance support.
O2 
VAD IN FAILING FONTAN: SIMULATION OF VENTRICULAR, CAVO-PULMO-
NARY AND BIVENTRICULAR ASSISTANCE IN SYSTOLIC/DIASTOLIC VEN-
TRICULAR DYSFUNCTION AND IN PULMONARY VASCULAR RESISTANCE 
INCREASE
A. Di Molfettaa, G. Ferraria, M. Pilatib, R. Iacobellib, L. Fresielloa, M.G. Trivellaa, 
A. Amodeob
aInstitute of Clinical Physiology, CNR, Rome-Pisa, Italy; bPediatric Hospital 
Bambino Gesù, Rome, Italy
Aim: Due to the lack of donors, VADs could be an alternative to heart transplan-
tation for Failing Fontan patients (PTs). Considering the complex physiopathol-
ogy and the type of VAD connection, a numerical model (NM) could be useful 
to support clinical decisions. The aim of this work is to test a NM simulating the 
VADs effects on failing Fontan for systolic dysfunction (SD), diastolic dysfunc-
tion (DD) and pulmonary vascular resistance increase (PRI).
Methods: Data of 10 Fontan PTs were used to simulate the PTs baseline using a 
dedicated NM. Then, for each PTs a SD, a DD and a PRI were simulated. Finally, 
for each PT and for each pathology, the VADs implantation was simulated. 
Results: NM can well reproduce PTs baseline. In the case of SD, LVAD in-
creases the cardiac output (CO) (35%) and the arterial systemic pressure (ASP) 
(25%). With cavo-pulmonary assistance (RVAD) a decrease of inferior vena cava 
pressure (IVCP) (39%) was observed with 34% increase of CO. With the BIVAD 
an increase of ASP (29%) and CO (37%) was observed. In the case of DD, the 
LVAD increases CO (42%), the RVAD decreases the IVCP. In the case of PRI, the 
highest CO (50%) and ASP (28%) increase is obtained with an RVAD together 
with the highest decrease of IVCP (53%).
Conclusions: The use of NM could be helpful in this innovative field to evaluate 
the VADs implantation effects on specific PT to support PT and VAD selection.
O3 
TRANSIENT NUMERICAL ASSESSMENT OF THE RISK OF THROMBUS 
FORMATION IN ROTARY BLOOD PUMP
S. Groß-Hardt, A. Ali, U. Steinseifer
RWTH Aachen University, Aachen, Germany
Aim: Thrombus formation and haemolysis associated with the exposure to high 
levels of shear stress, strain rates and stagnation regions remain a challenge 
for rotary blood pumps (RBPs). Numerical prediction of potential risk regions 
for thrombus aggregation, deposition and growth during the cardiac cycle al-
lows for comparative prototype pump evaluation. Therefore, the aim of this 
study is the development of a flow dependent risk factor for the prediction of 
thrombosis in rotary blood pumps and optimization towards a more haemolysis 
and thrombus free design.
Methods: Transient assessment of the pump performance and flow during car-
diac support is achieved using Computational Fluid Dynamics (CFD). A factor 
for the prediction of thrombosis based on the local platelet concentration cal-
culated by various flow induced threshold weighted contributions is derived, 
followed by a risk analysis within the pump. Four significantly different impel-
ler blade and three volute geometries are compared with regard to thrombus 
formation risk.
Results: The results are in good agreement with experimental findings of throm-
bus formations from haemolysis tests, encouraging the application of numerical 
prediction for problematic regions of actual thrombus growth.
Conclusions: This study presents an approach to identify problematic regions 
of thrombosis within a RBP. Furthermore, it allows for the comparative evalua-
tion of risk potential for thrombosis within the pump and is applicable for future 
device optimizations.
O4 
A NOVEL APPROACH TO ACCOUNTING FOR TURBULENCE IN BLOOD 
DAMAGE MODELING
L. Goubergritsa, J. Osmana, R. Meverta, U. Kertzschera, H.-Ch. Hegeb, K. Pöthkowb
aBiofluid Mechanics Laboratory, Charité - Universitätsmedizin Berlin, Germany; 
bZuse Institute Berlin, Germany 
Aim: To account for the impact of turbulence in blood damage modeling a novel 
approach based on the generation of instantaneous turbulent fields generated 
from RANS-simulations is proposed.
Methods: Turbulent flow in a mechanical heart valve was simulated using 
RANS-based (SST k-w) flow solver FLUENT. The Reynolds Shear Stress (RSS) 
field is transformed into a divergence-free random vector field of velocity fluc-
tuations using procedural noise functions. To consider the random course of 
the blood cells, for each time step an instantaneous turbulent flow field was 
computed by adding the turbulent velocity fluctuations and the mean velocity 
at each cell of the computational grid. On this instantaneous flow field, path 
lines and corresponding point-wise instantaneous shear stresses were calcu-
lated. For a comparison, path lines based on mean velocity field and respective 
viscous shear stress together with RSS values were calculated. Finally, blood 
damage index was integrated along the path lines using a power law approach. 
Results: We found that the use of RSS parameter is not appropriate to blood 
damage modeling because RSS overestimates damaging stress and does not 
reflect a distribution of damage in a volume.
Conclusions: RSS should be avoided in blood damage modeling. A novel ap-
proach to calculate blood damage without RSS in RANS based flow simulations 
is established.
O5 
DESIGN OPTIMIZATION OF DIALYSIS CATHETERS USING CFD
D. Galloa, G. Isua, S. Cristofanellia, P. Verdonckb, T.W. Clarkc, U. Morbiduccia
aPolitecnico di Torino, Turin, Italy; bGhent University, Ghent, Belgium; cUniversity 
of Pennsylvania, Philadelphia, USA
Aim: A virtual test bench is set for the evaluation of the fluid mechanics perfor-
mance of new dual lumen catheters for hemodyalisis, using computational fluid 
dynamics (CFD). 
Methods: Eight different catheter designs were evaluated. The risk for throm-
bogenic events was evaluated in terms of shear-induced activation of platelets, 
quantified by a Lagrangian-based model of blood damage (Platelet Activation 
State, PAS). Convection-diffusion equation was solved to quantify the detrimen-
tal recirculation of dialyzed blood from the venous to the arterial lumen. The 
effect of central tip and side holes geometry/position on thrombogenic fluid 
structures was evaluated. 
Results: The analysis of flow separation regions generated by catheters holes 
and of the shear-induced platelet activation in both lumens and in direct and 
inverted configuration allowed to identify critical features in catheters design 
and to rank their performance. Among the main findings: (1) the presence of 
geometric asymmetry reduces the risk of thrombus formation, with number, 
position and dimension of side holes playing a major role; (2) PAS is higher in 
the venous lumen, and in the inverted configuration; (3) recirculation is negli-
gible in all models. In conclusion, this comprehensive comparison allowed to 
select an appropriate design for the device, highlighting the benefits of side 
hole number and their geometric asymmetry in catheter performance. The 
output of the study is an asymmetric catheter design suitable for pre-market 
prototype testing.
DOI: 10.5301/ijao.5000346
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O6 
AN ELECTRICAL ANALOG MODEL FOR LIVER PERFUSION: VALIDATION 
AND CALIBRATION
C. Debbauta, D. Monbaliub, P. Verdoncka, P. Segersa
aGhent University, Ghent, Belgium; bUniversity Hospitals Leuven and KULeuven, 
Leuven, Belgium
Aim: Hypothermic machine perfusion (HMP) is reviving as a better preserva-
tion method for donor livers than the gold standard of cold storage, but faces 
some potential hazards (e.g. endothelial damage, flow competition). For that 
reason, we previously developed an electrical analog model of liver perfusion 
to investigate the effect of different HMP settings. Since its performance was 
not experimentally verified before, we present a new method to validate and 
calibrate the model.
Methods: A human liver (discarded for transplantation after failed reallocation) 
was subjected to pressure-controlled HMP. Pressure and flow waveforms were 
recorded simultaneously at the hepatic artery (HA) and portal vein (PV) dur-
ing varying pressure settings (5-99 mmHg). Signal processing enabled calcu-
lating hydraulic input impedances (Z) based on Fourier analysis. A two-step 
approach, involving reduced p-element Windkessel models, was adopted to 
fit the measured Z spectra (coherence >0.9; 0-10 Hz) to the electrical model 
(unconstrained nonlinear optimization). 
Results: Calibrated Z spectra agreed well with experimentally acquired spectra. 
Notably, results showed that - to date - viscoelastic effects have been largely un-
derestimated in models presented in literature (factor of ±104), speculatively due 
to neglecting the viscoelastic effects of liver tissue surrounding blood vessels.
Conclusions: A novel methodology was developed to calibrate the electrical 
model of liver HMP to one specific liver. Future research may focus on other 
clinical applications (e.g. liver cirrhosis).
O7 
COMPUTATIONAL FLUIDYNAMIC DESIGN OF A NEW ENDOTRACHEAL 
TUBE FOR TOTAL LIQUID VENTILATION
P. Bagnoli, M.L. Costantino
Politecnico di Milano, Milan, Italy
Aim: This work is aimed at designing an instrumented endotracheal tube (ETT) 
dedicated to neonatal Total Liquid Ventilation (TLV) with perfluorocarbons by 
means of computational fluidynamics (CFD). 
Methods: A 3D model of an ETT, interfaced with a model of tracheal bifurcation 
with size typical of preterm infants, was developed. Unsteady-state simulations 
(k-p turbulent model) were performed (Fluent 14.0, ANSYS Inc.) to replicate the 
flow rate pumped by a new TLV prototype (Pro-Li-Ve) developed by our group. 
A lumped parameter model was coupled to the CFD model to simulate realistic 
lung impedance and pulmonary pressure. The fluidynamic effects of different 
positions of the ETT tip with respect to the carina were evaluated to minimize 
wall shear stresses (WSS). The effects of different tip shapes and of the pres-
ence of a pressure transducer in the ETT lumen were also analysed on single or 
double lumen ETTs.
Results: The model allows reliable simulations of the tracheal pressure obtained 
during in vivo trials. Any ETT tips convey the 57% of the flow rate to and from 
the right bronchus. Maximum WSS acts on the internal side of the carina during 
inspiration. A minimum distance (13 mm) between tip and carina is required to 
minimize WSS. The presence of the pressure transducer does not affect airways 
fluidynamics. A double lumen ETT would reduce dead space improving gas 
exchange although increasing in WSS and pressure. 
Conclusions: The use of an ETT designed according to the developed model 
outcomes, instead of commercial ETTs, would be a fundamental step for the 
optimization of the ventilator-patient interface during TLV treatments.
Oral SeSSiOn – CardiaC aSSiSt: ValVeS, O8-O14
O8 
DESIGN OPTIMIZATION OF AN ANATOMICALLY ADAPTED PERCUTANE-
OUS HEART VALVE FOR THE TRICUSPID POSITION
D. Potta, M. Küttinga, U. Steinseifera, R. Autschbachb, J. Spillnerb, A. Amerinib
aInstitute of Applied Medical Engineering, RWTH Aachen University, Aachen, 
Germany; bDepartment of Thoracic and Cardiovascular Surgery, University 
Hospital RWTH Aachen, Aachen, Germany 
Background: The concept of an anatomically adapted tricuspid heart valve 
(THV) prosthesis for percutaneous implantation was developed and assessed 
in an initial proof of principle study. The device consists of two functional 
elements, a Vena cava superior-stent for secure anchoring and a tricuspid annu-
lus-stent containing a THV with pericardial leaflets. The elements are connected 
by flexible struts. Shortcomings of the first design included a difficult positioning 
and insufficient structural stability.
Methods: To address the structural stability of the valve-bearing annulus-stent 
and optimize integration of the valve, the design was altered from 72° to 60° de-
gree symmetry. The number of struts connecting the two stents was decreased 
to three. Strains and stresses were assessed by finite element analyses (FEA) 
for crimping, expansion and interaction of leaflets and stent. The design was 
assessed in porcine hearts from a slaughterhouse to analyze the anatomical fit 
of the new design. The prosthesis was tested in a right heart mock-loop inside 
an anatomically correct silicone model.
Results: The design changes led to better device stability in FEA and in-vitro 
tests. A good anatomical fit was achieved in anatomical fitting studies in porcine 
hearts.
Conclusions: Design optimization successfully addressed the issues of the first 
generation percutaneous THV prosthesis.
O9 
DEVELOPMENT OF A NOVEL MODULAR HEART VALVE PROSTHESIS FOR 
THE PULMONARY POSITION
D. Pott, M. Kütting, U. Steinseifer
Department of Cardiovascular Engineering, Institute of Applied Medical 
Engineering, RWTH Aachen University, Aachen, Germany 
Background: Due to the anatomical variance of the right ventricular outflow 
tract and resulting difficult anchoring, transcatheter pulmonary valve implan-
tation (TPVI) has received little attention. In order to create anatomically fit, 
patient-customized prostheses, a modular TPVI prosthesis consisting of stan-
dardized connectable elements was developed.
Methods: Anatomical studies were performed to define the dimensions of the 
elements needed to provide satisfactory anatomical adaptation. Finite element 
analyses (FEA) were performed using Abaqus/CAE (Simulia, USA) to iteratively 
optimize the mechanical properties. The considered conditions include expan-
sion from a 10 mm nitinol tube during fabrication, as well as the crimping and 
deployment processes. Stent-leaflet interaction was assessed, considering the 
physiological pressure curve in the RVOT during 3 cardiac cycles. The designs 
of the stent frame elements and leaflets were optimized until the strains and 
stresses met acceptable values.
Results: Maximum stresses were 800 MPa for crimping and deployment simu-
lation at 37°C. The design of the central valve bearing element considers the 
need for leaflet integration and their dynamics. Prototypes were manufactured 
by laser cutting and assembled.
Conclusions: Using the approach of iterative stent frame optimization, satisfac-
tory designs of all elements needed to assemble modular customizable TPVI 
prostheses were found.
O10 
THROMBOGENICITY AND BIOCOMPATIBILITY STUDY OF REDUCED 
GRAPHEN OXIDE MODIFIED TISSUE AS A PROMISING VERSATILE 
MATERIAL FOR TISSUE ENGINEERED HEART VALV
P.M. Wilczeka, A. Cyganeka, B. Kubina, R. Majorb, A. Mzyka, L. Lipinskac
aHeart Proststhesis Institute, Zabrze, Poland; bInstitue of Metallurgy and Material 
Science, Krakow, Poland; cInstitute of Electronic Materials Technology, Warsaw, 
Poland 
Aim/Background: The modern tissue engineering, combine the acellular scaf-
folds seeded with cells ex vivo or in vivo. The scaffold should be non throm-
bogenic and biocompatible. The aim of our study was to evaluate the platelet 
activation effect of acellular tissue scaffold, modified by reduced Graphen Oxide 
(rGO). 
Materials/Methods: Graphene oxide was prepared by modified Hummers 
method. For the study the acellular pulmonary valve conduit modified by rGO 
was used. The tissue sample were subjected in vitro to the interaction with 
whole blood in the simulated laminar flow condition. The following receptors 
was analysed: CD42a, CD42b, CD41a, CD40, CD65P and PAC-1. As a refer-
ence the non-coated acellular tissue, Poli-L lysisne and fibronectin coated 
tissue was used. Also the biocompatibility study was tested, for this purpose 
the cytotoxicity test, TUNEL assay and Cell Cycle analysis was performed. 
Results: Platelet activation upon contact with the tissues modified with rGO 
was not significantly different from the level of activation observed in the control 
and reference group. 
Conclusions: The studies indicate that rGO can be very attractive material used 
for the scaffold modification designed to create heart valves bioprosthesis, 
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based on tissue engineering techniques. These studies are necessary to bring 
the composite materials closer to the clinical application.
O11 
DEVELOPMENT OF CUSTOMIZABLE HEART VALVE PROSTHESES FOR 
ACQUIRED AND CONGENITAL DISEASES OF THE RVOT
C. Roseforta, M. Küttinga, D. Potta, S. Schmitza, S. Sonntaga, A. Sedaghatb, 
J. Vodiskarc, U. Steinseifera
aRWTH Aachen University, Aachen, Germany; bUniversity Hospital Bonn, Bonn, 
Germany; cUniversity Hospital of RWTH Aachen, Aachen, Germany
Aim: Acquired and congenital diseases of the right ventricular outflow tract 
(RVOT) are commonly associated with complex anatomies requiring dedicated 
custom prostheses. In order to achieve safe and effective device based treat-
ment options for patients in need of RVOT replacement or repair, the project 
INTER-Heart deals with the design and regulatory approval process of dedi-
cated pulmonary valve and RVOT prostheses, specifically a transcatheter heart 
valve (THV) and a conduit.
Methods: A kit with connectable elements for the assembly of customizable, 
patient specific prostheses was conceived. The elements include a central Niti-
nol valve element with pericardial leaflets, a range of custom Nitinol stentframes 
for anatomical adaptation of the shape and device anchoring of the THV as well 
as a polyurethane vascular graft with sinuses to form a conduit. The process of 
choosing peripheral stentframes to connect to the central element relies on 3D 
analyses of the RVOT based on CT or MRI patient data.
Results: Prototypes of the customizable THV demonstrate the feasibility of the 
concept. Virtual anatomical fitting studies of the patient specific prostheses 
prove the adaptability of the prostheses using standardized elements.
Conclusions: By using a modular system it is possible to develop customized and 
still profitable prostheses. The approval process is facilitated by the lower risks.
O12 
IN VITRO EVALUATION OF A NOVEL AUTOLOGOUS BIOVALVE WITH A 
STENT FOR PULMONARY VALVE
H. Sumikura, Y. Nakayama, K. Ohnuma, Y. Takewa, E. Tatsumi
National Cerebral and Cardiovascular Center, Osaka, Japan
Aim: Using “in-body tissue architecture” technology and a novel method for 
constructing a stent valve, an autologous heart valve-shaped tissue with a stent 
was developed as stent-biovalve. In this study, we evaluated the hydrodynamic 
performances of stent-biovalve by changing its leaflet size in in vitro test in order 
to determine the appropriate stent-biovalve form for pulmonary valve (PV).
Methods: A specially designed stent-mounted cylindrical acrylic mold was 
placed in a dorsal subcutaneous pouch of a goat and the implant was extracted 
1 month later. The acrylic mold was removed and a tube structure of connec-
tive tissue impregnated with the stent strut was obtained. The tube was folded 
in half inwards and 3 commissures were fabricated to form 3 leaflets and we 
obtained the stent-biovalve (25 mm ID). The stent-biovalve was connected to 
a specially designed pulsatile mock circulation in the PV position. The hydro-
dynamic performances of stent-biovalves with 6 different axial leaflet lengths 
(13, 14, 15, 17, 20 and 25 mm) were examined under pulmonary circulation 
conditions using saline.
Results: The leaflet length was found to significantly affect the hydrodynam-
ics of these valves. The stent-biovalve with 15 mm leaflet length demonstrated 
improved flow characteristics compared to others and the flow rate ranged from 
6.2 to 7.6 L/min at a mean PAP of 18 mm Hg as the HR was increased from 
70 to 120 bpm. The regurgitation rate was approximately 11%.
Conclusions: The developed completely autologous stent-biovalve with appro-
priate leaflet size may be potentially useful for PV.
O13 
PREDICTORS OF FUTILE REDO AORTIC VALVE SURGERY REGARDLESS 
OF RISK-SCORES IN TAVI ERA: AN ANALYSIS FROM THE MULTICENTER 
RECORD INITIATIVE
M. Dodonova, R. Abbascianoa, F. Biancarib, G. Mariscalcoc, M. De Feod, A. Messinae, 
F. Onoratia, G. Santarpinof, F. Santinig, E. della Rattad, C. Beghic, G. Nappid, 
G. Troisee, T. Fischleinf, G. Passeroneg, J. Heikkinenb, A. Mazzuccoa, G. Faggiana
aDivision of Cardiac Surgery, University of Verona Medical School, Verona, Italy; 
bDivision of Cardiac Surgery, University of Oulu, Oulu, Finland; cCardiac Surgery 
Unit, Varese University Hospital, Varese, Italy; dDepartment of Cardiothoracic 
and Respiratory Sciences, Second University of Naples, Naples, Italy; eCardiac 
Surgery Unit, Poliambulanza Foundation Hospital, Brescia, Italy; fDepartment of 
Cardiac Surgery, Klinikum Nürnberg, Nuremberg, Germany; gCardiac Surgery 
Unit, San Martino University Hospital, Genoa, Italy
Aim: Redo aortic valve replacement (RAVR) carries higher perioperative risks. 
We aim to identify factors determining early (within 6 months) mortality after 
RAVR defining “futile” surgery, and potentially indicating less-invasive trans-
catheter procedures. 
Methods: Death within 6 months from surgery defines “futile” RAVR. Seven-
hundreds-fourteen patients out of 763 (93.6%) enrolled in RECORD registry 
have a minimum 6-month follow-up or died within 6 postoperative months. 
Predictors of “futility” were identified at multivariate analysis. Classification tree 
analysis with Chi-squared automatic interaction detection (CHAID) method was 
used to identify those categories of patients at “highest-risk” to undergo a futile 
surgery. 
Results: Six-month mortality was 9.9%. Left ventricular ejection fraction (LVEF) 
<30% (p<0.0001, OR 5.85), active endocarditis (p<0.0001, OR 3.58) and aortic 
cross clamping time (XCT) >150’ (p = 0.006, OR 2.47) were predictors of “futile 
surgery” (Hosmer-Lemeshow’s p = 0.892; AUC: 0.71). Independent predictors of 
XCT >150’ were “urgent/emergent” procedures (OR 2.50) and procedures “other 
than RAVR ± CABG” (OR 6.36). CHAID analysis showed active endocarditis as 
the most relevant risk factor, followed by LVEF <30% and XCT >150’ (AUC: 0.71, 
95% CI 0.64-0.78). Endocarditis + LVEF <30% configured the highest risk cat-
egory (56.2% 6-month mortality), followed by endocarditis + LVEF >30% + XCT 
>150’ (36.4% 6-month mortality). Patients without endocarditis but with LVEF 
<30% had 24.0% 6-month mortality, followed by non-endocarditic patients with 
LVEF >30% + XCT >150’ (11.3% mortality). 
Conclusions: Left ventricular dysfunction, complex surgical procedures and 
urgent/emergent indications have unacceptable 6-month mortality, and can be 
better served by TAVI.
O14 
STS-SCORE AND EUROSCORE IN INDICATING VASCULAR ACCESS FOR 
TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI)
A. Kawaguchia,b, J.P. Colleta, P. Cluzela, R. Makria, M. Laalia, C. DeFrancea, 
P. Leprincea
aHôpital de La Pitié-Salpêtrière, Paris, France; bTokai University School of Medi-
cine, Isehara, Japan
Aim: Although TAVI has been indicated for patients with a prohibitive surgical 
risk, indication for or against TAVI becomes increasingly difficult as its vascular 
access evolves surgically more invasive and its results having been improved. 
Methods: We compared STS-scores (STS) and Euroscores (Euro) with survival 
in 194 patients undergoing TAVI during the last 2.5 years, when the vascular 
access has been evolved from iliofemoral (Fm), axillo-subclavicular, apical and 
direct aortic approach. 
Results: Poorer survival after TAVI in patients with a high-risk in Euro or STS 
is natural since these scores portray comorbidities and therefore parallel long-
term survival regardless of surgical intervention. It may be more relevant to 
30-day survival (open circle), which showed no correlation with these scores 
among patients undergoing TAVI via Fm access. Whereas among patients 
undergoing TAVI via an access other than Fm, a high-risk score, STS>40 or 
Euro>20, led a significantly high 30-day mortality; 5 high-risk patients in both 
scoring systems had only 20% (1/5) 30-day survival while 26 patients with a 
low-risk in both systems undergoing TAVI via access other than Fm had 96.2% 
(25/26) 30-day survival rate. 
Conclusions: The result suggest that patients with a low surgical risk may tol-
erate TAVI through any vascular access with an acceptable risk while patients 
with a high-risk (Euro>20 and/or STS>40) may better be treated with Fm access 
without invasive approach.
Oral SeSSiOn – liVer SuppOrt, O15-O17
O15 
EVOLUTION OF MARS: HE MARS
R. Marangoni, G. Bellati, C. Corradi, O. Spinelli
S. Anna Hospital, Como, Italy
Aim: We carried out modifications to MARS (Molecular Adsorbent Recirculat-
ing System) in order to increase its efficiency in hepatic metabolite removal in 
liver failure.
Methods: Patients: 4 affected by liver failure, 2 with high biliruibinaemia (52.50 
and 48.75 mg/dL in patients A and B respectively) and 2 with high bile acid 
serum concentrations (92.0 and 98.5 mMol/L in patients C and D respectively). 
Treatments: 1) a 5-hour session with standard MARS (flows: 220 ml/min for 
blood, 150 ml/min for albumin) (1st S); 2) a session with the same blood and 
albumin flows but modified albumin circuit with parallel double adsorber units 
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(AC 250 and IE 250) (2nd S, HE MARS: High efficiency MARS); 3) a session of 
HE MARS with higher albumin flow (180 mL/min) (3rd S) Analyses: clearances 
of total bilirubin (TB) in A and B and total bile acids (TBA) in C and D, at the 2nd 
and 4th hour of treatment in the albumin circuit; blood TB (in A and B) and serum 
TBA (in C and D) and their reduction rate (RR%) at the beginning and at the end 
of each session.
Results: In HE MARS the clearances of TB and TBA in the albumin circuit were 
markedly higher than in standard MARS. As a consequence, RR% increased 
with HE MARS for both TB (1st S: 27.6-27.9, 2nd S: 52.3-49.1 and 3rd: 55.6-56 
in patient A and B respectively) and TBA (1st S: 40.0-39.9; 2nd S: 59.8-60.0; 3rd S: 
65.1-65.6 in C and D respectively). 
Conclusions: This preliminary investigation demonstrates the possibility of an 
evolution of MARS, joining the high tolerability of the standard method with high 
efficiency in hepatic metabolite removal.
O16
PORTAL BLOOD ARTERIALIZATION WITH AN EXTRACORPOREAL DEVICE 
TO TREAT TOXIC ACUTE HEPATIC FAILURE IN THE SWINE MODEL
A. Zulloa, M. Cannistràa, L. Puviania, G. Cavallaria, E. Bonaiutoa, M. Parialia, B. Nardoa,b 
aCRBa S. Orsola Hospital; bDepartment of Medicine and Surgical Sciences, 
University of Bologna, Bologna, Italy
Aim: The present study aimed to determine whether a controlled portal blood 
arterialization by a liver extracorporeal device, called L.E.O2 NARDO which 
means Liver Extracorporeal Oxygen NARDO, is effective in treating acute liver 
failure (AHF) induced in swine by CCl4 administration.
Materials and Methods: Twenty swine with AHF induced by intraperitoneal 
injection of carbon tetrachloride (CCl4) in oil solution at a dose of 480 mg/Kg of 
body weight were randomly divided into two groups: animals received L.E.O2 
NARDO treatment 48 hours after the intoxication, and swine that were not treat-
ed (control group). Blood was withdrawn from the iliac artery and reversed in 
the portal venous system. An extracorporeal device was interposed between 
the outflow and the inflow in order to monitoring the hemodynamic parameters. 
Each treatment lasted 6 hours. Serum and liver samples were collected in both 
groups. The survival was assessed at 7 days.
Results: L.E.O2 NARDO treatment yielded beneficial effects for CCl4 induced-
AHF swine with decreased transaminases as compared with the untreated 
group. INR recovered rapidly in the L.E.O2 NARDO group remaining significantly 
lower than in untreated animals. The survival of L.E.O2 NARDO group swine 
was significantly higher than that of untreated animals, with a statistically sig-
nificant difference (p<0.05). Eight swine in the L.E.O2 NARDO group survived 
at 5 days from surgery and sacrificed while only two of the swine in the control 
group were alive at that time. 
Conclusions: Arterial blood supply in the portal system through the L.E.O2 
NARDO device is easily applicable, efficacious, safe and may represent a novel 
approach for ALF swine induced by CCl4 intoxication.
O17 
HUMAN PLASMA TOXICITY IN THE AMC-BIOARTIFICIAL LIVER
M. van Wenum, R.A.F.M. Chamuleau, E. Hendriks, R. Hoekstra
Academic Medical Center, University of Amsterdam, The Netherlands
Background and Aim: The AMC-Bioartificial Liver (BAL) facilitates the human 
liver cell line HepaRG. Previously we found that both acute liver failure and 
healthy rat plasma reduced hepatic transcript levels. Here, we studied the effect 
of human plasma on HepaRG cells in monolayer and BAL culture, and investi-
gated the effect of plasma enrichment to test whether the observed damage is 
due to a lack of differentiation stimuli and/or oxidative stress.
Methods: Monolayers and BAL cultures kept in medium (control) were exposed 
to 100% plasma with a mix of antioxidants, a corticosteroid and an urea cycle 
enhancer (plasma+), or without (plasma-). Subsequently, ammonia elimination, 
urea synthesis, and hepatic transcript levels were assessed. In BAL-cultures, 
additionally LDH/AST leakage and lactate elimination were quantified.
Results: Monolayer cultures showed a significant decrease in hepatic transcript 
levels and ammonia elimination, after 16 and 24 hours in both the plasma + 
and plasma – group compared to control. In BAL-cultures (16 h plasma) there 
was a trend towards lower hepatic gene transcription in both plasma groups 
compared to control. This effect was less pronounced in the plasma+ group. 
No change in functionality or cell damage was observed. There was a trend 
towards improved lactate elimination in the plasma+ group compared to the 
plasma- group (p = 0.053).
Conclusions: BAL culturing renders HepaRG cells more resistant to detrimental 
effects of human plasma, which may be caused by oxidative stress and/or lack 
of differentiation stimuli. Plasma enrichment may limit these negative effects.
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O18 
NURSING INNOVATIONS IN CARDIOVASCULAR THERAPIES BY QUALITY 
AND PROJECT MANAGEMENT STRUCTURES AT A UNIVERSITY LEVEL
C. Rosefort, M. Kütting, S. Fiehe, U. Steinseifer
RWTH Aachen University, Aachen, Germany
Aim: Development of novel devices and treatment concepts at a university re-
search level is essential in advancing therapeutic cardiovascular technologies. 
Bridging the gap between early university level device developments and clinical 
application is often complicated by incomplete documentation, disregard of reg-
ulatory requirements and poor organization. The loss of time and knowledge dur-
ing the transfer to an industry standard is costly and detrimental to innovation.
Methods: Quality and project management (QM and PM) were implemented 
in university research. A main focus was placed on technical documentation, in-
cluding design changes and setbacks to adhere to industrial standards. To prove 
the feasibility of the concept, QM and PM processes were incorporated into the 
everyday workflow of specific projects with the aim of clinical application.
Results: Implementation of QM and PM was well tolerated once the benefits 
like shortened processing times, ensured compliance with regulatory require-
ments, and improved sustainability in knowledge were noticeable. Defined 
organizational structures provided more transparency for complex and creativ-
ity-driven projects.
Conclusions: Our experience shows that integration of QM and PM stan-
dards at a university level is possible. It constitutes a solid basis for the trans-
fer to clinical application. Since every research project needs and withstands 
different degrees of QM and PM, an adapted and scalable QM system for 
university research projects is under development based on our findings and 
experience.
O19 
THE CALON MINIVAD – A NEW LVAD WITH SMALL SIZE, MECHANICAL 
SIMPLICITY AND HAEMOCOMPATIBILITY AS DESIGN GOALS 
G.D. Foster
Calon Cardio-Technology, Swansea, UK 
Aim: The Calon MiniVAD™ is a new LVAD that utilises a novel layout to 
potentially improve implantability, manufacturability and haemocompat-
ibility. It is hoped that this will lead to commensurate improvements to the 
device cost and complication rate, improving the overall health-economic 
proposition.
Methods: The MiniVAD comprises a novel ‘T’ shaped layout with a motor ro-
tor incorporated into the inflow cannula (implanted into the LV), and a compact 
centrifugal impeller that (outside of the LV but inside the pericardium). The per-
formance of the MiniVAD has been evaluated in-vitro against a series of well 
established metrics and also against novel assays developed by our group to 
gain better insight into haemocompatibility. 
Results: Current performance, size and haemocompatibility results are:
Power: <1 W/l/m @ 100 mmHg
Hydraulic characteristic: 0-8 L/m average flow range with ‘flat’ HQ curve (low 
shut off pressure and good preload/afterload sensitivity).
Physical size: <100 g weight; 15 mm depth x 35 mm diameter package (outside 
of heart, inside pericardium); 30 mm length x 22 mm diameter inflow cannula 
(implanted into LV). 
Haemolysis: <0.002 g/100 L NIH. (bovine blood, 6 hrs loop test, 500 ml loop, 5 l/m)
Platelet activation: 11% compared to 9% in CentriMag and 6% in static control. 
(bovine blood, 6 hrs loop test, 500 ml loop, 5 l/m) 
Leukocyte damage: 8% compared to 5% in Centri Mag and 6% in static con-
trol. (bovine blood, 6 hrs loop test, 500 ml loop, 5 l/m)
Conclusions: The haemocompatibility of the small, implantable MiniVAD is 
comparable to larger, extra-corporeal blood pumps such as the CentriMag and 
the Rotaflow. Further in-vitro evaluations are ongoing and in-vivo evaluations 
are planned for quarter four 2014.
O20 
DEVELOPMENT, VALIDATION AND USE OF A CFD MODEL FOR ITERATIVE 
DESIGN IMPROVEMENT OF THE CALON MINIVAD
A. Moltenia, K. Frasera, H. Yousefb, K.W.Q. Lowb, S. Rollandb, G. Fostera
aCalon Cardio- Technology Ltd; bSwansea University, Swansea, UK
Aim: Develop and validate a computational fluid dynamics (CFD) model of the 
Calon MiniVAD, and use it to produce an impeller design with a flat pressure–
flow (HQ) curve, maximum efficiency (η) and minimal shear stress.
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Methods: A set of impellers were designed and built with identical blade 
shapes, but with differing heights. Flow domains were extracted from 
the CAD drawings and meshed. ANSYS CFX was used to calculate the 
blood flow. A discretization study was performed, and the effects of 
pressure-pressure vs pressure-flow boundary conditions, steady vs tran-
sient, time step and residuals sizes have been analysed. Flow fields were 
then calculated at points along the HQ curve and the estimated pres-
sure heads were compared with those measured in an experimental flow 
loop. The validated numerical model was then used to implement a se-
ries of design improvements on the blade (shape, length, width, outlet/ 
inlet angle and number) and on the rotor geometry, volute, outlet pipe and 
secondary flow.
Results: As the height of the blades on the initial impellers increased from 
1.5 to 4.5 mm the speed to reach the design point (100 mmHg and 5 l/min) 
decreased from 5,900 to 5,000 rpm. Characteristics at 10 l/min were: 
H<35 mmHg and η<12%. After the changes the design speed was reduced 
(4150 rpm) and the HQ curve was significantly flatter: at 10 l/min, H = 70 mmHg 
and η = 32%. Additionally pressure loss and shear stress have been 
decreased.
Conclusions: A validated numerical model of the Calon MiniVAD has been de-
veloped and used to improve the characteristics of the pump.
O21 
NUMERICAL SIMULATION OF A ROTARY PISTON TYPE TOTAL ARTIFI-
CIAL HEART FOR THE DEVELOPMENT OF A NOVEL DRIVE AND BEARING 
CONCEPT
S.J. Sonntaga, J. Wappenschmidta, A. Goetzenichb, U. Steinseifera, R. Autschbachb
aInstitute of Applied Medical Engineering, RWTH Aaachen University, Aachen, 
Germany; bDepartment of Cardiothoracic and Vascular Surgery, RWTH Aachen 
University Hospital, Aachen, Germany
Aim: In our concept study, a rotary piston pump is designed and evaluated 
for the use as Total Artificial Heart (TAH). The rotary piston design offers a 
pulsatile blood flow along with no need of heart valves. To support the devel-
opment of a novel drive and bearing concept of the TAH design, a robust and 
efficient numerical Fluid-Structure-Interaction (FSI) model was developed. 
The simulation was used to identify the forces and momentums which must 
be applied to the rotary piston to meet the hydraulic needs for circulatory 
support.
Methods: The Immersed Boundary Method (IBM) was applied to simulate 
the piston motion. The model involves two immersed meshes (solid and 
fluid). During solving, the region of intersection is determined and the veloc-
ity inside the solid domain is constrained by applying a momentum source 
term. 
Results: The hydraulic forces and momentums were concluded as the cause 
from the effect of the pressure and flow profiles and plotted as a function of the 
position of the rotary piston.
Conclusions: The proposed IBM method provides a robust and efficient al-
ternative to computationally heavy and unstable mesh deforming techniques. 
Based on the simulation results, it was possible to determine the requirements 
for a suitable drive and bearing solution. Furthermore, critical locations in the 
design for hemolysis and thrombogenicity were identified and design optimiza-
tion was performed accordingly.
O22 
CIRCADIAN PUMP FLOW VARIATION IN ROTARY BLOOD PUMP RECIPIENTS
M. Graneggera,b, T. Schlöglhoferab, L. Muralidharana, D. Zimpfera, H. Schimaa,b, 
F. Moscatoa,b
aMedical University of Vienna, Vienna, Austria; bLBC for Cardiovascular Research, 
Vienna, Austria
Aim: Overstimulation of the sympathetic system is typical for end-stage heart 
failure patients. For this reason the physiological circadian hemodynamic vari-
ability is diminished. Aim of this study was to investigate the circadian variability 
and long-term trends of the pump flow in the first 22 weeks after rotary blood 
pump (RBP) implantation.
Methods: In 20 RBP patients, estimated pump flow and speed signals, sam-
pled every 15 minutes, were collected. The circadian variation in the pump flow 
signal was quantified by fitting a sine wave to each day’s pump flow signal and 
by determination of its amplitude. For the long-term trends, mean pump flow 
was calculated for each day.
Results: Mean hospital stay after implantation was 36 ± 10 days. Circadian 
variation in pump flow increased significantly during this first 5 weeks from a 
daily variation of 0.42 ± 0.16 L/min to 0.63 ± 0.25 L/min. After hospital discharge 
the mean circadian variation did not change significantly and was between 0.49 
to 0.62 L/min. Mean pump speed did not change substantially throughout the 
whole observation period (range: 2760 to 2810 rpm), mean pump flow was be-
tween 5.2 and 5.5 L/min.
Conclusions: Circadian pump flow variability increased in the first 5 weeks 
after RBP implantation. This could indicate post-operative improvement of 
the cardiovascular function, which remains quite stable afterwards. However, 
it must be noted that the circadian rhythm could also be influenced by the 
daily physical activity which increases especially around the initial hospital 
discharge.
O23 
VALIDATION OF THE ACCELERATED DURABILITY TESTING OF A TAH’S 
MEMBRANE
F. Gräf, R. Roßbroich, S. Schmitz, T. Finocchiaro, U. Steinseifer
Department of Cardiovascular Engineering, Institute of Applied Medical 
Engineering, RWTH Aachen University, Germany
Aim: The most critical component regarding the risk of the ReinHeart total ar-
tificial heart (TAH) is the biocompatible membrane, which separates the drive 
unit from the ventricles. Hence a durability tester was designed to investigate 
its required 5 year lifetime. The aim of this study was to prove the validity of 
accelerated testing of this polyurethane membrane. Those in vitro tests are 
necessary, because animal trials will not permit sufficient prediction about a 
TAH’s lifetime.
Methods: The durability tester allows simultaneous testing of 12 membranes 
under physiological conditions. To accelerate the time of testing it operates with 
an increased speed at a frequency of 8 Hz. To prove the correctness of this 
acceleration, a servo-hydraulic testing machine was used to study the effect of 
different frequencies and their corresponding forces. Therefore the viscoelastic 
behaviour of the polyurethane could be investigated. Additionally, high-speed 
video measurements were performed.
Results: The force against frequency and the high-speed video measurements 
showed constant behaviour. In the range of 1 to 10 Hz the maximum resulting 
forces varied by 3% and the membrane movement was identical. A reduction 
of the membranes’ reset force from 8 N to 4.5 N after 220 million cycles was 
detected.
Conclusions: Frequencies below 10 Hz allow a valid statement of the mem-
brane’s mechanical durability in the TAH. Viscoelasticity of the polyurethane in 
the considered frequency-range is negligible. The accelerated durability test is 
applicable to polyurethane membranes.
O24 
A HYBRID CARDIOVASCULAR SIMULATOR AS TEST BENCH FOR VAD 
AUTOREGULATION CONTROL
L. Fresielloa, K. Zielin´skib, G. Tortorac, R. Fontanac, A. Di Molfettaa, G. Ferraria, 
M. Silvestric, M. Vatteronic, M.G. Trivellaa, M. Darowskib, P. Darioc, M. Kozarskib
aIFC CNR Rome-Pisa, Italy; bIBBE PAS, Warsaw, Poland; cSSSA, Pisa, Italy
Aim: Continuous flow ventricular assists device (VAD) drew the attention to VAD 
speed control development and testing. Aim of this work is to demonstrate the 
effectiveness of a hybrid (hydro-numerical) simulator (HCS) as a test bench for 
VAD autoregulation control.
Methods: The HCS is a computational cardiovascular model in which the 
left atrium and ascending aorta are connected in real time with the hydraulic 
part (impedance transformers). This permits to physically connect a Circulite 
Synergy® Micropump and to reproduce the HCS-VAD interaction in real time. 
The resulting inlet and outlet VAD pressures and VAD flow are sent to the ARU 
as inputs. This latter is a FPGA-based control unit allowing to adjust VAD speed 
remotely via Bluetooth or to automatically control VAD speed in order to keep 
VAD flow constant.
Results: HCS was used to reproduce an ischemic cardiomyopathy, the ARU 
was tested activating the VAD from 20000 to 26000 rpm via Bluetooth. Sec-
ondly, the ARU flow control was activated to 2 l/min and tested on the HCS 
reproducing ischemic cardiomyopathy, systemic hypertension and then hy-
potension. This caused a change of VAD afterload (74-94-49 mmHg) inducing 
ARU to automatically change VAD speed (25000-26000-24200 rpm).
Conclusions: The HCS, thanks to the connection to a real VAD and the repro-
duction of different pathologies, is a valid tool for testing different VAD speed 
control algorithms.
Acknowledgments: The work was supported by the SensorART (N. 248763) 
project.
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O25 
ELECTROSPINNING OF SMALL DIAMETER VASCULAR PROSTHESES 
WITH FREELY ORIENTABLE FIBER DIRECTIONS
C. Grasla,b, M. Stoibera,b, V. Hörmanna, H. Bergmeistera,b, H. Schimaa,b
aMedical University of Vienna, Vienna, Austria; bLudwig Boltzmann Cluster for 
Cardiovascular Res., Austria
Aim: Conventional electrospinning suffers from uncontrolled fiber deposition. 
However, an increased control of fiber deposition would be beneficial for the 
fabrication of small diameter vascular prostheses to match the mechanical 
properties of the host vessel.
Methods: Vascular prostheses with an inner diameter of 2 mm were manufac-
tured from a polyetherurethane by our recently developed “dynamic deflection” 
electrospinning method. Four types of prostheses with longitudinal, circum-
ferential, random and 30° fiber orientation were fabricated. Orientation effects 
were examined by optical means in the scanning electron microscope and by 
measuring the radial compliance of these constructs in the physiological range. 
Results: Although complete straightness of the fibers was not achieved yet, 
macroscopic fiber alignment in the predominant direction of each selected ori-
entation angle was observed. The grafts with longitudinal fiber orientation had 
a compliance of 15.6 ± 3.2%/100 mmHg, whereas the prostheses with circum-
ferential orientation exhibit the lowest compliance of 6.1 ± 0.9%/100 mmHg. 
The prostheses with random and 30° fiber orientation were inferior to the lon-
gitudinal grafts.
Conclusions: The intrinsic charges of the electrospinning jet were used to con-
trol the electrospinning jet and to fabricate small diameter vascular prostheses 
with pre-defined fiber orientations.
O26 
LIPOSOME-ENCAPSULATED HEMOGLOBIN PRESERVES VO2 AND PRO-
TECTS MYOCARDIUM AFTER MYOCARDIAL ISCHEMIA/INFARCTION AS 
A BIOLOGICAL ASSIST IN THE RAT
A. Kawaguchia, M. Yamanob, H. Furuyaa
aTokai University School of Medicine, Isehara, Kanagawa, Japan; bOsaka Prefec-
ture University, Habikino, Osaka, Japan
Aim: We tested the hypothesis that liposome-encapsulated hemoglobin (LEH) 
increases blood O2 content and maintains VO2 even at low cardiac output 
(LOS), simultaneously preserving hemodynamics and myocardium as assisting 
medication. 
Methods: Effect of LEH was tested in 52 rats undergoing myocardial ischemia 
for 40 min and reperfusion for 40 min. Rats were randomly assigned to 3 groups 
after pretreatment with 10 mL/kg of LEH with high O2-affinity (P50 = 10 mmHg, 
n = 19), homologous RBC at the same amount as hemoglobin (RBC, n = 15) or 
saline (SL, n = 18). Cardiac function was determined by monitoring pressure- 
volume relationship, inspiratory and expiratory O2 and CO2 gas analyses, 
A-V blood gas analyses and evaluating endpoint immunohistochemically- 
determined area of myocardial infarction.
Results: After myocardial ischemia, stroke volume, ejection fraction, stroke 
work and cardiac output (CO) bounced back better in SL and RBC groups than 
LEH-treated rats, in which these variables remained suppressed during isch-
emia and reperfusion. The suppression in hemodynamic variables became sig-
nificant in LEH rats compared with the SL group 20 and 40 min after reperfusion, 
when CO reversely correlated with A-V O2 difference as if to keep their prod-
ucts, or VO2 constant among the groups. LEH rats had a significantly smaller MI 
area (9.7 ± 9.1 mm2, P<0.05) than SL (20.8 ± 6.2 mm2) or RBC-treated animals 
(26.4 ± 14.2 mm2). 
Conclusions: The results suggest that LEH pretreatment may preserve VO2 and 
spare cardiac compensation that further aggravates ischemia, thereby preserving 
myocardium undergoing ischemia and reperfusion, suitable for treating LOS and 
priming for mechanical ventricular assist device (VAD) as biologic assistance.
O27 
A SECOND-LOOK AT NERVE REGENERATION BY ARTIFICIAL NERVE-
GUIDES IN HUMAN UPPER LIMB
A. Merolli, L. Rocchi, L. Mingarelli, A. Morini
The Catholic University Gemelli Medical School, Orthopedic Institute, Rome, Italy
Aim: Macroscopic observations of nerve regeneration in humans are rare. 
However, nerve-gap-injuries may be associated with lesions in other structures, 
like tendons or bones. In these cases, it is common to plan a second surgery 
to improve functional recovery. We exploited these second surgeries for the 
purpose of studying nerve regeneration in Humans.
Methods: We assessed the clinical outcome of 50 implants of collagen-
based nerve-guides, which were implanted in the upper limb. We performed a 
“second-look” of 20, assessing macroscopically both nerve regeneration and 
collagen degradation.
Results and Conclusions: 1) pain was never recorded in these patients; 2) an 
adequate sensory recovery took place whenever a nerve-regenerate was found 
inside the guide; 3) motor recovery seemed to occur only when gap-lesion was 
shorter than 10 millimeters; 4) the degree of degradation appeared to be vari-
able and not directly correlated with time; we make the hypothesis that it could 
be associated with the site of implantation.
O28 
EFFECTS OF DES-ACYL GHRELIN ON VASCULAR CELLS
F. Boccafoschi, M. Botta, L. Fusaro, M. Ramella
Università del Piemonte Orientale “A. Avogadro”, Novara, Italy
Aim: Ghrelin is a 28-amino acid peptide existing in two major forms: n-Octanoyl- 
modified Ghrelin and Des-Acyl Ghrelin (DAG), an identical peptide in which the 
third amino acid serine is not acylated. Recently, ghrelin role in cardiovascular 
functionality has been discovered. Our work is focused on effects of DAG on 
vascular smooth muscle cells (VSMCs) and endothelial cells (ECs). In particular, 
the role of DAG on cell proliferation and differentiation, and also the anti-calcify-
ing effect on VSMCs, have been studied.
Methods: VSMCs and ECs were isolated from porcine aorta and cultured with 
10-7 M DAG. Western Blot analyses were performed in order to evaluate the ex-
pression of proliferation and differentiation cell markers (PCNA, Myogenin and 
eNOS). Moreover, Real Time PCR was performed to evaluate the expression 
of the Osteocalcin gene (BGLAP). The anticalcifying effect was evaluated 
through a calcein assay on VSMCs cultured in calcifying medium with and with-
out 10-7 M DAG.
Results: Western Blot analysis showed the ability of DAG in controlling VSMCs’ 
proliferation while the expression of PCNA on ECs was not affected by DAG. 
VSMCs contractile phenotype was not affected by the presence of DAG, while 
ECs showed eNOS up-regulation in the presence of DAG. The expression of the 
BGLAP gene decreased in the presence of DAG with respect to control. Calcein 
assay confirmed the results.
Conclusions: Our work suggests an important role of DAG on VSMCs and ECs 
phenotype preservation. Moreover, also as an anti-calcifying effect for VSMCs 
has been established.
O29 
AMNIOTIC FLUID STEM CELLS AND CHRONIC KIDNEY DISEASE
S. Sedrakyana, S. Da Saccoa, A. Petrosyana,b, K.V. Lemleya,b, R.E. De Filippoa,b, 
L. Perina,b
aChildren’s Hospital, Los Angeles, USA; bUSC, Los Angeles, USA
Aim: Alport Syndrome (AS) is characterized by a hereditary form of glomeru-
lonephritis, wherein an abnormal level of glomerular basement membrane is 
produced, gradually leading to interstitial fibrosis and eventual loss of renal 
function. At present, there is no definitive therapy to delay progression of re-
nal failure. Current therapeutic options are limited to ACE inhibitors, dialysis 
and eventually transplantation, with end result that is far from being adequate. 
Stem-cell based therapies may provide alternative therapeutic opportunities. In 
this study we evaluate the role of amniotic fluid stem cells (AFSC) in a mouse 
model of AS.
Methods: AFSC were administered and blood and urine samples were ana-
lyzed for renal function. Kidneys were harvested at different time points and 
processed for histologic and molecular evaluation.
Results: Injected animals presented increased life span and lower albumin-
uria, creatinine and BUN along with lower levels of inflammatory cytokines. 
AFSC stimulated activation of M2 macrophages, involved in tissue remod-
elling. While preserving podocyte number, AFSC do not differentiate into 
podocytes and do not stimulate production of collagen IVa5, suggesting a 
paracrine/endocrine mechanism of action through modulation of the renin-
angiotensin system.
Conclusions: AFSC are capable of slowing down the progression of AS by in-
curring structural and functional benefits to the kidney. These cells may present 
an alternative approach to treat medical conditions where currently therapeutic 
options are either limited or inadequate.
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O30 
CREATION OF A BLOOD DAMAGE EVALUATION “HANDBOOK” – A SUITE 
OF IN VITRO HAEMOCOMPATIBILITY TESTS FOR VENTRICULAR ASSIST 
DEVICES
I.L. Piepera,b, C.H.H. Chana,b, R.J. Hamblya,b, G.N. Radleyb, A. Jonesb, 
K.M. Hawkinsa, G.D. Fosterb, C.A. Thorntona
aSwansea University, Swansea, United Kingdom; bCalon Cardio-Technology 
Ltd, Swansea, United Kingdom
Aim: Our goal is to develop a comprehensive suite of blood damage testing 
methods that together amount to a handbook for the assessment of the overall 
in vitro safety profile beyond the standard haemolysis tests currently used. This 
could be used to optimise the design of blood-handling devices such as ven-
tricular assist devices (VADs).
Methods: Multicolour flow cytometry (MFC) methods have been developed 
for: platelet activation, von Willebrand factor (vWF) activity as well as leukocyte 
viability/activation and microparticle formation. Biochemistry methods measure 
haemolysis and the contact-activation pathway of the coagulation caused by 
surfaces in the VAD. Finally immunoblotting is used to assess the degrada-
tion of high molecular weight vWF multimers. Absolute counting methods have 
been developed to quantify changes in the flow cytometry tests. All methods 
are developed from a multi-species approach for human/ bovine/ovine/porcine 
blood to cover species normally used in the pre-clinical validation phase and 
to ensure results translate to the clinic. Species-specific differences are identi-
fied to ensure we chose the optimal species for the pre-clinical verification. The 
main instrument platform used is MFC because it is easily quantifiable, rapid 
and uses minimal sample volumes and all assays are validated using controlled 
levels of shear stress in rheometers. 
Results: We have results that enable us to clearly show differences in haemo-
compatibility between different blood pumps including RotaFlow, VentrAssist, 
CentriMag and the Calon MiniVAD.
Conclusions: In summary, we herein present an approach to obtain a substan-
tially better insight into damage to blood cells and proteins during in vitro testing 
of VADs.
O31 
FULL FACTORIAL MULTIVARIATE ASSESSMENT OF THE EFFECT OF 
PUMP GAP DESIGN PARAMETERS ON BLOOD TRAUMA
R. Graefe, U. Steinseifer
RWTH Aachen University, Aachen, Germany
Aim: Adverse events like bleeding, hemolysis and thrombosis are associated 
with the washout of pump gaps of rotary blood pumps (RBP). The aim of this 
study is to understand the quantitative effect of design parameters of pump 
gaps on blood trauma.
Methods: The flow in an axial gap is determined by the length, diameter, clear-
ance, rotational speed, pressure difference and a poten tial force moving the 
impeller to an eccentric position. Assuming val ues for an LVAD, a full factorial 
investigation leading to 64 configurations was con ducted by predicting the flow 
numerically. Due to the lack of eccentricity, 32 of 64 configurations are (Taylor-)
Couette flows. A particle-based Lagrange-approach was employed estimating 
trauma and combing stress and residence time. Statistical significance was 
assessed by pooling effects of multi-factor interactions and quantifying the 
variance.
Results: The results correspond well to published experimental findings of 
comparable configurations of (Taylor-)Couette flows. Based on the experimental 
design, 34% of a statistical total damage is due to the gap size. Surprisingly, the 
pressure affecting the residence time plays an important role with 18% whereas 
the effect of a force (eccentricity) is not significant. Moreover, the relative ef-
fect of the diameter is more important than speed and gap size. Eight 2-factor 
interactions show significant results indicating the need to consider interde-
pendencies.
Conclusions: The results yield substantial insight into the importance of design 
parameters for gaps in RBP. Further experimental investigations are planned 
to confirm and render the findings more precisely. The study suggests that an 
elaborate design of pump gaps can reduce adverse events and improve the 
patient’s quality of life.
O32 
WALL SHEAR STRESS MEASUREMENTS IN A HEART MATE II VAD AT 
MULTIPLE STATES OF OPERATION
C. Schülea, M. Lommela, B. Blümelb, K. Affelda, U. Kertzschera
aBiofluid Mechanics Laboratory, Charité Universitätsmedizin Berlin, Berlin, 
Germany; bChair of Fluid Dynamics, Hermann-Föttinger-Institut, Technische 
Universität Berlin, Berlin, Germany
Aim: During clinical application, blood pumps such as ventricular assist devices 
(VAD) can cause blood damage and thrombus formation due to shear loading of 
the blood. These adverse events occur mostly in the vicinity of walls. The objec-
tive is to assess the wall shear stress vector fields with an optical flow measure-
ment method. This is taken as an indicator for the blood damaging potential, 
which is a function of the flow rate and rotational speed.
Methods: An upscaled model of a Heart Mate II VAD is investigated, which 
is based on the dimensions of an explanted HM II blood pump. The model is 
upscaled 3:1 in order slow down velocities. The wall particle image velocimetry 
(Wall-PIV) method permits to track particles moving with the flow close to the 
wall. From this movement wall shear stress can be assessed. In order to vali-
date the assumed similarity between the original and 3:1 upsized model, throttle 
curves at three rotational speeds were estimated and compared applying Reyn-
olds and Euler similarity. 
Results: The comparison of the 1:1 and 3:1 throttle curves using Reynolds and 
Euler similarity indicate that the 3:1 upscaled model yields similar flow. The wall 
shear stress data are consistent and show good agreement with computational 
fluid mechanics on a corresponding HM II.
Conclusions: This work demonstrates that the wall-PIV method can be used 
to obtain meaningful data at different states of operation of a commercially 
available LVAD. 
O33 
A NEW COUETTE SHEARING DEVICE FOR THE INVESTIGATION OF 
SHEAR-INDUCED BLOOD DAMAGE
M. Lommel, K. Affeld, U. Kertzscher
Biofluid Mechanics Laboratory, Charité – Universitätsmedizin Berlin, Berlin, 
Germany
Aim: Shear induced blood damage is the cause for complications in the clini-
cal use of rotary blood pumps. Blood damage is known to be dependent on 
shear forces and exposure time. Both are highly dynamic and repetitive in blood 
pumps. Different concepts of Couette flow devices have been used to simu-
late the shear experienced by the blood. However, these investigations were 
focused on long exposure times and single stress exposure. Objective of this 
study is the design and experimental use of a device, which permits short expo-
sure times of 25 ms and repeated use.
Methods: A rotational Couette flow chamber has been developed with a rotating 
outer cylinder to avoid Taylor vortices. The ranges of shear rates and exposure 
times were determined by Computational Fluid Dynamics (CFD) simulations 
of current blood pumps (Thoratec HeartMate II, Heartware HVAD). Geometric 
models have been obtained by dimensional measurement of explanted pumps.
Results: The shear device has a gap of 180 µm between two coaxial hollow 
cylinders and a diameter of 60 mm. It holds a blood sample of 4 ml. The outer 
cylinder is made of silicon coated precision glass. The inner cylinder is made 
of stainless steel. The drive is achieved by using torsion bars. By changing the 
number and twist angle of the torsion bars the stress exposure can be varied. 
With this shear device a field of high dynamic stresses in the range of these 
determined in the CFD simulations can be realized.
Conclusions: With the shear device concept highly dynamic and repetitive 
stresses as occurring in rotary blood pumps can be realized.
O34 
INVESTIGATION OF THE FLOW IN AN AXIAL BLOOD PUMP WITH THE 
PAINT EROSION METHOD
B. Mönnicha, T. Karakayaa, B. Blümelb, K. Affelda, U. Kertzschera
aBiofluid Mechanics Laboratory, Charité – Universitätsmedizin Berlin; bChair 
of Fluid Dynamics, Hermann-Föttinger-Institut, Technische Universität Berlin, 
Berlin, Germany
Aim: Pump thrombosis and thromboembolic events are serious complications 
related to the clinical use of ventricular assist devices (VAD) and are also seen in 
the Thoratec© HeartMate IITM VADs (8.4% after 3 months reported by Starling et 
al 2014). Thrombus formation is likely to happen in flow separation and stagna-
tion zones. Objective of our study was to assess the near wall flow of the device. 
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This is achieved experimentally with the paint erosion method. Also, computa-
tional fluid dynamics (CFD) simulations were performed.
Materials and Methods: From an explanted VAD a CAD model was estab-
lished, fabricated scaled up three times and integrated in an experimental 
setup. The surfaces of flow straightener, rotor and stator were painted with a 
mixture of turpentine and oil-paint. In accordance with the similarity laws, dif-
ferent operating points corresponding to physiological pressure build-ups were 
investigated. A run of 6 min was recorded with a video camera. In addition, the 
pump was investigated by transient numerical simulations using sliding mesh 
and a k-omega SST turbulence model.
Results: With the paint erosion method typical flow patterns on the pump sur-
face could be visualized. A recirculation zone downstream the flow straightener 
was identified. The experiments are in good agreement to the CFD results. 
Conclusions: Recirculation regions in a HeartMate II model were shown experi-
mentally by the paint erosion method and CFD calculations. These regions may 
be prone to thrombus formation.
O35 
IN VITRO THROMBOSIS RESULTING FROM SHEAR RATE AND BLOOD 
COAGULABILITY
O. Maruyamaa, R. Kosakaa, M. Nishidaa, T. Yamanea, E. Tatsumib, Y. Taenakab
aNational Institute of Advanced Industrial Science and Technology (AIST), 
Tsukuba, Japan; bNational Cerebral and Cardiovascular Center, Suita, Japan
Aim: In vitro antithrombogenic testing with a mock circulation is a useful pre-
evaluation for an ex vivo testing of a mechanical assist devices. In order to es-
tablish the in vitro testing, we have been making clear a quantitative thrombosis 
model resulting from shear rate and blood coagulability using a rheometer, and 
apply to experimental conditions of the in vitro testing. 
Methods: Bovine blood was used as a testing blood, and the activating clotting 
time (ACT) was adjusted with trisodium citrate and calcium chloride from 200 to 
1,000 s, and applied to a rheometer followed by sheared at between 100 and 
2,880 s-1. Blood coagulation time and the amount of thrombus was measured 
by the torque sensor of the rheometer. Prothrombin time (PT) and activated 
partial thromboplastin time (APTT) of the testing blood were also measured after 
sheared.
Results: The blood coagulation time increased and the degree of thrombus 
amount decreased, with an increase of shear rate at between 50 and 2,880 s-1 
for the testing blood with an ACT of 200-250 s. Then, the ACT of 200-250 s is 
considered to be appropriate coagulability condition for in vitro antithrombo-
genic testing under shear rate of 2,880 s-1. APTT prolonged while PT did not 
change with the increase of shear rate, that is, shear rate to reduce thrombosis 
related to the intrinsic clotting system. 
Conclusions: The ACT between 200 and 250 s was suitable condition for the 
in vitro antithrombogenic testing, and the increasing shear stress generated in 
the mechanical assist devices reduce thrombosis through the intrinsic clotting 
system.
O36 
A NEW APPROACH FOR SEMI-EMPIRICAL MODELLING OF MECHANICAL 
BLOOD DAMAGE
A. Poorkhalila,b, G. Amoabedinyb, A. Kashefia, M. Behbahanic, K. Mottaghya
aInstitute of Physiology, ECC Lab., RWTH University, Aachen, Germany; 
bResearch Center for New Technologies in Life Science Engineering, University 
of Tehran, Tehran, Iran; cUniversity for Applied Sciences, Aachen, Germany
Aim: Evaluation of blood trauma in devices e.g. internal artificial organs, is con-
sidered as one of the major parameters for modelling and designing. The current 
models, Continuous and Threshold models are defined based on empirical cor-
relations. Also recently introduced two alternative semi empirical models (SEM) 
which are based on a “physical” problem description, demonstrate still devia-
tion in comparison with experimental data. Here we introduce a modified semi-
empirical approach in order to get closer to the already achieved experimental 
data on red blood cell (RBC) trauma.
Methods: A combined SEM is here applied as haemolysis caused by a) mem-
brane permeation of RBC and b) membrane breakdown. This is defined as a 
weighted average damage index of both permeation and non-uniform threshold 
models. For experimental validation, we developed a high shear Couette device 
using native blood.
Results: The results demonstrate that here presented model predicts, by taking 
the dominated phenomena into account in a wide range of shear stress i.e. up 
to 610 Pa, a high fitting behaviour toward the experimental data. Furthermore, it 
is shown that the consideration of simultaneous effect of physical phenomena 
minimizes the deviations down to 5%. 
Conclusions: Analysis of the presented model confirms its potential applicabil-
ity for the prediction of blood damage in connection with development of blood 
contacting devices or artificial organs.
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O37 
INFLUENCE OF SURFACE ROUGHNESS PARAMETERS ON MG63 CELL 
VIABILITY: A STUDY ON LASER MICROTEXTURED Ti6AL4V SURFACES
S. Mukherjee, S. Dhara, P. Saha
Indian Institute of Technology, Kharagpur, India
Background: Surface roughness of biomedical implants is important in deter-
mining the biocompatibility of the implant. Average roughness (Ra) is the most 
commonly used surface roughness parameter, but it does not describe the ex-
act nature of roughness of the surface. Though a range of the average surface 
roughness has been identified to be suitable for implants, often contradictory 
results show up. In this study, laser microtextured surfaces have been studied 
to find out the correlation between MG63 cell viability and different 3d surface 
roughness parameters.
Methods: Laser microtexturing was done on Ti6Al4V surface to create grooves 
with ~20 µm depth, ~200 µm width. MG63 cells were cultured on three types 
of microtextured surfaces, which had similar Ra value. Cell counts after 3 and 
5 days, found from MTT assay, were correlated with the 3d surface roughness 
parameters like skewness, kurtosis etc. 
Results: Statistical analysis showed that kurtosis is the most influential param-
eter for cell adhesion in case of surfaces having similar Ra. Projected area ratio, 
skewness, etc. also had strong correlation with cell viability.
Conclusions: Higher kurtosis value means sharp peaks are present at the sur-
face profile. As a result, surface charge density will be higher in the peaks, which 
may lead to adherence of cells to those peaks. This can be a possible explana-
tion of the higher adherence of cells to the surfaces with higher kurtosis, as 
found in this study.
O38 
GENERATION OF HIGHLY PURE PHYSIOLOGICALLY AND PHARMACO-
LOGICALLY FUNCTIONAL SINUS-NODAL-BODIES FROM PLURIPOTENT 
STEM CELLS 
J. Junga, C. Rimmbacha, B. Hussec, J. Stieberb, G. Steinhoffa, A. Dendorferc, 
W. Franzc, R. Davida
aUniversitätsmedizin Rostock, Rostock, Germany; bUniversität Erlangen, Erlangen, 
Germany; cLudwig-Maximillian-Universität, München, Germany
Aim: The “sick sinus syndrome” comprises pathological, symptomatic sinus 
bradycardia, sinoatrial block, sinus arrest as well as the tachycardia-brady-
cardia syndrome. Therapy relies on electrical pacemakers. However, the latter 
lacks hormone responsiveness and bears hazards such as infections and bat-
tery failure. This may be overcome via “biological pacemakers” derived from 
pluripotent stem cells (PSCs). 
Methods: Our group has previously shown that “forward programming” of 
pluripotent stem cells towards specific cardiomyocyte sub-types is feasible 
via overexpression of distinct early cardiovascular transcription factors such 
as MesP1 (early/intermediate type cardiomyocytes) and Nkx2.5 (ventricular 
cells). In order to generate pacemaker cells, we used the T-box transcrip-
tion factor Tbx3, as it is required for normal size and function of the sino-
atrial node (SAN). Tbx3 is a transcriptional repressor acting to suppress 
the atrial myocyte phenotype and therefore specifying SAN versus atrial 
cells.
Results: Here, we first demonstrate directed differentiation of PSCs which 
leads to cardiomyocyte aggregates consisting of over 80% physiologically 
and pharmacologically functional pacemaker cells. These induced sino-
atrial bodies (“iSABs”) exhibited highly increased beating frequencies (300- 
400 bpm) for the first time close to mouse hearts. Additionally, performed 
Ca2+ measurements showed Calcium gradients typical of pacemaker cells. 
Our iSABs were able to robustly pace myocardium ex vivo. In addition, we 
have started RNA-Seq to define the iSAB transcriptome with the vast ma-
jority of ontologies related to heart function/development and to structures 
of contractile cells.
Conclusions: Overall, we provide the first example of highly pure functional 
cardiac pacemaker tissue derived from stem cells, a crucial step towards future 
cell therapy and drug-testing in vitro.
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O39 
AUTOLOGOUS CONNECTIVE TISSUE MEMBRANE (BIO-SHEET) AS A 
SUBSTITUTE FOR SELF-PERICARDIUM
T. Watanabea, H. Kawajiria, M. Yamanamia, O. Sakaia, K. Kandaa, H. Yakua, 
Y. Nakayamab
aCardiovascular Surgery, Kyoto Prefectural University of Medicine, Kyoto, 
Japan; bMedical Engineering and Materials, National Cerebral and Cardiovascular 
Cntr, Osaka, Japan
Aim: Autologous pericardium is commonly used for cardiovascular surgery. 
However, since the amount of pericardium is limited, tissue engineered material 
that has potential to grow and assimilate to native tissue is desired. We have 
developed autologous prosthetic tissues using “in-body tissue architecture” 
technology, which is a novel and practical approach of regenerative medicine 
based on tissue encapsulation of foreign materials in living bodies. We evalu-
ated the durability and safety of a connective tissue membrane (Bio-Sheet) used 
as an atrial wall patch.
Methods: Silicone rod molds (diameter 8 mm) were embedded into dorsal sub-
cutaneous pouches of beagle dogs (10 kg). After 8 weeks, we harvested the 
molds covered with connective tissue, and obtained the connective tissue tube 
(Biotube) by removing the rod molds. The Biotubes were cut open and sheeted, 
which had almost equal strength compared to autologous pericardium. Under 
general anesthesia right lateral thoracotomy was made. We created a right atrial 
defect (size: 20 mm × 10 mm) by using a side-binding aortic clamp and closed 
the defect with a Bio-Sheet patch. No antiplatelets or anticoagulants were 
administrated after implantation.
Results: We evaluated the implanted beagle dogs 7 days (n = 2), 30 days 
(n = 2), and 3 months (n = 2) after the patch repair. No aneurysmal change was 
found in the Bio-Sheet patches macroscopically. In histological evaluation, the 
luminal surfaces of the Bio-Sheets were completely covered with endothelial 
cells without formation of intra-atrial thrombosis after 3 months.
Conclusions: Bio-Sheet, which can be made and implanted easily showing 
a fine mid-term result, may have potential to be used as a substitute for self-
pericardium in cardiac surgery including congenital cardiac surgery.
O40 
TRITON-TRIPPLE NITINOL-CELLULOSE-MODIFIED SMALL DIAMETER 
VASCULAR GRAFTS
B. Winkler, F.S. Eckstein, M.T.R. Grapow 
Department of Cardiac Surgery, University Hospital Basel, Basel, Switzerland
Objective: According to the WHO report in 2012, atherosclerosis-related dis-
eases are known to cause over seven million deaths a year worldwide. For pa-
tients undergoing surgical treatment of diseased vessels alternatives to using 
native bypass material are urgently needed as up to 25% of patients lack suit-
able bypass material. Previous materials and designs had shortcomings spe-
cific to small diameter application. This project aims to construct an artificial 
graft suitable for the small diameter clinical application in the near future. Clini-
cal translation through design and practical handling are key points as well as in 
vivo endothelialization without preseeding.
Methods: A 3.5 Millimetre nitinol mesh is coated in a novel rotation reactor 
with a specific type of inert and antithrombogenic cellulose synthesized by an 
Acetobacter strain. Different series, in terms of media composition as well as 
culture settings, of total 35 vessels are analyzed according to burst strength, cell 
attachment and surgical properties.
Results: Arterial-like grafts showed high-burst pressure and ultrafine highly 
pure fibrous structure similar to that of collagen with a maximum burst strength 
of up to 600 mm Hg. The composition allows an arterial-like behaviour due to 
the nitinol elasticity of 15% luminal diameter in all series.
Conclusions: The novel Nitinol mesh adds stability, cellulose represents the 
inert antithrombogenic barrier and surface optimization leads to a biological 
endothelium. High burst strength, arterial-like vessel wall elasticity and short 
production times characterize this novel promising graft.
O41 
IMAGE-BASED COMPREHENSIVE CHARACTERIZATION OF POROUS 
SCAFFOLD TEXTURE 
D. Massaia, F. Pennellaa, P. Gentilea,b, D. Galloa, G. Ciardellia, C. Bignardia, 
A. Audeninoa, U. Morbiduccia 
aPolitecnico di Torino, Turin, Italy; bUniversity of Sheffield, Sheffield, United 
Kingdom
Aim: The microstructure of three porous composite scaffolds for bone tis-
sue engineering was characterized by performing a lacunarity analysis, which 
allowed to quantitatively assess the influence of bioactive glass on scaffold 
architecture and structural heterogeneity. 
Methods: The three-dimensional models of three porous scaffolds, composed 
of bioactive glass (BG) and chitosan/gelatin (PS) with different weight ratios 
(BG/PS) between the components (S1:0/100; S2:40/60; S3:70/30), were recon-
structed starting from micro-CT images (spatial resolution = 8.7 µm). In order to 
measure the spatial distribution and heterogeneity of scaffold pores, the scaf-
fold architecture was analyzed in terms of porosity (ratio between void space 
volume and total volume) and by applying the ‘gliding box’ algorithm, lacunarity 
(measure of the deviation of scaffold texture from the translational invariance). 
The relative lacunarity function (RLF) was adopted to minimize the influence of 
varying porosity on scaffolds architecture heterogeneity.
Results: The presence of the BG component affects both (1) porosity, S1 is 
characterized by higher porosity (81%) than S2 (70%) and S3 (68%), dem-
onstrating that the deposition of BG particles on the pore walls has the con-
sequence to reduce the available void area, and (2) heterogeneity, in fact S3 
presents higher spatial heterogeneity than S1 and S2, as confirmed by the RLF 
analysis, and a scale of randomness which is slightly wider than for S1. This 
higher heterogeneity could be ascribed to the higher content of BG particles 
with respect to S1 and S2, that cause micropore occlusion.
Conclusions: The adopted approach allows to investigate the scale-dependent 
spatial pore distribution over the 3D reconstructed scaffold models and to catch 
related structural heterogeneity features, providing a comprehensive character-
ization of the scaffold texture.
O42 
CELL BEHAVIOUR IN SANDWICH-LIKE CULTURES
 J. Ballester-Beltrána,b, M. Lebourga, M. Salmerón-Sánchezb
aUniversitat Politècnica de València, Valencia, Spain; bUniversity of Glasgow, 
Glasgow, United Kingdom 
Aim: The distribution of cell receptors anchored to the 2D surface of biomateri-
als highly differs from that observed in the extracellular matrix (ECM) in vivo, 
which triggers a different, less physiological, cell response. Hence we suggest 
that sandwich culture, that targets ventral and dorsal receptors, could be a ro-
bust system to study cell behaviour in 3D environment more similar to the ECM.
Methods: Cells were seeded on 2D substrates and immediately or after 3 hours 
of culture, sandwich-like cultures were obtained by gently laying the upper 
(dorsal) substrate. Cell morphology, adhesion, migration and differentiation 
were studied under different conditions by changing the substrates or protein 
coatings (both in the ventral and the dorsal side). 
Results: Our results suggest that both biological and mechanical stimuli within 
sandwich-like culture play an important role in cell behaviour that resembles 3D 
systems. For example, the ability to reorganise the ECM in sandwich culture has 
been shown to influence cell adhesion and morphology similarly as in hydrogels. 
Cell migration also differs to 2D substrates and can be tuned according to the 
culture conditions (substrates and protein coatings). Finally, sandwich culture 
increased myogenic differentiation and further experiments are being carried 
out in order to better characterize the process.
Conclusions: Our results support the hypothesis that sandwich culture can 
be used as a versatile intermediate system between 2D and 3D cultures and 
has the potential to provide further insights into the role of dimensionality in 
cell-material interactions.
O43 
NEW ENZYMES AND HARVESTING STRATEGIES FOR THE PRODUCTION 
OF HMSC THERAPEUTICS
K. Cierpkaa, J. Lebera, C. Elseberga, D. Salziga, P. Czermaka-d
aUniversity of Applied Sciences Mittelhessen, Giessen, Germany; bKansas State 
University, Manhattan, KS, USA; cUniversity of Giessen, Giessen, Germany; 
dFraunhofer Institute for Molecular Biology and Applied Ecology (IME), Project 
group Bioresources, Giessen, Germany
Aim: The cell harvest step is of great importance in hMSC manufacturing. In 
contrast to the manufacturing of other therapeutics (e.g. antibodies), hMSCs 
must stay viable and unaffected. As hMSCs grow strictly adherent to a surface, 
cell harvesting is ultimately required. In consideration of cGMP guidelines, cell 
harvest is a challenging assignment. As required by the authorities, detachment 
enzymes of non-animal origin are needed.
Methods: Several enzymes of non-mammalian origin (e.g. Accutase, Collage-
nase, and a new prolyl-specific peptidase (PsP) from fungus Wolfiporia cocos) 
were investigated for their suitability for hMSC harvest. Investigations were 
performed in static hMSC expansion systems as well as in dynamic systems 
(STR, FBR). 
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Results: Conventional trypsin showed disadvantages for hMSC harvest from 
dynamic bioreactor systems. New enzyme candidates like Accutase or the PsP 
showed comparable or even better results in detachment time and efficiency 
than standard trypsin. While harvest in a closed system was unproblematic for 
FBR expansion, a STR was modified to allow carrier-based expansion and en-
zymatic detachment of hMSCs from carriers within the same closed system.
Conclusions: The study showed that new promising enzyme candidates for 
hMSC detachment are available. Nonetheless, it is still necessary to study 
hMSC harvest in dynamic systems because the results from static culture ex-
periments cannot be adapted to dynamic culture. Undoubtedly, hMSC expan-
sion and harvest in dynamic systems is key to success of cell therapy.
Oral SeSSiOn – paSSiVe BOne prOStheSeS, O44-O46
O44 
CRANIAL CRUCIATE LIGAMENT RUPTURE: A MULTI-BODY ANALYSIS 
COMPARING CORRECTIVE TIBIAL OSTEOTOMIES
C. Bignardia, E.M. Zanettib, M. Terzinia, G. Pisania, A.L. Audeninoa
aPolitecnico di Torino, Torino, Italy; bUniversity of Perugia, Perugia, Italy
Aim: The aim of this study is to consider a new kind of tibial osteotomy for 
the treatment of Cranial Cruciate Ligament (CrCL) deficient stifle, that is the 
so called Center Of Rotation of Angulation CORA Based Leveling Osteotomy 
(CBLO), and to compare its outcome with the Tibial Plateau Leveling Osteotomy 
(TPLO), one of the most currently used osteotomies.
Methods: A Sawbones® (Pacific Research Laboratories) model of a canine right 
knee was used to generate the IGES geometries by means of a laser scanning 
system. The model included femur, tibia, fibula, menisci, patella, patellar liga-
ment, medial and lateral femoro-patellar ligaments, tendon of insertion of the 
quadriceps muscle group, cruciate ligament. Solidworks (Dassault Systèmes) 
was used to perform the tibial osteotomies and to identify the insertion and 
origin points of the ligaments. Four multi-body models of the stifle were then 
created in Adams (MSC Software). They included the femoro-tibial joint (FTJ), 
ligaments and contact forces. These four models represented a physiological, 
CrCL-ruptured, post-TPLO, post-CBLO stifle, respectively. Finally, a cranial 
drawer test was performed by applying a 44.5 N force to the tibia with or without 
applying a force to compress the femur against the tibia.
Results and Conclusions: There was no significant difference between the 
pathologic and post-surgery condition for a compressive force inferior or equal 
to 40 N, while craniocaudal stability was not reached, even when the CrCL is 
intact, unless the compressive force reached 150 N. Osteotomies outcomes are 
far better than pathologic condition. With reference to the comparison between 
TPLO and CBLO, the latter proved to be more stable.
O45 
A NOVEL NON-FUSION SCOLIOSIS CORRECTION SYSTEM 
M. Wesselsa, E.E.G. Hekmana, J. Hommingaa, G.J. Verkerkea,b
aUniversity of Twente, Enschede, The Netherlands; bUniversity Medical Center 
Groningen, Groningen, The Netherlands
Aim: Surgical treatment of scoliosis generally results in an almost completely 
rigid spine and can only be done after growth. We developed a revolutionary 
non-fusion correction system which slowly, but persistently corrects. It is ex-
tremely flexible and extendable. The system (XS-TOR) generates a torque to 
correct the axial rotation of the spine. Due to coupled motion, lateral bending is 
corrected as well. To deliver the appropriate torque, the system is pre-stressed 
before final anchoring to the spine. The system is fixed to only three vertebrae 
via cross-bridges.
Methods: To test the mechanical strength and performance, the XS-TOR was an-
chored to three metal vertebrae containing 6D force sensors, after which several 
spinal configurations were simulated and the reaction forces and moments were re-
corded. Animal experiments were performed with an inverse version of the implant 
that induces scoliosis instead of correcting it, since animals do not have scoliosis.
Results: The XS-TOR generated a correction torque that remains constant during 
growth and correction, due to a special design feature. The increase in spinal stiff-
ness is very limited, only 0.01-0.03 Nm/° in bending and 0.04-0.08 Nm/° in torsion. 
All animal experiments ended successfully. Scoliosis was induced, spinal 
growth was not inhibited and fusion of the spine prevented.
Conclusions: The XS LATOR is able to create scoliosis, a change in both tor-
sion and lateral bending, is able to allow spinal motion and growth, and does not 
induce vertebral fusion. The XS-TOR induces torsion as well as lateral deviation 
and we expect that it is, therefore, also capable of correcting it. We expect that 
the system behaves as intended in scoliosis correction. This means that a new 
way of treating scoliosis is possible, starting already during growth when scolio-
sis is less severe and ending after growth by removing the system.
O46 
NANOPOROUS POLYMER IMPLANT MATERIALS FOR MIDFACIAL 
OSEOSYNTHESIS
L. Grünhagea,b, A. Thormannb, S. Schwanb, C. Hesslerc, W.D. Knollc, A. Heilmanna,b
aAnhalt University of Applied Sciences, Köthen, Germany; bFraunhofer Institute 
for Mechanics of Materials IWM, Halle, Germany; cUniversity of Applied 
Sciences, Merseburg, Germany
Aim: Usually, stabilization of central midface fractures (Le Fort I) is achieved 
by means of L-shaped titanium miniplates. Replacing titanium with polymeric 
materials like UHMWPE or PEEK requires adapted mechanical stability and im-
proved biocompatibility of the polymeric materials. For this reason, beside sug-
gestions for geometrical improvement, the polymeric materials were modified 
with nanoporous surfaces.
Methods: UHMWPE (ultra high molecular weight polyethylene) and PEEK (poly-
etheretherketone) were laminated with HDPE (high density polyethylene) on 
both sides. Nanoporous surfaces were made by hot embossing with an alumina 
stamp having nanopores on top side. The nanopores were made by anodic 
oxidation of aluminum.
Results: With vacuum lamination, an almost perfect adhesion of HDPE on 
UHMWPE was achieved. For making HDPE adhere on PEEK, additional medical 
grade glue was necessary. In both cases, peeling tests were performed to prove 
adhesion. Nanostructured HDPE surfaces were produced by using of two dif-
ferent stamps with mean pore sizes of 235 and 120 nm. Polymer nanostructures 
were investigatedy by Scanning Electron Microscopy (SEM). Biocom patibility 
was verified using cell culture of chondrocytes. 
Conclusions: Together with an optimization of mechanical properties by using 
finite element modelling (FEM), prototypes of polymeric implants having excel-
lent biocompatibility were produced. As next step, the implants will be used for 
an animal study.
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O47 
INFLUENCE OF PROTEINS ON MAGNESIUM DEGRADATION IN BLOOD 
PLASMA
S. Knigge, F. Evertz, H.J. Maier, B. Glasmacher
Leibniz Universität, Hannover, Germany
Aim: Magnesium and its alloys are promising materials for medical application 
due to three special properties: the mechanical properties are similar to those of 
bone, magnesium is not toxic and degrades in the body. Controlled degradation 
of magnesium implants can be useful in medical care of bone injury because 
screws or plates do not need to be removed upon healing.
Material and Methods: To the above purpose, knowledge of the degradation 
process is necessary. To investigate the degradation process a suitable method 
especially for small magnesium samples (Æ 5 mm, height 2 mm) and low degra-
dation rates is used. Seven magnesium alloys were immersed in porcine blood 
plasma for 45 days. Magnesium released by the sample during degradation pro-
cess was measured photometrically. These values were compared with the mass 
loss which is the commonly used method to determine the degradation rate.
Results: The results show that the photometrical measurement of the degrada-
tion is an adequate method and allows a steady investigation of degradation. 
Hence, the results from degradation in blood plasma were compared with for-
mer results from magnesium degradation in simulated body fluid (SBF). They 
show that the chemical mechanism is the same but degradation was slowed 
down by the plasma proteins which adhere on the sample surface. In fact, the 
degradation in blood plasma is about ten times slower than in SBF.
Conclusions: The results of this study give a more detailed view into the deg-
radation process in the body which should be verified by in vivo experiments.
O48 
ENGINEERING OF BIODEGRADABLE POLYMERIC SCAFFOLDS AS DRUG 
DELIVERY CARRIERS USING CORE/SHELL FIBERS
A. Repanas, H. Zernetsch, M. Mueller, B. Glasmacher 
Institute for Multiphase Processes, Leibniz University, Hannover, Germany 
Aim: Polymeric micro/nanostructures have received great interest as drug-
delivery systems and various techniques have been employed to control and 
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modulate the characteristics of these structures. These include electrospinning 
(espin) methods such as Coaxial E-spin which enables the encapsulation of 
various drugs into the core of the fibers.
Methods: Both single jet and coaxial jet E-Spin were use to produce fibers. 
Polycaprolactone (PCL) and Aspirin (ASA) were dissolved in 2,2,2-Trifluoroetha-
nol (TFE) at concentrations of 150 mg/mL and 15 mg/mL respectively for the 
single jet E-Spin. For the coaxial jet E-Spin the same solution was used both for 
the core and the shell (without ASA in the shell solution). Structure and morphol-
ogy of the fibrous scaffolds were examined by Scanning Electron Microscopy 
(SEM). Uniaxial dynamic mechanical testing was performed to investigate the 
mechanical properties of the fibers. To study the cumulative release of ASA, 
samples were incubated in PBS (pH 7.4) at 37ºC inside a water bath and the 
absorbance was measured by using a UV-Vis spectrophotometer.
Results: The coaxial approach resulted in fibers with an average diameter of 
680 nm and an average pore size of 9.09 µm2 while the values of Elastic Modu-
lus and Stress at 30% Strain were 64.89 MPa and 6.63 MPa, respectively. More-
over, the amount of drug released in the first 8 hours was reduced from 58.32% 
to 33.14% and the encapsulation efficiency increased from 34.36% to 86.13% 
in contrast to single jet fibers following a Fickian diffusion in both cases.
Conclusions: Coaxial E-spin can be utilized as a technique to encapsulate 
hydrophobic pharmaceuticals inside biodegradable scaffolds for clinical appli-
cations in drug delivery. 
O49 
COMBATTING INFLAMMATION AND INFECTION THROUGH TAILORED 
NANOSTRUCTURED DESIGN
S.R. Sandeman, C. Howell, Y. Zheng, G. Ingavle, S. Mikhalovsky
Biomaterials and Medical Devices Research Group, University of Brighton, 
Brighton, UK
Aim: There are major global healthcare issues associated with the rising inci-
dence of non-communicable diseases and the need to reduce dependence on 
antibiotics. Our aim has been to develop a range of pure and composite nano-
porous sorbent systems in different structural forms which can absorb biologi-
cal toxins and microbial contaminants. Such therapeutics offer the potential for 
cost effective and efficient treatments to target adsorption of the instigators of 
infection and inflammation.
Methods: A range of polymer resin derived adsorbents with nanoporous do-
mains in bead and monolith form were characterised using SEM and poro-
simetry. Cell models were used to assess biocompatibility. Removal of toxins, 
including inflammatory cytokine TNF, microbial endotoxin, acetaldehyde were 
measured by HPLC, ELISA, LAL assay and flow cytometry.
Results: Nanoporous domains allowed adsorption of high molecular 
weight inflammatory molecule TNF and gram negative bacterial endotoxin. 
Low molecular weight and protein bound toxins were adsorbed to some 
extent by adsorbents with porous domains of less than 2 nm but adsorp-
tive capacity was significantly increased (p<0.01, n = 3) using advanced 
nanoporous materials with superior surface area and porous domains for 
adsorption. 
Conclusions: Pure and composite nanoporous sorbent systems may be de-
signed in a range of structural forms for extracorporeal, oral and dermal delivery 
to adsorb biological toxins, microbial contaminants and suppress excessive 
inflammatory stimulus.
O50 
POLYELECTROLYTE ASSEMBLY ON NANOSTRUCTURED BIOMATERIAL 
SURFACES
M.S. Niepela, O.Rhiela, H.S. Leipnerb, B. Fuhrmannb, T. Grotha
aInstitute of Pharmacy, Biomedical Materials Group, Martin Luther University 
Halle-Wittenberg; bCenter of Materials Science, Martin Luther University Halle-
Wittenberg, Halle (Saale), Germany
Aim: A system with unique surface properties was designed here using nano-
sphere lithography (NSL) and layer-by-layer (LbL) technique. Owing to its ability 
to guide not only cell adhesion, but also growth and differentiation, a potential 
application in regenerative medicine is aimed.
Methods: Tetrahedral gold nanostructures of different dimension were 
obtained by varying the size of colloids during NSL. Dip as well as spray coat-
ing were applied to modify the nanostructures with polyelectrolytes (PEL) of 
different origin (e.g. poly (ethylene imine) (PEI), heparin (HEP), etc.) by con-
trolling their pH value. Pristine and modified nanostructures were intensively 
characterized using various methods (AFM, SEM, and WCA). Further, the 
cellular response to such unique systems was investigated using immunocy-
tochemistry.
Results: Nanostructure size and distance clearly influenced the surface 
wettability. Moreover, the effect was even more pronounced introducing 
PEL, which also affected the surface charge. Hence, the nanostructured sur-
faces could be rendered highly hydrophilic (HEP) or moderately wettable (PEI) 
controlling feature dimensions as well as the terminating molecule. Further, 
cells responded positively to the surface chemistry (HEP) as well as topog-
raphy (PEI).
Conclusions: We show that gold nanostructures on planar surfaces could be 
specifically modified with a PEL system. Due to their economic effectiveness as 
well as simplicity, both techniques could be applied to develop unique systems 
for stem cell therapy.
O51 
DESIGNING A NOVEL BIODEGRADABLE CYANOACRYLATE-BASED TISSUE 
PATCH
M. Zarek, A. Elyashiv, D. Cohn
The Hebrew University of Jerusalem, Jerusalem, Israel
Aim: Management of post-surgical leaks from different organ systems is a pe-
rennial concern. Existing tissue sealants are composed of fibrin-based seal-
ants, synthetic compounds, or glutaraldehyde-albumin cross-linked systems. 
Each one of these compounds presents benefits and drawbacks for the surgical 
management of post-surgical leaks. This talk aims to report on a novel biode-
gradable tissue patch under development as another tool for the management 
of post-surgical leaks. 
Materials and Methods: We synthesized and characterized a family of poly-
urethane copolymers composing polyethylene glycol and polycaprolactone to 
function as the patch backing. The bulk material was processed into films and 
fabrics and both were solvent welded together. Monomeric cyanoacrylate was 
added to the surface layer of the fabric and functioned as the active layer. The 
adhesive strength of the patch prototypes were tested on bovine tissue as a 
model. The degradation rate for the patch prototypes were tracked by placing 
them in PBS in a 37°C incubator. 
Results: The synthetic tissue adhesive patches had a tensile modulus on 
the order of magnitude of soft tissue and displayed an adhesive strength of 
10.1 ± 2.6 N, surpassing that of the biological glues. 
Conclusions: The prototype patches exhibited adhesive strengths on par and 
better than the existing tissue adhesives, on a human tissue model. The in vitro 
patch degradation was tailored according to different material compositions to 
span a range of rates.
O52 
HYDROPHOBICALLY-MODIFIED GELATIN BASED ADHESIVES WITH HIGH 
BONDING STREGTH AND BIOCOMPATIBILITY
T. Taguchia, M. Matsudab, M. Inouea
aNational Institute for Materials Science, Tsukuba, Japan; bUniversity of Tsukuba, 
Tsukuba, Japan 
Aim: Tissue adhesive is a biomedical material that can bond tissues together 
after surgical operations. However, these commercial adhesives still have dis-
advantages on bonding strength and biocompatibility. The aim of this study is 
to develop biocompatible tissue adhesives with high bonding strength using 
hydrophobically-modified gelatin.
Methods: Hydrophobically-modified gelatins with different hydrophobicity 
and introduction ratio were prepared by the reaction of active ester of fally 
acid chloride or cholesteryl chloroformate with the primary amine of gelatin. 
The measurement of bonding strength was performed using fresh arterial media 
as an adherent. Quantitative determination of tissue reaction after implanta-
tion of tissue adhesive was also performed using NF-κB/luciferase transgenic 
(NF-κB/luc tg) mice.
Results: Tissue adhesives composed of hydrophobically-modified gelatin and 
biocompatible crosslinker were developed. Resulting adhesives had 2-fold 
higher bonding strength compared with commercial adhesive. Cross sectional 
views revealed that developed adhesives still remained on the surface of arterial 
media even after bonding strength measurement. These adhesives also showed 
excellent biocompatibility, bioabsorbability and only mild tissue reaction in a rat 
subcutaneous tissue model.
Conclusions: Developed adhesives can be applied in the field of not only car-
diovascular surgery but also chest surgery.
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O53 
PROSPECTION OF IMPLANT BASED ON NANOSTRUCTURED MEMBRANES 
ASSOCIATED WITH DOPAMINERGIC NEURONS - AUTOLOGUE PURPOSE 
FOR TREATMENT OF PARKINSON DISEASE*
K.A.T. Carvalhoa, A.C. Iriodaa, C.M.C.O. Souzaa, D. Souzaa, R.J. Ferreirab, 
B.F. Morghabela, J.C. Franciscoa, L.C. Guarita-Souzac, M.A. Cardosoa, 
C.F. Souzab, M.A. Woehlb, M.-R. Sierakowskib
aPequeno Príncipe Faculties, Curitiba, Brazil; bParaná Federal University, Curitiba, 
Brazil; cParaná Catholic University, Curitiba, Brazil
Aim: To develop of implant based on nanostructured membranes seeded with 
dopaminergic neurons from human adipose-derived mesenchymal stem cells 
(h-ADMSC) for treatment of Parkinson Disease.
Methods: Development membrane, the total mass based on dried films was 
performed according to the commercial samples donated by MEMBRACEL®. 
In addition, the inclusions of drugs (lysozyme-LZ and/or fluconazole-FZL), 
with antibacterial and antifungal properties, are also evaluated in these sys-
tems. The bionanocomposites were obtained after defibrillation using a never-
dried bacterial cellulose (BC) to form a pulp and the films of BC regenerated 
(RBC), in the presence or not of the hydrocolloids: tamarind xyloglucan-XG 
or gellan gum-GL or collagen-C (10% w/w) and/or drugs (10% w/w) were 
developed by dry casting (Patent). In vitro assays were performed to test for 
adhesion and proliferation with the h-ADMSC from human adipose liposuc-
tion. Then, those cells, 1 × 103/cm2 were seeded and differentiated to dopa-
minergic neurons in established medium conditions and time, maintained in 
an Incubator with 5% CO2 at 37°C (Patent); thereafter, it was analyzed the 
dopamine production by ELISA assay for allowing the quantification of their 
performance. Optical and Electron Microscopies were done in membrane 
and cells. The Flow Cytometric analysis was done in h-ADMSC fraction 
and tri-lineage pluripotency test. The immunoassay was done to demon-
stration the dopaminergic neuron differentiation by ß-tubulin and Tyrosine 
Hydroxylase.
Results: RBC-tamarind xyloglucan nanostructured membrane incorporated 
with lysozyme presented the best performance in adhesion and proliferation 
tests as 35.3% more efficiency than the control. The h-ADMSC had differenti-
ated to dopaminergic neurons on the membrane and those cells were able to 
product 1,0 ng/ml of dopamine.
Conclusions: The results allow the utilization the developed implant in preclini-
cal studies of Parkinson Disease Model.
*Financial supports: CAPES.
O54 
NEW GENERATION OF THE HOLLOW FIBRE MEMBRANES FOR DIALYSIS 
TREATMENT
D. Pavlenko, D. Stamatialis
University of Twente, Enschede, The Netherlands
Aim: Mixed matrix membranes (MMMs), which combine the benefits of adsorp-
tion and filtration in one step, represent a novel concept for blood purification. 
Current research is focused on fabrication and optimization of double layer hol-
low fibre membranes, which consist of a particle free inner layer attached to the 
MMM outer layer.
Methods: Polyethersulfone/polyvinylpyrrolidone polymer blend was used 
as membrane forming material for inner and outer layer of the hollow fi-
bres. As the adsorptive particles, activated carbon was incorporated into 
the outer polymer matrix in order to provide enhanced removal of blood 
toxins. Membrane characterization was performed by scanning elec-
tron microscopy (SEM) and clean water flux (CWF). Additionally, adsorp-
tion experiments of various toxins under static and dynamic conditions 
were performed to estimate the adsorptive properties of newly fabricated 
membranes. 
Results: Based on previous experience of our laboratory, double layer MMMs 
were fabricated and spinning parameters were optimized. Specifically, the 
diameter of the hollow fibre membranes was decreased by using different 
spinneret type. Additionally, influence of polymer and bore liquid composition 
and pumping speed was tuned to obtain membranes with properties suitable 
for dialysis. Conclusions: Decrease in hollow fibre diameter improves sur-
face to volume ratio of hollow fibres, which results in improved efficiency of 
dialysis. 
Acknowledgements: This work is financially supported by the EU Marie Curie 
ITN – BIOART Project.
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O55 
ELECTROSPUN GELATIN MATS AS A SUITABLE PLATFORM TO SUPPORT 
ANGIOGENSIS
C. Del Gaudioa, S. Baiguerab, D. Ribattic, A. Biancoa, P. Macchiarinib
aUniversity of Rome “Tor Vergata”, Rome, Italy; bKarolinska Institutet, Stockholm, 
Sweden; cUniversity of Bari, Bari, Italy
Aim: Dealing with a readily vascularized tissue/organ is a crucial issue to 
be addressed for an effective tissue engineering approach. For this aim, a 
supportive scaffold should not provide only structural and morphological 
natural extracellular matrix-like properties, but also elicit a proper biologi-
cal response mediated by specific factors. In this context, cross-linked elec-
trospun gelatin mats conditioned with human vascular endothelial growth 
factor (hVEGF) were tested as bioresorbable naturally-derived angiogenic 
substrates.
Methods: Gelatin powder was dissolved in a mixture of acetic acid/deion-
ized water to be electrospun onto a metallic target. The collected mats were 
cross-linked by soaking into a genipin alcoholic solution. Morphological and 
mechanical characterization were carried out. Sterilized samples were loaded 
with hVEGF solution. Temporal release and angiogenic properties were then 
evaluated.
Results: Gelatin mats were characterized by a homogeneous fibrous architec-
ture which was retained after cross-linking, even if larger fibers were observed. 
Mechanical characterization confirmed an improved response of the tested 
samples in the dry state. A burst release of hVEGF was measured in the first day 
followed by a sustained one within the experimental period (28 days). Released 
hVEGF demonstrated in vitro chemoattractive and angiogenic properties. More-
over, hVEGF-loaded mats revealed an in vivo pro-angiogenic effect, promoted 
human mesenchymal stromal cells viability, and initial differentiation towards 
endothelial pathway.
Conclusions: The proposed electrospun gelatin mats induced early angiogen-
esis and can contribute to optimize hVEGF release for a potential therapeutic 
protocol.
O56 
VASCULAR-LIKE LAYERED CONSTRUCT FORMATION BY ONE-DAY-
SELF-ORGANIZATION
R. Iwaia, R. Harukia, Y. Nemotob, Y. Nakayamaa
aDivision of Medical Engineering and Materials, National Cerebral and Cardio-
vascular Center Research Institute, Japan; bDevelopment Department, Chemi-
cal Products Division, Bridgestone Co., Japan
Objective: It needs sophisticated cell management processes for vascular 
tissue engineering such as introducing different cell types into scaffolds with 
positional specificity to construct three-layered vascular structure. We have 
developed the smart culture surface, on which one aggregate or mesh tissue 
formation can be produced by self-organization of seeded cells. In this study, 
we firstly developed a quick method for the preparation of vascular-like tissue 
only by stepwise seeding of vascular constructing cells on the culture surface 
with rectangular size.
Methods and Results: The rectangular culture surface (2.5 × 8.0 mm) was pre-
pared by regional coating of our developed copolymer with thermoresponsive 
and zwitterionic character on a hydrophilic-treated culture dish. Upon seeding 
of adipose-derived vascular stromal cells (ADSCs), as the first species, ADSCs 
adhered only on the copolymer-coated rectangular region, and almost all the 
regions were covered with ADSCs. After reaching confluence of ADSCs, vascu-
lar endothelial cells (VECs) as the second species, were seeded on the ADSCs 
layer. After additional 3 h-incubation, the 2-layered cell sheet was delaminated 
from its both edges of the major axis by spontaneous shrinkage of the cell 
sheet without any stimulations. Finally, the cell sheet was rolled and fused to 
form rod-shape within about 6 h from the start of the delamination. Interestingly, 
VECs selectively accumulated at the center of the circumferential cross-section 
of the obtained rod tissue with covering of ADSCs layer, which was similar to 
native microvessels.
Conclusions: Scaffold-free entirely self-organized vascular-like tissue was ob-
tained only by step-wise seeding vascular constructing cells on our originally 
developed culture surfaces.
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O57 
MONITORING OF GLUCOSE CONSUMPTION AND LACTATE PRODUC-
TION BY ENDOTHELIAL CELLS CULTURED IN CAPILLARY MEMBRANE 
BIOREACTORS
A. Ciechanowska, P. Ladyzynski, G. Hoser, S. Sabalinska, J. Kawiak, A. Chwojnowski, 
C. Wojciechowski, J.M. Wojcicki
Nalecz Institute of Biocybernetics and Biomedical Engineering PAS, Warsaw, 
Poland
Aim: The objective is to monitor glucose consumption and lactate production 
by human umbilical vein endothelial cells (HUVEC) cultured in capillary mem-
brane bioreactors to be used as a model of a blood vessel.
Methods: Isolated HUVECs were cultured in modified Medium 199. After the 
second passage, HUVECs were introduced into bioreactors in different quanti-
ties (2, 4, 6 and 15 x 104 cells per cm2). Bioreactors were rotated for 4 h to 
seed cells on the inner surface of capillaries. We used original bioreactors with 
14 polysulfone capillaries, inner diameter of 640 µm and total surface area of 
16.3 cm2 covered with fibronectin to promote cells attachment. HUVECs were 
subjected to the shear stress resulting from medium flow generated by a peri-
staltic pump. Glucose and lactate were measured every 24 h in the circulating 
medium for 4 days.
Results: Glucose consumption was the highest during the first day of culture 
and then it stayed relatively stable. Lactate production was stable during the 
whole monitored period in all cultures but the one with 150,000 cells per cm2. In 
this case, cells produced 3.5 times more lactate during the first day than in the 
other cultures, which might be attributed to a limited oxygen supply for such an 
amount of cells.
Conclusions: The obtained results suggest that HUVECs can be safely seeded 
in the assessed bioreactors with densities ranging from 2 to 6 x 104 cells/cm2 
and that cell cultures stabilize after 24 to 48 h.
O58 
NANOPARTICLE LABELLING FOR VASCULAR TISSUE ENGINEERING
J. Fresea, F. Wolfa, M.E. Mertensb, P. Schusterc, V.N. Geschec, S. Kocha, 
T. Lammersb, F. Kiesslingb, P. Melaa, S. Jockenhoevela 
aDepartment of Tissue Engineering & Textile Implants, Institute of Applied Medi-
cal Engineering, RWTH Aachen University, Aachen, Germany; bDepartment of 
Experimental Molecular Imaging, RWTH-Aachen University, Aachen, Germany; 
cDepartment of Tissue Engineering & Textile Implants, Institut für Textiltechnik, 
RWTH Aachen University, Aachen Germany
Aim: The incorporation of imaging agents into tissue-engineered implants ena-
bles non-invasive, long term in vitro and in vivo monitoring and has the potential 
to facilitate the translation of tissue-engineered constructs into clinical applica-
tion. We used ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles to 
label and monitor endothelial cells on tissue-engineered vascular grafts.
Methods: The cell labeling procedure was optimized with respect to labeling 
efficiency, biocompatibility and in vitro validation during bioreactor cultivation, 
using flavin mononucleotide (FMN)-coated fluorescent USPIO (FLUSPIO). 
Results: No negative influence of FLUSPIOs on cell proliferation and viability 
was detected for particle concentrations up to 3 mM. FLUSPIO-labeled cells 
were successfully employed for the fabrication of tissue-engineered vascular 
grafts which could be clearly visualized by MRI during bioreactor cultivation. 
Conclusions: Labelling of endothelial cells with functionalized USPIO particles, 
due to their high T2 –relaxation, is a promising method for imaging and long 
term monitoring of tissue engineered implants. Incorporation of the contrast 
agent into the implant endothelium can deliver valuable information about its 
remodelling.
O59 
BIOPHYSICAL CHARACTERIZATION OF NATIVE WHARTON’S JELLY FOR 
TISSUE ENGINEERING APPLICATIONS
S. Sahaia, M. Wilkersona, F. Vitaleb, D. Tsentalovichb, S. Kirana, M. Pasqualib, 
C.S. Cox Jr.a, F. Trioloa
aUTHealth - The University of Texas Health Science Center at Houston, USA; 
bRice University, USA
Background: The mechanical properties of a regenerative biomaterial are fun-
damental to define critical design considerations for implant success. A natural 
biomaterial of great potential is native Wharton’s Jelly (nWJ), the connective 
tissue of the umbilical cord (UC), rich in proteoglycans, collagens and perinatal 
stem cells. To date, little is known on its mechanical characteristics despite their 
importance in developing innovative nWJ-based therapies.
Methods: nWJ was harvested from 5 UCs and mechanical characterization was 
carried out using atomic force microscopy (AFM) and shear rheology. AFM in-
dentation curves were measured using 5 µm ramp sizes at a scan rate of 0.5 Hz 
and Young’s modulus was calculated using the Hertz model with a Poisson’s 
ratio of 0.4. Dynamic and steady shear rheology experiments were performed 
to measure the viscoelastic moduli (G’, G’’) and shear viscosity (η), respectively.
Results: AFM of nWJ yielded a Young’s modulus range consistent with that 
of some of the body’s softest tissues (e.g., brain). Elastic and viscous moduli 
(G’, G’’) of nWJ increased with increasing frequency, indicating that the tissue 
stiffens in response to mechanical stress. Furthermore, the shear viscosity (η) 
showed an inverse dependence on shear rate, which indicates a shear thinning 
behavior.
Conclusions: nWJ is a natural 3D biomatrix with elastic and resilient thixotropic 
properties that are desirable for potential applications in tissue engineering.
O60 
INTEGRATED BIOCOMPATIBILITY CHARACTERIZATION OF TUBULAR 
SCAFFOLDS FOR VASCULAR TISSUE ENGINEERING
M. Mueller, B. Krolitzki, L. Dreyer, H. Zernetsch, B. Glasmacher
Institute for Multiphase Processes, Leibniz University, Hannover, Germany
Background: Scaffolds for vascular tissue engineering have to meet specific 
biocompatibility requirements regarding mechanical properties, cellular re-
sponse and overall haemocompatibility. Since proper preparation and mount-
ing of electrospun matrices is crucial for the various analyses and particularly 
time-consuming, a reliable device needs to be developed for standardizing test 
procedures.
Methods: Three-layered electrospun tubular scaffolds with an inner diameter 
of 4 mm spun from PCL/PLA (I) or PCL/PLA/PEG (II) were used for all experi-
ments. A single simplified mounting mechanism was developed and evaluated 
in a comprehensive sequence of experimental analyses regarding cell seeding, 
mechanical data, biocompatibility and cell viability.
Results: Mechanical properties decreased with the addition of PEG to the poly-
mer blend, demonstrated by a reduction of tensile strength from 5.8 MPa (I) to 
3.9 MPa (II). Young’s modulus increased in circumferential (7.6 MPa/7.5 MPa) as 
well as in longitudinal direction (40.1 MPa/28.8 MPa). Furthermore, an influence 
of fiber diameter on the haemocompatibility could be observed, since scaffolds 
with thinner fibers caused a significant decrease in number of platelets in dy-
namic haemocompatibility testing. Endothelial cell seeding (RBE-4) of PCL/PLA 
scaffolds led to a confluent monolayer after 7 days of cultivation, proved by 
fluorescence microscopy.
Conclusions: We developed a combination of methods and devices that en-
able a broad characterization with optimized work flow for parameter studies. 
The mounting mechanism provides a simplified, standardized interface not only 
for electrospun scaffolds but for all kinds of fragile porous scaffolds, e.g. from 
directional solidification.
O61 
BIOREACTOR-BASED MODEL PLATFORM FOR CARDIAC TISSUE
D. Massaia, G. Pisania, A. Rodrigueza, F. Lograndb, G. Falvo D’Urso Labatec,d, 
X.Y. Xue, C. Bignardia, G. Taroneb, U. Morbiduccia 
aPolitecnico di Torino, Turin, Italy; bMolecular Biotechnology Center, Turin, Italy; 
cLaboratori Biomicron Srl, Turin, Italy; dUniversità della Calabria, Rende, Italy; 
eImperial College London, London, United Kingdom
Aim: A bioreactor-based model platform was developed for culturing cardiac 
constructs in a native-like environment and for investigating cardiac tissue 
developmental aspects and factors that influence the generation of functional 
cardiac tissues. 
Methods: The platform is composed of: (1) a stand-alone sensorized bioreac-
tor, which provides cyclic stretch and on-line monitoring of culture parameters; 
and (2) 3D fibrin engineered heart tissue (fEHT) rings, acting as cardiac pseudo- 
tissues. The culture chamber is equipped with sensors (temperature, pH, and 
CO2/O2) and a heating strip, and can house up to three fEHT rings. The mechani-
cal stimulation unit supplies controlled cyclic stretch (1-200% deformation, 
1-6 Hz frequency). The monitoring/control unit allows real-time monitoring and 
control of the stimulation unit and chamber temperature. The operating condi-
tions are set and monitored by a purposely-built software. As for the fEHT rings, 
neonatal rat cardiomyocytes were mixed with fibrin and medium, cast into circu-
lar moulds, incubated for 48 hours, and finally dynamically cultured.
Results: In-house tests confirmed the effectiveness of chamber isolation, me-
chanical stimulation unit, and monitoring/control unit. fEHT rings were obtained 
and characterized by histological analyses before and after physiological/ 
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pathological stimulation. Preliminary tests demonstrated the system suitability 
to culture cardiac constructs.
Conclusions: By allowing control and monitoring of individual parameters to 
be separated from in vivo systemic effects, this closed automated platform pro-
vides a reliable model system, with high reproducibility and low contamination 
risk, to study the effects of chemical-physical stimuli on cardiac tissue matura-
tion and function.
O62 
DESIGN AND QUALIFICATION OF A SINGLE-USE STIRRED BIOREAC-
TOR FOR THE EXPANSION OF HUMAN MESENCHYMAL STEM CELLS AT 
BENCHTOP SCALE
V. Jossena, S.C. Kaisera, A. Otta, S. Spickerb, A. Siehoffb, J. Herrmannc, A. Tappec, 
C. van den Bosb, R. Eibla, D. Eibla
aZurich University of Applied Sciences, Switzerland; bLonza Cologne GmbH, 
Germany; cSartorius Stedim Biotech, Göttingen, Germany
Objective: For a broad range of therapies there is clearly a growing interest in 
human mesenchymal stem cells (hMSCs) isolated from adipose tissue and bone 
marrow. However, this trend is accompanied by the need for a large number of 
cells of consistent quality and thus alternatives to the prevailing planar cultiva-
tion systems, which are non-instrumented and limited in scale. 
Stirred bioreactors operated with solid and porous microcarriers at benchtop 
and pilot scale have shown promising results. Recently, published results have 
indicated the advantages of single-use versions, even though these were origi-
nally designed to grow more robust continuous cell lines (e.g. CHO cell lines).
Methods: To improve cultivation conditions for human adipose tissue- and bone 
marrow-derived hMSCs when generating therapeutically relevant cell numbers 
for autologous cell therapies with microcarrier solid fractions exceeding 0.3%, 
we modified the fluid flow characteristics of the commercially available Uni-
Vessel® SU 2L using Computational Fluid Dynamics (CFD). The goal was peak 
cell numbers of approximately 1∙109 cells within 10 days while maintaining stem 
cell marker profiles. For this purpose, 12 different models were investigated 
with regard to the impeller diameter and blade angle as well as the off-bottom 
clearance. The optimization criterion was to reduce required impeller speeds, 
and consequently shear stresses, while maintaining a homogenous microcarrier 
suspension. 
Results: By increasing the impeller blade angle and reducing the off-bottom 
clearance, the required specific power inputs for microcarrier suspension were 
reduced by factors of between 2.2 and 4.6 in comparison to the standard version 
of the UniVessel® SU, depending on the microcarrier concentration. This finally 
resulted in 3.4 to 11.1 times higher peak cell densities (1.17∙109 hBM-MSCs and 
1.44∙109 hADSCs) than in the standard version and the desired peak cell number 
of 1∙109 cells in the modified UniVessel® SU under low-serum conditions.
O63 
ENGINEERED SMART TOOLS FOR NEURODEGENERATIVE DISORDERS: 
CHONDROITIN SULPHATE DELIVERY IN NEUROPROTECTION
M. Tunesia,b, E. Bedinic, P. Petrinia,b, A. Iadonisic, D. Albanid, M.T. Raimondia, 
C. Giordanoa,b
aPolitecnico di Milano, Milan, Italy; bUnità di Ricerca Consorzio INSTM, Politec-
nico di Milano, Milan, Italy; cUniversità degli Studi di Napoli “Federico II”, Naples, 
Italy; dIRCCS-Istituto di Ricerche Farmacologiche “Mario Negri”, Milan, Italy
Aim: We aim at applying a miniaturized and optically accessible bioreactor to 
study the neuroprotective effect of chondroitin sulphate (CSs) released from a 
hydrogel matrix on neuronal cultures after oxidative stress.
Methods: CSs differing for the sulfation pattern were prepared and their neu-
roprotective effect was screened under static conditions with SH-SY5Y human 
neuroblastoma cells challenged with oxidative stimuli like hydrogen peroxide. 
The same cell line was used to assess the in vitro cytocompatibility of pro-
prietary hydrogels composed of agarose and Carbomer 974P, to be further 
exploited for CPS release. SH-SY5Y cells were also seeded on custom-made 
poly(styrene) scaffolds and cultured under dynamic conditions in a recently de-
veloped bioreactor for interstitial perfusion of 3D cell-seeded scaffolds.
Results: The concentrations of the proposed CSs able to counteract the oxida-
tive stress were identified. The in vitro tests suggested that the selected hydro-
gel formulations were cytocompatible with neuronal cultures and suitable for 
the application. The use of the perfusion bioreactor as a dynamic culture model 
allowed to keep cell viability while enhancing cell functionality.
Conclusions: The obtained results suggested that the proposed CSs might be 
effective to counteract neurodegeneration and the optimized bioreactor might 
be an appealing test platform to evaluate their efficacy before moving to in vivo 
tests.
O64 
DESIGN OF MICRO SLIT FOR CELL SORTING
S. Hashimotoa, H. Hinoa, K. Kitagawaa, T. Yasudab
aKogakuin University, Tokyo, Japan; bTokyo National College of Technology, 
Tokyo, Japan
Aim: Biological cells might pass through a path narrower than their diameter 
in vivo. The spleen, for example, has the slits. The narrow path is able to sort 
cells, according to their size and deformability. The photolithography technique 
enables manufacturing a micro slit. In the present study, the micro slit has been 
designed to observe behavior of a biological cell passing through the narrow 
path in vitro.
Methods: A silicone disk was used for a photolithography mold. Both a laser 
drawing system and a dry etching process were used for the micro-fabrication. 
The slit, width 0.85 mm and height 0.001 mm, has been designed between 
two parts of transparent polydimethylsiloxane disks. The disks have rectangular 
micro ridges on the inner surface. The dimension of the fabricated micro ridges 
was measured with a laser microscope. A suspension of swine red blood cells 
or C2C12 (mouse myoblast cell line originated with cross-striated muscle of 
C3H mouse) was alternatively introduced into the slits by drawing with a syringe 
pump. The behavior of cells passing through the micro slit was observed with 
an inverted phase-contrast microscope.
Results: The mean height of the ridges measured with the microscope is 
0.0010 mm, which keeps space of the slit. Several red blood cells can pass 
through the micro slit, although C2C12 cannot pass through the micro slit.
Conclusions: The experimental results show that the micro slit can be fabri-
cated with photolithography technique and has the potential of sorting biologi-
cal cells.
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O65 
NUMERICAL FLOW SIMULATIONS OF EFFECTS OF VIRTUAL SURGERY 
OF THE INTERNAL CAROTID ARTERY 
P. Reorowicz, D. Obidowski, P. Klosinski, K. Jozwik
Lodz University of Technology, Institute of Turbomachinery, Lodz, Poland 
Aim: Under normal conditions, the brain is supplied with a blood flow in three 
large arteries. Two symmetrical internal carotids, which provide almost seventy 
percent of blood, and one basilar artery which supplies the remaining volume 
of blood. The occlusion of carotid arteries due to plaque may bring risk of brain 
ischemia or even death. The objective of this study is to investigate the effect of 
stenosis on the blood supply of the brain and simulations of the effects of artery 
widening during surgical intervention.
Methods: The patient’s specific geometry was reconstructed on the basis of the 
computed tomography examination. A 3D geometry of the arterial system, start-
ing from the aorta, via carotid and vertebral arteries up to cerebral arteries, was 
generated in the CAD software (SolidWorks). The numerical experiment, with 
the Ansys CFX 14.5 code, was carried out for time-varying boundary conditions 
within the physiological range. The simulation results were compared with the 
measurements of the flow rates (Doppler ultrasonography). Vessel walls were 
assumed to be rigid and non-deformable, however, an additional element com-
pensating deformation was used for more realistic flow modelling.
Results: The results of numerical simulations of the natural cycle of heart op-
eration show an influence of the vessel stenosis on the flow through the carotid 
artery and the flow pattern of blood through the Circle of Willis.
Conclusions: The presented numerical experiment accurately reproduces the 
flow in the cerebrovascular system. Modifications of the geometry of the arteries 
(CAD model), their shape or diameter, might be useful in planning and execution 
of surgical intervention. Moreover, the functional severity of the carotid artery 
stenosis can be quantified.
O66 
VALIDATION OF ULTRASOUND IMAGING VELOCIMETRY
K.H. Frasera, C. Poelmab, B. Zhouc, M-X. Tanga, P.D. Weinberga
aImperial College London, UK; bTechnische Universiteit Delft, The Netherlands; 
cSoutheast University, China
Aim: Doppler ultrasound is standard for measurements of blood velocity. An 
inherent limitation is that Doppler methods only measure the velocity parallel 
to the ultrasound beam. In Ultrasound Image Velocimetry (UIV) regions of two 
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sequential B-mode images are cross-correlated to calculate 2-D velocity vec-
tors. UIV results were compared with Doppler and transit-time flow measure-
ments.
Methods: In vitro experiments were performed in a pulsatile flow loop. The 
working fluid was water/glycerol with ultrasound contrast agent (microbub-
bles). The latex tube was imaged using an Ultrasonix RP500 and a novel 
imaging sequence was used to interleave two ultrasound frames, enabling a 
short and variable (0.3-39 ms) interframe time separation (δt). A rabbit was 
anaesthetised and imaged through the abdomen, with microbubbles admin-
istered via the ear vein. Radiofrequency data were post-processed offline 
using in-house code which calculates the local correlation between succes-
sive frames, then sums correlation results for identical phases of all cardiac 
cycles. 
Results: Peak velocities >2 m/s were accurately measured across the entire 
field-of-view in vitro, while peak systolic velocities in the rabbit were 0.99 m/s 
and 1.04 m/s with UIV and Doppler respectively. As δt was increased flow insta-
bility during deceleration caused the UIV velocity measurement to drop to zero. 
Comparing velocity measurements of decelerating flow with different values of 
δt leads to a new method for investigating flow instability.
Conclusions: With short δt UIV and derived flow rates agreed excellently with 
Doppler and transit time flow rates.
O67 
PERFORMANCE OF WALL-LESS CANNULAS FOR MINIMAL ACCESS 
PERFUSION
B. Mhedi, S. Abdel-Sayed, L.K. von Segesser
Cardiovascular Research Laboratory, University Hospital, Lausanne, Switzer-
land
Aim: The aim of this study was to assess whether smaller diameters of the wall-
less venous cannulas are sufficient for venous drainage with augmentation, thus 
allowing in smaller access orifices.
Methods: Flow rate (Q) and negative pressure (P) were measured for the 24F 
wall-less (Smartcanula) restricted to 23F and 17F, and the control (Biomedicus 
cannula) 23F and 17F, using centrifugal pump and an experimental bench set-
up, with after load 60 mmHg. 
Results: 288 measurements were recorded. At 1500, 2000, 2500, and 3000 
RPM pump speed, the Q values for the 23F access were 2.62 ± 0.02, 4.66 ± 
0.03, 6.47 ± 0.08, and 8.21 ± 0.09 l/min for the wall-less cannula, versus 1.56 ± 
0.03*, 2.77 ± 0. 02*, 3.82 ± 0.05*, and 4.77 ± 0.05*: p<0.05* l/min for the con-
trol cannula. The P values were -28.58 ± 0.14, -70.62 ± 0.41, -124.64 ± 0.43, 
and -191.20 ± 1.11 mmHg, versus -37.38 ± 0.66*, -95.54 ± 0.61*, -170.25 ± 
1.43*, and -257.55 ± 1.05* mmHg. The Q values for the 23F access were 3.40 ± 
0.02, 6.25 ± 0.03, 8.65 ± 0.05, and 10.94 ± 0.02 l/min versus 2.69 ± 0.02*, 
4.86 ± 0.02*, 6.81 ± 0.02*, and 8.55 ± 0.03* for the 23F control cannula. The 
walls-less cannula provides a promising solution for improved venous drainage 
for scenarios, the 17F and 23F access. One single cannula dimension for vari-
ous access vessel diameters simplifies minimal invasive surgery.
O68 
DEVELOPMENT AND IMPLANTATION OF TISSUE ENGINEERED SELF-
EXPANDABLE AORTIC STENT GRAFTS (BIO STENT GRAFTS) USING 
IN-BODY TISSUE ARCHITECTURE TECHNOLOGY IN BEAGLES
H. Kawajiria,b, T. Mizunoa, T. Moriwakia, H. Ishibashi-Uedac, M. Yamanamia,b, 
K. Kandab, H. Yakub, Y. Nakayamaa
aDivision of Medical Engineering and Materials, National Cerebral and 
Cardiovascular Center Research Institute, Osaka; bDepartment of Cardiovas-
cular Surgery, Kyoto Prefectural University of Medicine, Kyoto; cDepartment 
of Pathology, National Cerebral and Cardiovascular Center Research Institute, 
Osaka, Japan
Aim: Endovascular aortic repair had spread widely for the last decade. Stent 
grafts which can assimilate to native aorta are desirable for avoiding endole-
aks and migration. We have developed autologous prosthetic vascular tissues 
using “in-body tissue architecture” technology, which is a novel and practical 
approach of regenerative medicine based on the tissue encapsulation phenom-
enon of foreign materials in living bodies. Using the technology, we firstly de-
veloped novel stent grafts covered with only connective tissue (bio stent grafts: 
BSG). Their in vivo preparation method and early adaptation to aorta after im-
plantation in a beagle model will be presented.
Methods: Preparation molds for BSGs were assembled by insertion of acryl 
rods (outer diameter: 8.6 mm) into self-expanding nitinol stents (internal diam-
eter: 9.0 mm). The molds (n = 6) were embedded into subcutaneous pouches 
of 3 beagles for 4 weeks. Upon trimming excessive tissues around the 
molds after harvesting and removing each rod, BSGs were obtained. Of 6 
BSGs, 3 were implanted into abdominal aorta of beagles. Follow-up aorto-
gram and examination of aortic specimens were performed 30 days after 
implantation.
Results: Struts in BSGs were completely impregnated in connective tis-
sue membrane. Luminal surface of BSGs was extremely flat and smooth. 
BSGs were easily delivered to abdominal aorta without migration after their 
placement. Only after 4 weeks, luminal surface of the BSGs completely 
covered by neointimal layer with endothelial lining and smooth muscle cells 
content.
Conclusions: The BSGs prepared easily embedding of the molds into subcuta-
neous layer were completely fused with native aorta in short-term implantation, 
which is excellent performance for avoiding endoleaks and migration.
O69 
HIGH INFLUENCE OF PROSTHESIS SURFACE PROPERTIES ON THROM-
BOGENICITY 
S. Schmitz, P. Henning, J. Maas, I. Mager, F. Gräf, U. Steinseifer
Institute of Applied Medical Engineering, RWTH Aachen University, Aachen, 
Germany
Aim: Vascular prostheses are widely used in medical applications, for example 
in conjunction with LVADs, TAHs and for conduits. At our institute, we devel-
oped a spraying process enabling the production of adaptable prostheses with 
a non-woven structure of polycarbonaturethan (PCU). The process also allows 
the manufacturing of surfaces with different properties. In this study, the poten-
tial influence of these surface properties on the thrombogenicity is investigated.
Methods: Porcine in-vitro blood trials using bowry chambers were performed 
with sprayed PCU samples and negative and positive references. The surface 
of the PCU samples was varied with regard to the density of the fibre struc-
ture. The bowry chambers were placed on a laboratory roller mixer for 2 hours 
at 37°C. Blood samples were taken before and after the experiment. Different 
parameters, for example tromboelastography, hemogram, various coagulation 
factors and platelet factors were analysed. The PCU samples were also evalu-
ated using laser-scan microscopy.
Results: We found that surface properties have a great influence on the throm-
bogenicity of the sprayed PCU samples. Depending on the chosen surface, the 
thrombogenicity parameters ranged between the values of positive and nega-
tive reference.
Conclusions: The parameter set-up of our spraying process, and the various 
surface properties, has a high influence on its hemocompatibility. Further in-
vestigations are planned to fully understand the phenomenon and to achieve 
biocompatibility.
O70 
IN-VITRO/IN-VIVO BEHAVIOUR OF THERMOPLASTIC POLYURETHANE 
GRAFT 
M. Enayatia,b, M. Strobla,b, P. Riedla, C. Grasla,b, B. Messnera, N. Zwirchmayrc, 
R. Liskac, H. Schimaa,b, J. Wojtaa,b, H. Bergmeistera,b
aMedical University Vienna, Austria; bLudwig Boltzmann Cluster of Cardiovascular 
Res., Vienna, Austria; cTech. Uni. Vienna, Austria
Aims: Despite of the intensive research in vascular graft development, an ef-
ficient small diameter vascular graft (SDVG) is still currently unavailable for 
clinical use. In this study, synthesis thermoplastic polyurethane (TPU) vascular 
grafts were fabricated via electrospinning. The in-vitro study was carried out by 
developing a macrophage/fibroblast (M/F) co-culture (CC) model. The in-vitro 
and in-vivo behaviour of the grafts were compared with polytetrafluoroethylene 
(ePTFE) conduits.
Methods: Structure and porosity of the grafts were characterized via SEM and 
liquid intrusion method. Crystal violet staining, XTT cell viability, PCR gene 
expression (CD163 and CD68 genes) and 3D cell distribution/IF microscopy 
studies were carried out in-vitro. TPU and ePTFE grafts were implanted into 
the infrarenal aorta rats for immunohistochemistry (ED1 and ED2 staining) 
studies.
Results: The porous structure of the TPU grafts supported cell attachment, vi-
ability and growth more than the ePTFE grafts. Macrophages were both CD68+ 
and CD163+ cells, in-vitro. TPU grafts revealed notable early cellular ingrowth 
in-vivo compared to ePTFE. Also, CD68+ macrophages significantly migrated 
into all parts of the graft wall within 1 week. CD163+ cells were much less than 
CD68+ cells in both grafts.
Conclusions: The TPU grafts supported viability, attachment and distribution 
of the cells more than ePTFE grafts. Migration of the cells was more noticeable 
in TPU grafts in-vivo.
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O71 
SUCCESSFUL ONE-DEVICE-TREATMENT OF INTRACRANIAL GIANT AND 
WIDE NECK ANEURYSMS
Y. Nakayama, T. Satow, T. Mizuno, T. Moriwaki, E. Hamano, D. Ishi, M. Hayashi, 
H. Kawajiri, M. Funayama
National Cerebral and Cardiovascular Center, Osaka, Japan
Aim: We have developed a microporous covered stent for the one-device-treat-
ment of giant and wide neck intracranial aneurysms, which are particularly hard 
to complete treatment with existing clinical methods. The aim of this study is to 
establish animal experimental models for the establishment of pre-clinical func-
tional evaluation to assess the feasibility of this stent for use in the characteristic 
intracranial vessels.
Methods: Three types of animal experimental models were prepared: 1) Canine 
carotid siphon model, which was made by fixing anastomosed CCAs into a 
skeletonized acrylic framework designed according to the geometry of human 
ICA based on 3D rotational angiography; 2) Canine sidewall aneurysm model 
with modification by creating curves using a part of acrylic casing noted above 
while capable of making wide necked aneurysms on its outer curvature; 3) Stent 
placement in rabbit aorta at the branching of lumbar arteries.
Results: 1) Our stents smoothly went through the canine carotid siphon model 
in all cases. 2) Our stents fitted well in the curved vessels in all cases and spon-
taneous occlusion was confirmed in all cases after stent placement. Follow-up 
angiography at 12 weeks revealed patency of the parent vessels with com-
pletely thin neo-intimal layering. The aneurysms completely disappeared and 
were replaced by connective tissue. 3) The flow of lumbar arteries, the ostia of 
which were even covered by the stents, was maintained for 12 weeks. This is 
also observed in overlapping stent placement.
Conclusions: These experimental models in combination seem feasible and 
sufficient to assess the devices designed for endovascular treatment of intra-
cranial aneurysms on tortuous vessels with small branches. This will be useful 
as world standard for the development of intracranial endovascular devices.
O72 
LONG-TERM OBSERVATION OF RABBIT CAROTID ANEURYSMS TREATED 
BY MULTI-POROUS COVERED STENTS
Y. Nakayama, S. Nishi, H. Ishibashi-Ueda
National Cerebral and Cardiovascular Center, Osaka, Japan
Sapporo Higashi Tokushukai Hospital, Sapporo, Japan
Aim: Our covered stents can embolize aneurysms, prepared experimentally at rab-
bit carotid arteries, immediately after their placement with maintenance of side 
branching flow of vertebral arteries and internal arteries. The aim of this study is 
the evaluation of long-term patency of parent arteries and branching arteries, and 
embolization of aneurysms for clinical application in the intracranial area.
Methods: The covered stents were prepared using the specially designed bal-
loon-expandable stents with open cell structure (CoCr, 3 mm x 20 mm). The 
stents had thin polyurethane cover membrane (thickness: 20 mm), in which the 
strut was completely impregnated, with a larger amount of micropores (diame-
ter: 100~300 mm, opening ratio: 10~30%). Experimental aneurysms (10~15 mm) 
were created at rabbit brachiocephalic arteries (3 mm) by distal ligation and 
intraluminal elastase incubation at right common carotid arteries. Upon placing 
the covered stents at the neck of the aneurysms, all aneurysms were occluded 
immediately (n = 50). All the parent arteries were patent after implantation for 
over 2 years. After 3 months of implantation, the inner space of the aneurysms 
was filled completely with granulomatous tissue and luminal surface was cov-
ered with extremely thin neointima. Its thickness was extremely thin (ca. 150 mm) 
throughout the entire observation period. The branching flow through the cover 
membrane was maintained completely in all cases.
Conclusions: Our covered stents performed well in that they yielded less inti-
mal hyperplasia with maximum embolization effect without disturbing branching 
flow for over 2 years.
O73 
ELASTIN-LIKE RECOMBINAMERS BIOSTENT
I. González de Torrea, F. Wolfb, M. Alonsoa, L. Rongenb, S. Jockenhoevelb,c, 
J.C. Rodríguez-Cabelloa, P. Melab
aBIOFORGE, CIBER-BBN, University of Valladolid, Spain; bDepartment of 
Tissue Engineering & Textile Implants, Institute of Applied Medical Engineering, 
RWTH Aachen University, Aachen, Germany; cInstitut für Textiltechnik, RWTH 
Aachen University, Aachen, Germany 
Aim: Restenosis and thrombosis after stent implantation remain important clini-
cal complications, which drive continuous development in the fields of percuta-
neous interventional cardiology and radiology. We explored the use of recently 
developed gels obtained by catalyst free click reaction of elastin-like recombi-
nant polymers (ELR) to fabricate a new class of vascular stents, with the ultimate 
goal of creating endovascular devices that exclude the atherosclerotic plaque 
from the blood stream, prevent cellular ingrowth in the vessel’s lumen, have high 
biocompatibility, physiological hemocompatibility and elicit a reduced response 
of the immune system. 
Methods: The approach consists in embedding bare metal stents in the ELR-
gels by injection molding, followed by endothelialization under dynamic pres-
sure and flow conditions in a bioreactor. 
Results: The elastin-like hydrogel-bioStents (ELR-bioStents) exhibited mechan-
ical stability under high flow conditions in vitro and could undergo crimping and 
deployment without damage. The presence of RGD in the ELR supported full 
endothelialization in less than two weeks in vitro. Minimal platelet adhesion and 
fibrin adsorption were detected after exposure to blood as shown by immunos-
taining and scanning electron microscopy. 
Conclusions: These results prove the potential of the proposed approach 
towards a new and more effective generation of stents.
O74 
DYNAMIC MECHANICAL CHARACTERIZATION OF SMALL DIAMETER 
VASCULAR GRAFTS ORIENTATED FIBER STRUCTURES
M. Stoibera,b, C. Grasla,b, V. Hörmanna, H. Bergmeistera,b, H. Schimaa,b
aMedical University of Vienna, Austria; bLudwig-Boltzmann-Cluster for Cardio-
vascular Research, Austria
Aim: Electrospinning is a promising method to create small diameter vascular 
grafts. For good functionality mesh structure and mechanical behaviour are es-
sential. Fiber orientation and mesh density influence tensile strength, elasticity 
and cell growth. Due to different structural requirements between inside (cell 
attachment) and outside (cell in-growth), multilayered grafts are favourable. In 
this work, the effect of highly oriented fibers on mechanical behaviour was in-
vestigated by dynamic tensile tests.
Methods: Four types of electrospun vascular grafts were investigated: Fibers 
oriented randomly, in circumferential, longitudinal and cross-wise direction 
(with 30° angle). In hoop tensile measurements rings of 2 mm length were load-
ed sinusoidally for 1000 cycles at 10 Hz between 0.03 and 0.06 N, correspond-
ing to a blood pressure of 80 to 120 mmHg. Finally, a quasi-static tensile test 
until rupture was performed.
Results: Circumferential oriented fibers exhibited the highest tensile force but 
the lowest compliance with 6.1 ± 0.9%/100 mmHg. The other types had sig-
nificant lower tensile force but enhanced compliance with best performance of 
longitudinally oriented types (15.6 ± 3.2%/ mmHg). However, continuous creep-
ing was seen in longitudinally oriented type by a diameter change of 8.8% after 
1000 cycles compared to 3.4% in circumferential oriented type.
Conclusions: Oriented fiber structures allow the adjustment of biomechanical 
properties in electrospun vascular grafts.
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HEMODYNAMIC EFFECTS OF PARTIAL RIGHT VENTRICULAR SUPPORT 
IN THE ACUTE VS THE CHRONIC PRESSURE OVERLOADED RIGHT 
VENTRICLE 
T. Verbelena, M. Martinb, M. Godaa, K. Kasamaa, I. Van Tichelena, D. Burkhoffb, 
M. Delcroixa, F. Regaa, B. Meynsa
aUniversity of Leuven, Leuven, Belgium; bCirculite, Inc., Hackensack, USA
Purpose: Temporary right ventricular (RV) support for the acute pressure over-
loaded RV after heart transplantation or acute lung edema is well described. 
Patients with a chronic pressure-overloaded RV might also benefit from this 
support. We wanted to assess the hemodynamic effects of RV support in the 
acute vs the chronic pressure overloaded RV.
Methods: The pulmonary artery was banded in 16 sheep. In 8 sheep we im-
mediately [‘Acute’] implanted a CircuLite® Synergy® micro-pump draining blood 
from the right atrium to the pulmonary artery. In the second group, the same 
pump was implanted only 8 weeks after banding [‘Chronic’]. Hemodynamics 
were recorded before and after pump implantation.
Results: Only in ‘Chronic’, initiation of the pump resulted in a significant increase 
of left atrial pressure and a significant decrease of RV end systolic pressure.
The pump generated flows of 1.40 ± 0.47 L/min in ‘Acute’ and 2.81 ± 0.12 L/ 
min in ‘Chronic’ (p<0.0001), both at 22 kRPM. There was no difference in 
total cardiac output. However, the contribution of the RV in generating the 
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total cardiac output was significantly lower in ‘Chronic’ (19 ± 12 vs 59 ± 8%, 
p<0.00001).
Pressure-volume loop analysis showed that in supported ‘Chronic’ stroke vol-
ume, ejection fraction and end systolic pressure were significantly lower (15.4 ± 
5.8 vs 25.4 ± 4.4 ml, p<0.01; 17 ± 6 vs 25 ± 4%, p<0.05 and 27.7 ± 7.4 vs 
43.1 ± 12.0 mmHg, p<0.05, respectively), compared to supported ‘Acute’. 
Conclusions: Supporting the pressure overloaded RV optimizes hemodynam-
ics towards the same levels in ‘Acute’ vs ‘Chronic’. However, the contribution 
of the RV to the generation of the total CO is significantly lower in ‘Chronic’. 
Therefore, at our opinion, the failing RV might benefit even more from mechani-
cal support in case of chronic pressure overload.
O76 
NEUROHORMONAL MARKERS DURING MECHANICAL CIRCULATORY 
SUPPORT
S. Jacobsa, J. Danserb, F. Regaa, B. Meynsa
aCatholic University Leuven, Leuven, Belgium; bErasmus Hospital Rotterdam, 
Rotterdam, The Netherlands 
Aim: NT-proBNP and plasma renin activity (PRA) are used as biomarkers in 
chronic heart failure. NT-proBNP levels are frequently used for follow-up dur-
ing mechanical circulatory support. However NT-proBNP levels are affected by 
renal function of the patient. PRA measurement during mechanical circulatory 
support might have added value in follow-up of patients with a left ventricular 
assist device (LVAD).
Methods: Between 2009 and 2013 PRA, NT-proBNP and renal function was 
measured prospectively in 55 patients undergoing LVAD implantation (Heart-
Mate II, Thoratec), preoperatively and at fixed time points over the next 
12 months. Renal function (Glomerular filtration rate, GFR) was calculated using 
the Modification of Diet in Renal Disease (MDRD) formula. 
Results: PRA and NT-proBNP levels decreased significantly during the first 
14 days of support (37,4 ± 32,3 µg/L/h vs. 9,1 ± 12,3 µg/L/h; p<0,0001 and 
10356 ± 10807 ng/L vs. 4345 ± 7715 ng/L; p<0,01) and remained decreased 
during the first year of support. Renal function improved in the first 14 days 
(64 ± 35 mL/min vs. 106 ± 48 mL/min; p<0,0001), at 12 m this effect was no lon-
ger statistically significant (64 ± 35 mL/min vs. 73 ± 26 mL/min; p = 0,12). There 
was no significant correlation between PRA and NT-proBNP (Pearson correla-
tion coefficient = 0,063; p = 0,438) or PRA and GFR (Pearson correlation coef-
ficient = -0,094; p = 0,190). There was a strong correlation between NT-proBNP 
and GFR (Pearson correlation coefficient = -0,249; p<0,0001).
Conclusions: PRA and NT-proBNP levels decrease significantly during LVAD 
support. NT-proBNP showed a strong correlation with renal function. PRA had 
no correlation with the renal function. Measuring PRA might have added value 
in the follow-up of patients with a LVAD.
O77 
NUCLEAR AND MITOCHONDRIAL TRANSLOCATION OF PHOSPHORY-
LATED PKCΔ ASSOCIATES WITH TUNEL-POSITIVE AND UROCORTIN 
NEGATIVE STAINING IN THE HUMAN HEART FROM DIABETIC PATIENTS 
UNDERGOING ON-PUMP CARDIAC SURGERY
C. Chen-Scarabellia, R. Knightb, A. Stephanoub, R. Mccauleyc, L. Saravolatz IIc, 
F. Onoratid, M. Tessarid, A. Rungatscherd, D. Latchmanb, R. Abbascianod, 
L. Saravolatzc, A. Mazzuccod, T.M. Scarabellic, G. Faggiand
aVA Ann Arbor Health Care System, University of Michigan, USA; bMedical 
and Molecular Biology Unit, University College London, London, UK; cCenter 
for Heart and Vessel Preclinical Studies, St John Hospital and Medical Center, 
Wayne State University, Detroit, USA; dDivision of Cardiothoracic Surgery, Uni-
versity of Verona, Verona, Italy
Aim: Molecular mechanisms responsible for the reported worse outcome of dia-
betic patients (DMP) after on-pump cardiac surgery (OPCS) remain unknown. 
Opposite effects have been reported for Urocortin (Ucn)/PKCε and PKCδ, the 
former being cardio-protective and the latter pro-apoptotic. We investigated 
the role of PKCε and PKCδ in Ucn-induced cardio-protection in DMP and non-
diabetic patients (NDMP) after OPCS. 
Methods and Results: Two sequential biopsies were obtained from the right 
atrium of 27 DMP and 22 NDMP before Cardio-Pulmonary Bypass (CPB) and 
10 minutes after declamping. In post-cardioplegic NDMP, Ucn was induced at 
both mRNA and protein levels (p<0.01); conversely, post-cardioplegic induction 
was not observed in DMP (p = NS) and pre-cardioplegic levels of Ucn were 
50% lower than NDMP (p<0.05). In NDMP, cardioplegic arrest increased PKC-ε 
mRNA and protein (p<0.05), while overexpression of PKC-δ was not seen. In 
contrast, DMP showed increased expression of PKCδ (p<0.01) with no change 
in PKCε. Phosphorylation and mitochondrial relocation of PKCε were only 
detected in post-cardioplegic samples from NDMP, while nuclear and mitochon-
drial translocation of activated PKCδ was mainly evident in post-cardioplegic 
samples from DMP. Apoptosis was over 2-fold higher in post-cardioplegic 
samples from DMP than NDMP. Apoptotic myocytes were Ucn-negative and 
exhibited nuclear and mitochondrial relocation of PKCδ, while enhanced PKCε/
mitochondrial co-localization was observed in viable, Ucn-positive, myocytes. 
Conclusions: We report that in DMP, cardioplegic arrest failed to induce myo-
cyte over-expression of Ucn and PKCε, but was associated with induction and 
mitochondrial relocation of PKCδ, resulting in apoptosis. Failure to over-express 
Ucn makes the DMP more susceptible to apoptosis, thus contributing to the 
reported worse postsurgical outcomes.
O78 
OSCILLOMETRIC BLOOD PRESSURE MEASUREMENTS IN ROTARY 
BLOOD PUMP RECIPIENTS
M. Graneggera,b, F. Moscatoa,b, T. Schlöglhofera,b, D. Zimpfera, H. Schimaa,b
aMedical University of Vienna, Vienna, Austria; bLBC for Cardiovascular 
Research, Vienna, Austria
Aim: In rotary blood pump (RBP) recipients with low blood pressure (BP) pulsa-
tility usual methods to measure BP non-invasively are not suitable, both auto-
matic and manual measurements may become unreliable. Aim of this study was 
to determine the potentials and limitations of the oscillometric BP measurement 
in this patient population. 
Methods: In 15 RBP recipients BP was measured non-invasively up to 9 times 
(3 measurements at 3 different timepoints) during their stay on the ICU. The cuff 
was inflated and subsequently released at a rate of 3 mmHg/s. The pressure 
traces were detrended for determination of the envelope around the oscilla-
tions. A Gaussian-curve was fitted to the envelope and its maximum value was 
considered the mean arterial pressure (MAP). This value was then compared to 
the invasively measured BP. 
Results: A total of 99 measurements were performed. 11 recordings were vi-
sually excluded from further analysis due to obvious artefacts. The invasively 
determined BP in the 15 patients was 92.5 ± 14.9/79.8 ± 12.6/72.7 ± 13.0 (sys/
mean/dia). Pressure pulsatility was 19.8 ± 12.7 mmHg. Bland-Altman analy-
sis indicated good agreement between the noninvasively and invasively deter-
mined MAP (-1.4 ± 7.1 mmHg). 
Conclusions: MAP could be measured noninvasively in RBP recipients with 
mean accuracy comparable to studies with healthy subject. Whereas low pres-
sure pulsatility alone did not result in erroneous measurements, a combination 
of both low pulsatility and arrhythmia led to large deviations of the non-invasively 
measured MAP.
O79
THE COMPARISON BETWEEN SYNCHRONIZATION AND NON-SYNCHRO-
NIZATION WITH CARDIAC BEAT UNDER THE PULSATILE MODE WITH A 
ROTARY LVAD BY A NATIVE HEART LOAD CONTROL SYSTEM
D. Kazumaa,b, T. Nishimuraa, Y. Takewaa, S. Kishimotoa, M. Onob, E. Tatsumia
aNational Cerebral and Cardiovascular Center, Research Institute, Department 
of Artificial Organs, Osaka, Japan; bThe University of Tokyo, Department of 
Cardiothoracic Surgery, Osaka, Japan
Aim: We have previously developed a Native Heart Load Control System for a 
continuous-flow left ventricular assist device and demonstrated that the rota-
tional speed (RS) in synchronization with the cardiac cycle can alter pulsatility 
and left ventricular (LV) load. In this study, we compared these effects with the 
fix pulsatile mode by changing the RS independently of the cardiac cycle.
Methods: We implanted EVAHEART via left thoracotomy in seven goats (52.9 ± 
5.0 kg) with a normal heart. After the implantation, we administered propranolol to 
reduce heart rate around 60 bpm. In previous experiments, rotational speed of the 
pulsatile mode was increased during the initial 33% of RR interval of the systolic 
phase by an automatical control based on electrocardiogram. In the fix pulsatile 
mode, we made up pseud-RR interval by temporary pacemaker and increased 
RS regardless of systolic phase. We used three modes, the continuous mode 
(constant RS), the pulsatile mode (increase RS in systolic phase), and the fix pul-
satile mode and shifted pseud-RR interval 500 ms, 600 ms, 750 ms and 1000 ms. 
In these modes, we assessed the change of pulsatility (pulse pressure and dp/dt 
max of aortic pressure) and LV load (stroke work and LV end-diastolic volume).
Results: There were significant increases in pulsatility and LV load of the pul-
satile mode relative to the values of the continuous mode. However, in the fix 
pulsatile mode, there were much less increased in these values regardless of 
pseud-RR interval.
Conclusions: Fix pulsatile mode could produce less pulsatility and LV load than 
the pulsatile mode.
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O80 
ANALYSIS OF R WAVE AMPLITUDE DURING VAD IMPLANTATION, 
EXPERIMENTAL STUDY
L. Fresielloa, M.G. Trivellaa, A. Di Molfettaa, G. Ferraria, F. Berninib, O. Mestec
aIFC CNR Rome-Pisa, Italy; bSSSA, Pisa, Italy; cI3S UNS-CNRS, Nice-Sophia 
Antipolis, France
Aim: It is known in literature the coupling between the electrical and mechanical 
activity of the ventricle. This work is aimed at investigating if this relationship is 
still present during a ventricular assist device (VAD) and if it can be of help for 
VAD patient monitoring.
Methods: Data of 6 animals undergoing an atrio-aortic VAD implantation sur-
gery were analysed, 5 with a Gyro Centrifugal pump 2, and 1 with a Circulite 
Synergy Micropump. In all experiments VAD was activated and then speed was 
increased progressively. Electrocardiographic (ECG) and left ventricular volume 
data were recorded and analyzed: the R wave peak (RWA) was individuated and 
the volume in the corresponding time was identified. After a moving average 
analysis on both signals, a regression and correlation analysis was performed.
Results: For all experiments the increment of VAD speed provoked a decrement 
of ventricular end-diastolic volume and a corresponding increment of RWA. This 
trend was confirmed by the correlation analysis, showing a strong negative re-
lationship between the RWA and the corresponding ventricular volume (r~-0.8 
and p<0.001 for all experiments).
Conclusions: The present work evidences the potential usefulness of the ECG, 
a low invasive and low cost signal, in inferring information about the status of 
the ventricle during VAD. This may be a first step in a future remote monitoring 
of ventricular unloading and VAD therapy optimization.
Acknowledgments: This work was supported by SensorART (N. 248763) and 
CNR-CNRS bilateral project (N. 139804).
O81 
APPLICATION OF THREE-DIMENSIONAL VISUALIZATION AND PRINTING 
METHODS IN THE PREOPERATIVE PLANNING OF COMPLEX CONGENITAL 
HEART DEFECT REPAIR
M. Küttinga, Z. Zhonga, J. Vodiskarb, J. Vazquez-Jimenezb, U. Steinseifera
aDepartment of Cardiovascular Engineering, AME, Helmholtz Institute, RWTH 
Aachen University, Aachen, Germany; bPediatric Heart Surgery, University Clinic 
Aachen, Aachen, Germany
Background: Congenital heart defects are diverse and often complex in form. 
Their repair requires surgical experience and skill as well as preoperative plan-
ning using medical imaging data. In order to provide operating physicians with 
all available data, virtual anatomical studies are performed using preoperative 
CT and MRI datasets. 
Methods: Using the programs Mimics and 3Matic (Materialise, Belgium), ana-
tomical models are extracted and analysed. Measurements are performed along 
with physicians and models are visualized using 3D projection on a holobench. 
For a better understanding of dimensions, models are 3D printed in solid form 
or flexible silicone models are cast.
Results: Operating physicians quickly adapted to the proposed tools for pre-
operative planning. While measurement of the value that 3D imaging and print-
ing add to procedural planning and success are difficult, clinical outcome and 
feedback from physicians indicate a benefit and desire to continue developing 
and using these methods.
Conclusions: Complex congenital heart defects present a challenge for any 
operating physicians and any available method promising a potential improve-
ment to outcome should be applied and optimized. 3D visualisation and print-
ing should be available to physicians in the planning of complex cardiothoracic 
surgical procedures.
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O82 
THERAPEUTIC EFFECT OF NONWOVEN BIODEGRADABLE FILTERS WITH 
MESENCHYMAL STEM CELLS ON A RAT MODEL OF CHRONIC RENAL 
FAILURE
H. Hori, M. Shinzato, K. Kawaguchi, A. Ohashi, S. Nakai, S. Nagao, Y. Hiki, 
N. Kitaguchi 
Fujita Health University, Toyoake, Japan
Aim: Devices consisting of nonwoven filters and cells captured thereon have 
been investigated for regeneration or recovery of impaired kidneys. The cells 
on nonwoven filters were expected to serve as a local supply of growth factors 
and cell sources when they are placed near the injured kidney. In this study, 
biodegradable nonwoven filters made of polylactic acid (PLA) were investigated 
in combination with rat mesenchymal stem cells derived from bone marrow 
(rBMSCs).
Methods: PLA filter disks were placed into cell-capturing devices, then, rBMSCs 
were passed through the filters. The filters/rBMSCs complex was cultured for 
evaluating growth factor production, or implanted in the kidney of 5/6 nephrec-
tomy rats followed by resection of the kidney after eight weeks. This study was 
approved by the Institutional Animal Care and Use Committee of Fujita Health 
University.
Results: The capture rates of rBMSCs on five PLA filter disks were more than 
85%. The production of hepatocyte growth factor (HGF) by rBMSCs was sig-
nificantly enhanced by the interaction with PLA filters. The PLA filters/rBMSCs 
complex decreased glomerulosclerotic lesions when it was attached to the sur-
face of the injured kidney.
Conclusions: rBMSCs on PLA nonwoven filters enhanced their HGF produc-
tion, and improved glomerulosclerosis of chronic renal failure models.
Acknowledgments: This work was partly supported by Aichi Kidney Foundation 
and JSPS KAKENHI grant number 25410232.
O83 
AMNIOTIC FLUID RENAL PROGENITORS AND RENAL EXTRACELLULAR 
MATRIX: A NEW APPROACH FOR KIDNEY REGENERATION
I. Zanussoa,b, S. Da Saccoa, S. Lesliec, A. Petrosyana,c, K.V. Lemleya,c, MT. Conconib, 
L. Perina,c, R.E. De Filippoa,c
aChildren’s Hospital Los Angeles, Los Angeles, USA; bUniversity of Padova, 
Padova, Italy; cUSC, Los Angeles, USA
Aim: Renal congenital abnormalities still remain a significant contributing fac-
tor for chronic kidney disease. Current treatments aimed at slowing progres-
sion of the disease are insufficient and often dialysis and/or transplantation 
becomes necessary. Combination of a natural or biodegradable scaffold with 
cells could be a new approach to discover alternative tools for replacing sig-
nificantly impaired or non-functional kidney tissues. Our laboratory has previ-
ously reported that human amniotic fluid (AF) is a source of renal progenitor 
cells.
Methods: A subpopulation of renal progenitor cells expressing were isolated 
from AF. Using a detergent-enzymatic method, we decellularized whole mouse 
kidney extracellular matrix (ECM) that was seeded with renal progenitor cells, 
implanted into the kidney of nude mice, and harvested for characterization.
Results: One month after surgery, implanted ECM showed angiogenesis and 
formation of renal tubular-like structures. In addition to formation of 3D renal 
structures in the scaffolds, cells positive for markers associated with essential 
renal cell types, such as mesangial, podocytes and tubular cells were detected.
Conclusions: These results suggest that AF renal progenitor cells seeded into 
renal ECM could represent a unique investigational approach for kidney regen-
eration that may be used to augment or replace damaged or compromised kid-
ney tissue from either congenital or chronic disease.
O84 
KIDNEY TISSUE ENGINEERING BASED ON DECELLULARIZED MATRIX 
SCAFFOLDS
B. Bonandrinia, M. Figliuzzia, S. Silvania, I. Cattaneoa, F. Sangallia, A. Benignia, 
G. Remuzzia, A. Remuzzib
aIRCCS-Istituto “Mario Negri”, Bergamo, Italy; bUniversity of Bergamo, Dalmine 
(BG), Italy
Aim: Chronic kidney disease progressively deteriorates kidney function. New 
therapies for severely damaged kidneys are needed due to limited regenerative 
capacity of the kidney and organ donor shortages. One possibility is to create 
new kidneys by tissue engineering with decellularization and recellularization 
processes.
Methods: For decellularization, rat and porcine kidneys were perfused by so-
dium dodecyl sulfate. Integrity of scaffolds and ECM structure and composition 
was investigated by optical microscopy, micro-CT and immunofluorescence. 
Acellular scaffolds were then seeded with HUVEC and mES cells through the 
renal artery and ureter, respectively. Cell distribution was investigated by immu-
nofluorescence and H&E stainings.
Results: We obtained whole organ scaffolds with the intact 3D geometry by de-
cellularization as shown by histological examination and SEM analysis. Micro-
CT scan established integrity, patency and connection of the vascular network. 
The seeded cells infused through renal artery were uniformly distributed in the 
vascular network and in glomerular capillaries while cells infused through ureter 
reached the tubular compartments.
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Conclusions: Our findings indicate that rat and porcine kidneys can be 
successfully decellularized to produce intact renal ECM scaffolds able to 
support the engrafment of cells in glomerular and tubular structures. This 
study represents an initial step toward development of a transplantable 
organ.
Acknowledgments: The research was supported in part by the ERC Grant 
(RESET-268632).
O85 
CREATININE TRANSPORT THROUGH HUMAN PROXIMAL TUBULE CELL 
MONOLAYERS ADHERENT TO BIOFUNCTIONALIZED PES MEMBRANES
I.E. De Napolia, C.M.S. Schophuizenb, J. Jansenb, S. Texeiraa, M.J. Wilmerb, 
J.G.J. Hoenderopb, D.W. Grijpmaa, L.P.W. Van den Heuvelb, R. Masereeuwb, 
D. Stamatialisa
aUniversity of Twente, Enschede; bUniversity of Radboud UMC, Nijmegen, The 
Netherlands
Aim: Membranes for bioartificial kidney (BAK) have to be an ideal scaffold 
for cell adhesion, proliferation and function expression. Poor renal cells bio-
compatibility of polymer membranes calls for the need of their bio-function-
alization. We investigated the optimization of collagen IV (cIV)-based double 
coating on polyethersulfone membranes (PESM) to favor functional mono-
layer formation of a conditionally immortalized proximal tubule epithelial cell 
line (ciPTEC).
Methods: PESM were coated with 3,4-Dihydroxy-L-phenylalanine (L-DOPA) 
and cIV. Morphological and transport properties changes of differently coated 
PESM were investigated. CiPTECs monolayer formation on coated membranes 
was examined by immunocytochemical stain of tight junction protein ZO-1. 
Transepithelial transport of 14C-creatinine (Papp) was measured by liquid scin-
tillation. 
Results: Double coated PESM presented progressively more stable cIV ad-
hesion with increasing dissolution and exposure time to L-DOPA. Both ZO-1 
expression and creatinine Papp through ciPTEC monolayers was higher for 
cells cultured on double coated PESM than standard Transwells®. Trans-
port inhibitors addition significantly reduced the creatinine Papp for all 
conditions.
Conclusions: Optimal performance of CiPTECs on double coated PESM 
makes this a promising strategy for the development of BAK with functional 
cell monolayers. 
Acknowledgments: The authors acknowledge BMM institute for economic 
support.
O86 
INTEGRATION OF MULTI-PARAMETRIC SENSOR SYSTEMS IN BIOARTIFI-
CIAL LIVER SUPPORT SYSTEM
M. Richtera, S. Tröbsa, M-L. Cosnierb, H. Schuckc, N. Freyera, F. Schubertd, 
M.C. Wrighte, K. Zeilingera
aBCRT, Charité Universitätsmedizin Berlin, Germany; bCEA-Leti MINATEC, 
Grenoble, France; cFraunhofer IBMT, St. Ingbert, Germany; dStem Cell Systems, 
Berlin, Germany; eUniversity Newcastle, Newcastle, UK
Aim: Bioartificial liver support (BAL) technologies provide an option for tempo-
rary bridging of the liver function in severe diseases. Multi-parametric monitor-
ing of liver support systems could improve quality control and clinical safety of 
the systems.
Methods: Rat pancreatic progenitor-derived hepatocytes were cultured in a 3D 
multi-compartment bioreactor culture system. For non-invasive in-vitro moni-
toring foil-base impedance sensors were integrated in the cell compartment. 
A new ammonium sensor, and also optical-chemical pH and O2 sensors were 
integrated into the perfusion circuit.
Results: The metabolic activity of the cells in the bioreactor system was not 
influenced by sensor integration, as shown in comparison with sensor-free 
control systems. The time course of impedance signals recorded at differ-
ent locations in the cell compartment showed a comparable time course. 
Impedance signals reflected changes in the culture state and perfusion 
media. Online ammonia and O2 measurements correlated with daily tak-
en samples. Online monitoring of pH allowed supporting constant culture 
conditions.
Conclusions: Successful integration of non-invasive multi-parametric sensors 
in the 3D bioreactor system resulted in real-time monitoring of the cell behav-
iour. Thus, changes in the cell behaviour can be detected immediately and al-
lows for early decision making regarding BAL application.
O87 
ENCAPSULATED PRIMARY HETERO-SPHEROIDS FOR BIOARTIFICIAL 
LIVER APPLICATION
V. Pandolfi, U. Pereira, M.J. Fleury, P. Paullier, M. Dufresne, C. Legallais
Lab Biomechanics & Bioengineering, University of Technology, Compiègne, 
France
Aim: Biologically active hepatocytes culture is essential for bioartificial liver 
(BAL) devices. Primary hepatocytes dedifferentiate and rapidly lose their func-
tions after isolation from their in vivo environment. This work aims at improving 
in vitro hepatocyte-specific functionality over time by co-culturing primary he-
patocytes with the main sinusoidal lining cells, in the shape of micro-encapsu-
lated hetero-spheroids.
Methods: Isolated rat primary hepatic cells (hepatocytes, sinusoidal endothe-
lial cells, Kupffer cells, and hepatic stellate cells) were cultured according to 
optimized cell ratios on siliconized dishes under orbital oscillation. The result-
ing hetero-spheroids were encapsulated in alginate beads and maintained in 
culture for following analysis at settled time-points. Cell types were identified 
by immunocytochemistry and hepatic functions were examined. Biosynthetic 
function was assessed by analysing albumin secretion, detoxifying potential 
was measured as urea production from ammonium chloride, and phase I bio-
transformation activity was evaluated by quantitative cytochrome P450 assays. 
Results: Hetero-spheroids were found to form more rapidly than homo-spher-
oids. The former showed an encouraging maintenance of the hepatic functions. 
Conclusions: A mass production of these encapsulated hetero-spheroids 
could represent a promising tool for the clinical application of the fluidized bed 
BAL device developed in our laboratory. 
Acknowledgements: This work is sponsored by Marie Curie ITN – BIOART 
Project.
O88 
LIPOSOME-ENCAPSULATED HEMOGLOBIN IMPROVES TUMOR OXY-
GENATION AS DETECTED BY NEAR-INFRARED SPECTROSCOPY (NIRS) 
IN COLON CARCINOMA IN MICE
F. Kawaguchia, AT. Kawaguchia, A. Kamijyoa, M. Haidab, D. Kuritaa, C. Murayamaa
aTokai University School of Medicine; bJunior College of Nursing & Medical 
Technology, Kanagawa, Japan
Aim: Liposome-encapsulated hemoglobin with high (h-LEH, P50 = 10 mmHg) 
or low O2-affinity (l-LEH, P50 = 40 mmHg) may improve O2 delivery to sensitize 
tumor tissues for anti-tumor therapies. 
Methods: Ten mL/kg of h-LEH, l-LEH, red blood cells (RBC) or saline was in-
fused in mice transplanted with murine colon carcinoma with the near-infrared 
spectroscopy (NIRS) detector set at the tumor and intact muscle. NIRS record-
ed changes in the amount of oxy-hemoglobin (Oxy-Hb), deoxy-Hb and sum 
(Total-Hb). Then, inspiratory gas was turned to pure O2 and back to room air. The 
tumor was finally excised for the weight and histological examination. 
Results: Total-Hb increased in the order of mice receiving h-LEH> l-LEH> RBC> 
Saline in the intact muscle as well as in attenuated magnitude in the tumor tis-
sue. Relative changes in Oxy-Hb and Deoxy-Hb allowed assumption of average 
PO2 in the intact muscle at 35 mmHg and tumor at 10 mmHg, allowing that % 
SO2 increased about 1% both in the muscle and tumor tissue in mice treated 
with h-LEH, RBC or Saline, but not in l-LEH-treated mice. While pure O2 respira-
tion decreased Total-Hb in the intact muscle regardless of intravenous medica-
tion, it increased Total-Hb in the tumor only in mice treated with h-LEH or l-LEH. 
Conclusions: The results suggest that nanometer size LEH may result in an in-
crease in Total-Hb in tumor < muscle. Relative change in Oxy-Hb and Deoxy-Hb 
suggests intravenous infusion of h-LEH, but not l-LEH, increase PO2 and SO2 in 
the tumor, but not in the intact muscle. H-LEH may allow targeted O2-delivery to 
tumor and enhance anti-tumor therapies.
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O89 
IMMUNOPROTECTIVE MULTIBORE HOLLOW FIBER MEMBRANES FOR 
ISLET MACROENCAPSULATION
K. Skrzypek, M. Groot Nibbelink, A.A. van Apeldoorn, D. Stamatialis
University of Twente, Enschede, The Netherlands
Aim: The efficacy of clinical islet transplantation is hindered mostly by lack of 
vascularization, inflammatory response to the donor islets and high concen-
tration of immunosuppressive drugs. Here, we develop a macroencapsula-
tion device based on thin membranes, able to shield the islets from the host 
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was conducted at the initial driving condition and the ventricular suction condi-
tion, since the flow rate was determined to be 0 L/min under these conditions. 
For the evaluation of the developed flow meter, the initial driving condition and 
the ventricular suction condition were reproduced in the mock circulation study 
for 24 h. In the animal study with a goat, the blood flow rate was measured for 
19 h. In both studies, the measured flow rates were compared to those mea-
sured by a commercial flow meter.
Results: From the mock circulation study, the average measurement error was 
less than ± 0.25 L/min. From the animal study, the average measurement error 
was less than ± 0.27 L/min.
Conclusions: We confirmed that zero compensation method for the developed 
flow meter worked effectively, and the developed flow meter was able to mea-
sure flow rate accurately in the animal study.
O92 
POLYMER-PHOSPHOLIPID COMPLEXES FOR THE SOLUBILISATION AND 
DELIVERY OF DRUGS TO THE EYE 
V. Saez-Martinez, B.J. Tighe
Aston University, Birmingham, UK
Aim: Topical application of ophthalmic drugs is very inefficient; contact lenses 
used as drug delivery devices could minimize the drug loss and side effects. 
Styrene-maleic acid copolymers (PSMA) can form polymer-phospholipid 
complexes with dipalmitoyl phosphatidylcholine (DMPC) in the form of nano-
metric vesicles, which can easily solubilise hydrophobic drugs. They can be 
dispersed on very thin contact lens coatings to immobilize the drug on their 
surface.
Methods: Two types of complexes stable at different pH values (5 and 7 re-
spectively) where synthesized and loaded with drugs of different hydrophilici-
ties during their formation process. The drug release was studied in vitro and 
compared to the free drug. 
Results: The mean sizes of the complexes obtained by light scattering were 
50 nm and 450 nm respectively with low polydispersities. However, they were 
affected by the drugs load and release. An increase was observed in the du-
ration of the release in the case of hydrophobic drugs, from days to weeks, 
avoiding initial “burst” and with a lesser amount of total drug released due to 
the interaction of the drug with the phospholipid core. The size and charge of 
the different drugs and the complexes nature also affected the release profile. 
Conclusions: Polymer-phospholipid complexes in the form of nanoparticles can 
be used to solubilise and release hydrophobic drugs in a controlled way. The 
drug load and release can be optimised to reach therapeutic values in the eye.
O93 
COMPUTATIONAL MODEL OF RED CELL FLOW IN MICRO-CHANNELS 
FOR PROBING MOLECULES ENCAPSULATION
G. Casagrande, E. Bianchi, M.L. Costantino
Politecnico di Milano, Milan, Italy
Aim: Preliminary experiments confirm the possibility to load Red Blood Cells 
(RBCs) with probing molecules (PM) by applying mechanical shear stresses 
(τ) on RBCs stroma. This work is aimed at studying the optimal fluid dynamic 
conditions allowing the encapsulation of PM into RBCs flowing in a micro-
channel (MC).
Methods: A computational model was developed by using COMSOL Multi-
physics 4.2a (Stockholm, Sweden). A 50 x 50 µm cross-section and 58.5 mm 
length MC was considered. The Mixture Model was used to evaluate velocity (v), 
volume fraction of dispersed phase (Id) and τ for a suspension of RBCs and PM 
(FITC-Dextran) in a Phosphate Buffer. 
When the pair of τ values and duration lays in the sub-haemolytic portion of the 
Tillman Diagram, and the RBCs transit time into the MC is higher than the dif-
fusion characteristic time of PM into RBCs, encapsulation was promoted. The 
flow rate Q, and the haematocrit Ht and MC size were tuned to optimise fluid 
dynamic conditions and increase encapsulation. 
Results: Optimal conditions were Q = 40 µl/min and Ht <0.15 with the modelled 
MC. The resulting high pressure drop suggests to increase MC width (2000 µm) 
by keeping constant height and length. The new optimal conditions were 
Q = 1600 µl/min, 0.05<Ht<0.30. A normalized index (Ie) was defined as the 
product of v, τ and rd; encapsulation is higher in the round crown region of the 
MC section, where 0.8<Ie<1.
Conclusions: The developed model allows to characterize RBCs fluid dynam-
ics in MC and to identify the optimal conditions to promote PM encapsulation 
into RBCs. This model will be used to design a new experimental set-up, defin-
ing appropriate test conditions.
immune cells without compromising their insulin release in response to blood 
glucose.
Methods: Poly(ethersulfone)-based hollow fibre membranes were tested for 
encapsulation of islets of Langerhans. Hydraulic permeance and convective 
transport of glucose, insulin, BSA and IgG were determined. Islets viability and 
functionality in the bores were assessed by histology and response to glucose.
Results: Glucose and insulin permeance through the membranes is compa-
rable to that of water. The permeance of BSA and IgG is lower especially at low 
transmembrane pressures, and the sieving coefficient of IgG is almost zero. 
TUNEL assay showed hardly any apoptotic cells after 7 days of culture, while 
GIIST showed a moderate response to insulin changes due to relatively big bore 
size in comparison to islets. 
Conclusions: Transport measurements indicate that islets are able to sense 
glucose and IgG is mainly blocked by the membrane suggesting that our de-
vice is suitable for islet encapsulation. The device dimensions still need to be 
optimized.
O90 
A CFD ANALYSIS OF AORTIC FLOW DURING LINEAR AND PULSED 
EXTRACORPOREAL MEMBRANE OXYGENATION UNDER DIFFERENT 
INFLOW CONDITIONS
M.V. Carusoa, V. Gramignaa, A. Renzullib, G. Fragomenia
aBioengineering Unit, Magna Graecia University, Catanzaro, Italy; bCardiac Sur-
gery Unit, Magna Graecia University, Catanzaro, Italy
Aim: Extracorporeal Membrane Oxygenation (ECMO) is a medical procedure 
used to supply oxygen to blood circulation of patient with cardiac/pulmonary 
failure. Since linear flow in ECMO is often responsible of some clinical problems, 
aim of this study was to evaluate the hemodynamic modifications of blood 
behavior in aorta due to linear and pulsed ECMO.
Methods: A multi-scale study, realized coupling a 3D CFD analysis and a 
lumped-parameter model (0D boundary conditions), was carried out by using 
COMSOL 4.3a (COMSOL Inc, Stockholm, Sweden).
A 3D patient-specific model of the aorta with its three epiaortic vessels (in-
nominate or brachiocephalic artery, left carotid artery, left subclavian artery) was 
obtained from a series of in vivo CT-scan slices using a commercial software 
and the derived faced surface was simplified for the CFD analysis using the 
reverse engineering process. A standard 24 Fr arterial cannula was added to the 
ascending aorta on the site that is routinely adopted at our institution. To obtain 
pulsed flow during the extracorporeal circulation, a 40 cm3 intra-aortic balloon 
(IAB) was set in the descending aorta, as in clinical practice. The balloon radius 
change behaviour was approximated with a 8 degree Fourier general equation 
and a parameter solved was used to simulate balloon inflation.
As inlet boundary condition, different continuous flow values, (Case 1 = 2.5 L/
min and Case 2 = 5.5 L/min) delivered through the CPB arterial cannula, were 
used, while as outlet boundary conditions, resistance was adopted to represent 
the arterial system of the downstream branch regions.
Hemodynamic parameters for all vessels were evaluated and the comparison 
between linear and IABP-induced pulsatile ECMO flow rates was assumed as 
index of epiaortic perfusion improvement.
Results: Considering the inflation instant, IABP produced an increase of flow 
rates in all epiaortic vessels in both cases, with a mean value of about 14.9% in 
Case 1 and 14.3% in Case 2.
Conclusions: The IABP-induced pulsatile ECMO improves epiaortic perfusion 
and the flow pattern in aorta.
O91 
MINIATURIZED FLOW METER WITH ZERO COMPENSATION USING A 
CURVED CANNULA IN AN ANIMAL STUDY
R. Kosakaa, M. Nishidaa, H. Miurab, Y. Shiraishib, T. Yambeb, O. Maruyamaa, 
T. Yamanec
aAIST, Tsukuba, Japan; bTohoku University, Sendai, Japan; cKobe University, 
Kobe, Japan
Aim: For patients using a left ventricular assist system a reliable flow mea-
surement system is required. The purpose of the present study is to develop 
a miniaturized flow meter with zero compensation using a curved cannula, and 
evaluate the measurement accuracy both in a mock circulation study and an 
animal study.
Methods: The developed flow meter quantified a flow rate using centrifugal 
force generated by flow in a curved cannula. The strain gauges in the flow meter 
measured the centrifugal force using the strain of the outer wall of the cannula. 
The zero compensation, which compensated the drift of the measurement data, 
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O94 
ESTABLISHMENT OF THE GUIDELINE FOR INNOVATIVE MEDICAL 
DEVICES: COLLABORATION WITH ACADEMIA, CLINICIANS, INDUSTRY 
AND REGULATORY AGENCY
H. Nakada, E. Akagawa, T. Tsukiya, T. Mizuno, Y. Takewa, E. Tatsumi
National Cerebral & Cardiovascular Center, Osaka, Japan
Aim: To promote the development of medical devices with new clinical concept, 
assessment guidelines would be useful for stakeholders; clinicians, manufactur-
ers, patients and regulators. The guidelines would contribute to the accelera-
tion of the approval process and safe clinical application. While government-led 
guidelines could not reflect the actual situation, few guidelines have been estab-
lished by people in R&D field. In Japan, using ECMO for longer than approved 
periods (off-label use) increases, which can raise various risks for the stake-
holders. To reduce the risks and enhance the development of next-generation 
ECMO system for long-term use, we propose new assessment guidelines.
Methods: We compiled guidelines of ECMO system for long-term use via dis-
cussion at a committee which consisted of experts of medical devices, includ-
ing ECMO; academic experts, clinicians, manufacturers, and regulators.
Results: We drafted the assessment guidelines of ECMO system for long-term 
use. Academic experts examined non-clinical and clinical test issues. Clinicians 
shared the current clinical needs. Manufacturers showed the market situation 
and hurdles to approval application. Regulators requested that the guidelines 
be a reference for the review. Despite different backgrounds and standpoints, 
experts expanded their views and developed consensus towards the appropri-
ate ECMO use.
Conclusions: Partnerships with all experts play a prominent role in establishing 
“reasonable” assessment guidelines of long-term use ECMO in Japan.
O95 
STAGNATION AREAS AND A WASHOUT STUDY AS AN ASSESSMENT 
FACTOR FOR THE DESIGN PROCESS OF THE VAD
P. Klosinski, P. Reorowicz, D. Obidowski, K. Jozwik
Lodz University of Technology, Institute of Turbomachinery, Lodz, Poland 
Aim: Different assessment factors and a numerical flow analysis of the pneu-
matic VAD - Religa EXT - developed at the Foundation for Cardiac Surgery De-
velopment, Zabrze, under transient conditions are discussed. The main aim of 
the investigations was to assess a stagnation area and a washout method as 
valuable criteria for the VAD design process.
Methods: In the transient test, a motion of the diaphragm and valve discs was 
simulated. The valves based on J. Moll’s design were used. The washout and 
the stagnation areas inside the Religa EXT VAD for two angular positions of 
valves were investigated. The first angular position was based on experimen-
tal tests, whereas the second one was found in the optimization process with 
an objective function based on minimization of the stagnation areas. Four full 
cycles of operation of the Religa EXT VAD were performed. The non-Newtonian 
blood viscosity model based on Power Law formula was applied in all numerical 
simulations. The stagnation areas were described as regions with a low value of 
velocity, below 0.01 m/s, close to the VAD walls. To investigate the washout of 
blood, two fluids were used. Both of them are based on the same blood model. 
The ANSYS CFX v14.5 code is used to perform the numerical experiment.
Results: The calculated flow field showed a high level of agreement between the 
stagnation areas and the washout method. An angular position of valves has a 
significant influence on the stagnation areas and the washout of residual blood.
Conclusions: The numerical study shows that the stagnation areas and the 
washout method are reliable factors for the design process of a new pulsatile 
VAD. Similar areas of the VAD, for both methods, were detected as potentially 
prone to coagulation.
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O96 
PHOSPHATE REMOVAL DURING NOCTURNAL HEMODIALYSIS: A STUDY 
WITH TOTAL DIALYSATE COLLECTION
T. Zupancˇicˇa, J. Buturovic´-Ponikvarb 
aMedical Faculty, University of Ljubljana, Slovenia; bDepartment of Nephrology, 
University Medical Center, Ljubljana, Slovenia
Aim: To quantify phosphate removal during nocturnal HD (NHD) by measuring 
concentrations in serum, hourly and total dialysate collection.
Methods: 8 patients (3 women) receiving NHD were studied for one session on 
the longest break between NHD. Serum and total dialysate phosphate concen-
tration was measured every hour. Duration of the NHD was 8 hours in 3 patients 
and 7 in 5.
Results: Phosphate removal assessed in serum was more important during the 
first 2 hours, then a plateau was reached. Average serum concentration before 
NHD was 1,43 mmol/l and 0,78 mmol/l and 0,81 mmol/l after 7 and 8 hours, 
respectively. The reduction was statistically significant (p = 0,005 in p = 0,02, 
respectively). The highest average concentrations in total dialysate was in the 
1st hour (0,31 mmol/), then concentrations remained stable (0,23; 0,24; 0,24, 
0,25, 0,21, 0,21 and 0,18 mmol/l for every next hour, respectively). Average to-
tal reduced mass of phosphate quantified from hourly and total dialysate was 
5195,7 mg and 5466, 2 mg. Reduction ratio for 7 and 8 hours NHD was 45,3% 
and 43,1%.
Conclusions: Phosphate has been removed in a consistent manner during 
whole duration of nocturnal hemodialysis (despite the plateau in serum concen-
tration), indicating phosphate transfer from intracellular space. Total reduced 
mass quantified from hourly and total dialysate in our study was more than four 
times higher than previously reported.
O97 
RATE OF ACCUMULATION OF ADVANCED GLYCATION END-PRODUCTS: 
REPEATED SKIN BIOPSIES AND SKIN AUTOFLUORESCENCE MEASURE-
MENTS IN DIABETIC HEMODIALYSIS PATIENTS
S. Arsova, P. Dzekovab, L. Trajceskab, W. van Oeverenc, A.J. Smitc, B. Stegmayrd, 
C. Schalkwijke, A. Sikoleb, R. Graaffc, G. Rakhorstc
aDiamed-Macedonia, Skopje, Macedonia; bClinical Centre-Mother Teresa, 
Skopje, Macedonia; cUMC Groningen, The Netherlands; dUniversity Hospital 
Umeå, Sweden; eUniversity Hospital Maastricht, The Netherlands
Aim: To measure the rate of accumulation of different Advanced Glycation End-
products (AGEs) in the skin of diabetic hemodialysis (HD) patients over a period 
of one year and to find the factors that influence this process.
Methods: Twenty-two diabetic HD patients were enrolled in this study. The 
amount of pentosidine, carboxymethyl-lysine (CML) and carboxyethyl-lysine 
(CEL) in the biopsies was measured biochemically. Skin autofluorescence (SAF) 
was measured non-invasively to determine the AGEs accumulation in the skin. 
Dietary records from the HD patients were obtained to assess the AGEs, calorie 
and protein intake. Furthermore, BMI, as a measure of nutritional state, was 
obtained. 
Results: The pentosidine, CML and CEL content of the biopsies correlated with 
SAF, but all four variables were not significantly different between the two time 
points. We found that the independent predictors of the one year increase of 
pentosidine were: one year increase of SAF and the SAF value at the first time 
point. The independent predictors of the one year increase of CML were: one 
year increase of SAF, the SAF value at the second time point and the 4th quintile 
of BMI. The independent predictors of the one year increase of CEL were: the 
one year increase of SAF and the 4th quintile of BMI.
Conclusions: Biochemically determined skin AGEs of the diabetic HD patients 
did not show a significant increase in one year time. The rate of skin AGEs 
accumulation is independently associated with the increase of SAF and BMI.
O98 
HEPARIN-ALBUMIN PRIMING IN THE CLINICAL SETTING FOR HD PATIENTS 
AT RISK FOR BLEEDING
M. Skagerlind, B. Stegmayr
Department of Public Health and Clinical Medicine, University of Umea, Umea, 
Sweden
Objective: Patients on haemodialysis (HD) may have an increased risk for 
bleeding when performing HD, i.e., before or after surgery, after brain haemor-
rhage or intestinal bleeding.
Material and Methods: We use a priming solution containing heparin (H), 
10000 units, and 10 mL of albumin (A), 20%, added to 2 L of priming solution. 
This mixed solution is used to prime the dialysis circuit before connection of the 
patient. The residual fluid is removed when the blood fills up the circuit. A pilot 
study showed that it was possible to lower extent of added anticoagulation by 
this measure. The aim of this study was to evaluate a larger cohort of patients 
treated either by standard dose of anticoagulation only (Group-S, n = 526) or a 
group that had initial HA priming performed before HD (Group-HA, n = 882) with 
the aim to reduce the dose of systemic heparin or low molecular weight heparin. 
Results: Comparing baseline data between Group-S and Group-HA the mean 
age was higher (61.5 ± 16 vrs 59.5 ± 17, p = 0.021), dialysis time was longer 
(3.3 hours ± 0.7 vrs 3.2 ± 0.6, p = 0.002) while there was no difference in extent 
of ultrafiltration (1.76 vrs 1.74 L), systolic blood pressure (141 vrs 139), speed 
of blood pump (244 vrs 243). The total dose of anticoagulation/ dialysis was 
© 2014 Wichtig Publishing - ISSN 0391-3988
Int J Artif Organs (2014; :8)37
604
Abstracts: XLI ESAO Annual Congress, 17-20 September 2014, Rome, Italy
583-607
4846 ± 1950 U vrs 1844 ± 1974 U (p<0.001). In group-HA the total dose of 
anticoagulation (Units) was 0 Units/HD in 24%, and ≤1000 units/HD in 50% of 
procedures. Total clotting occurred to the same extent in both groups (4 versus 
9 dialyses) and genders.
Conclusions: Heparin-albumin priming significantly reduces the extent of 
anticoagulation during HD in patients at risk for bleeding.
O99 
CLINICAL ASSESSMENT OF HEMODIALYSIS ARTERIOVENOUS FISTULAS 
AT THE ELBOW
Y. Sato, M. Miyamoto, S. Sueki, T. Sakurada, K. Kimura, R. Nakazawa, M. Yoshioka, 
H. Sasaki, T. Chikaraishi
St. Marianna University, Kawasaki, Japan
Aim: When the superficial veins are unavailable in the forearm, we create an 
arteriovenous fistula (AVF) at the elbow using superficial or perforating veins, in 
order to extend the possibility of providing an autogenous vascular access. We 
examined two types of elbow AVFs to evaluate their clinical feasibility.
Methods: From January 2010 to June 2013 we created 60 AVFs at the elbow, 
including 43 AVFs with superficial veins (i.e., cubital-median, cephalic or basilic 
veins) and 17 AVFs with perforating veins, when the forearm veins were unavail-
able. The vein was anastomosed to the brachial or radial artery, according to to-
pological conditions so as not to exert an excessive tension to the anastomosis. 
We followed the survival of respective AVFs to obtain primary and secondary 
patency rates. To estimate the access flow, we measured time-averaged blood 
flow rate of the inflow brachial artery by Doppler ultrasound.
Results: Primary patency rate was not significantly different between AVFs with 
superficial and perforating veins, whereas secondary patency rate was inferior 
in those with perforating veins; two-year survival was 89 and 80%, respectively 
(Log-Rank p = 0.04). Estimated access flow was 690 and 890 mL/min, respec-
tively, which was not statistically significant, however AVFs created with the 
brachial artery showed greater blood flow, compared to those with the radial 
artery (1010 vs. 670 mL/min, p = 0.03). 
Conclusions: AVF creation with perforating veins at the elbow seemed to be a 
feasible option when the superficial veins are poor in the forearm. The arterial 
anastomotic site was revealed to significantly influence the access flow.
O100 
WHEN NATIVE ARTERIOVENOUS FISTULA FOR HEMODIALYSIS IS NOT 
POSSIBLE: PTFE GRAFTS VS TUNNELLED CUFFED CATHETERS
G. Donatia, G. Ciancioloa, R. Maurob, L. Panicalia, A. Scrivoa, M. Iorioa, E. Giampalmac, 
R. Golfieric, P. Ruccid, A. Marchettid, A. Stellab, G. La Mannaa, S. Stefonia
aNephrology Dialysis and Renal Transplant Unit, bVascular Surgery Unit, 
cRadiology Unit, S. Orsola University Hospital; dDepartment of Medicine and 
Public Health, University of Bologna, Bologna, Italy
Aim: Vascular access complications account for the high morbidity related to 
hemodialysis (HD). We compared vascular access and patient survival in pa-
tients with tunnelled cuffed permanent catheters (TCC) and with PTFE grafts.
Methods: We studied 87 HD patients, 56 with TCC and 31 with PTFE graft 
(follow-up: 2 ys). Patients with TCC were older than those with PTFE graft 
(73.5 ± 11.3 vs 63.8 ± 14.6 ys, p = 0.001). Atrial fibrillation was significantly more 
frequent in TCC group than in PTFE group (30.3% vs 6.5%, p = 0.01). 
Results: In an unadjusted Kaplan-Meier analysis, TCC survival at 24 months 
was 5.4 months longer, but not significantly (log-rank = 1.3, p = ns). Cox re-
gression analysis adjusted for age, sex, type and number of previous vascular 
accesses, diabetes, atrial fibrillation and smoking confirmed similar vascular as-
sess survival between the groups, with diabetes as an independent risk factor 
for the survival of both vascular accesses (p = 0.02). In an unadjusted Kaplan-
Meier analysis a higher 24-month mortality was found in TCC group than in 
PTFE group (log-rank = 10.07, p<0.01). The adjusted Cox regression analysis 
showed that TCC was associated with a 3.2-fold increased risk of death.
Conclusions: When arteriovenous fistula is not possible, PTFE grafts can rep-
resent the vascular access of second choice.
O101 
TRANSITIONAL FLOW IN PATIENT-SPECIFIC ARTERIOVENOUS FISTULAE 
FOR HEMODIALYSIS
A. Remuzzia,b, M. Bozzettob, B. Ene-Iordacheb
aBergamo University, Dalmine; bIstituto Mario Negri, Bergamo, Italy
Aim: Radial-cephalic arteriovenous fistula (AVF) is the first choice for providing 
the life-line vascular access for hemodialysis patients. Nowadays, the surgical 
placement of AVFs still has high failure rates due to neointimal formation. We 
have shown in idealized AVF models that disturbed flow (i.e., low and oscillating 
shear stress) may develop in areas that locate well the sites of future stenosis. 
Our present study was aimed at investigating the nature of disturbed flow in 
realistic geometry models of AVFs.
Methods: We employed patient-specific, image-based computational fluid dy-
namics (CFD) simulations. To extract the blood vessel geometry we used MR 
images of subjects starting HD treatment, performed 40 days post-operatively. 
We performed transient CFD simulations with subject-specific blood rheology 
and flow boundary conditions. We then characterized the blood flow field by 
means of velocity and wall shear stress (WSS) plots and categorized disturbed 
flow by means of the oscillatory shear index (OSI).
Results: In all simulated cases, we observed transitional laminar-to-turbulent 
flow developing in the juxta-anastomotic vein (JAV), but not in the proximal 
feeding artery. The disturbed flow zones (high OSI) were located on the inner 
wall of the JAV, and along the distal artery wall.
Conclusions: We have found transitional flow developing in the JAV. The oscil-
lations of the velocity vectors in these areas result in eddies that rotate WSS 
orientation. On these sites, the development of both oscillating and multi- 
directional disturbed flow on endothelial cells may be responsible for neointima 
formation in newly created AVFs.
O102 
HEMODIALYSIS TUNNELED CENTRAL VENOUS CATHETERS: SINGLE 
CENTER EXPERIENCE
V. Gerasimovska, B. Gerasimovska-Kitanovska, A. Sikole
University Clinic of Nephrology, Medical Faculty, Skopje, R. Macedonia
Aim: Central venous catheters used for hemodialysis are a common cause of 
complications. Catheter malfunction secondary to thrombosis or malpositioning 
of the catheter, and catheter-related bloodstream infections (CRBI) are common 
occurrences.
Methods: We looked at the outcome of a group of 185 patients (pts) receiving 
chronic HD treatment via tunneled-cuffed catheters during the 5-year period 
Criteria for catheter removal were: (1) persistent bloodstream infection and 
(2) catheter dysfunction. Event rates were calculated per 1,000 catheter days, 
and Kaplan Meier analysis was performed to estimate THC cumulative survival.
Results: 282 THC were included in the analysis and were grouped by insertion 
site of the catheter: (TFC) n = 155; (TJC) n = 68, (TSC) n = 59. Duration time of 
THC, average 129-429 days. Infection rates were: TFC – 3,1 episodes/1000 
catheter days; TJC – 2,8, and TSC – 2,9. A total of 63 CRBI events in 35 pts were 
identified. The most common isolated microorganisms were Gram-positive. An-
tibiotic therapy was statistically significant for catheters survival in group with 
TSC. Risk factors were most likely to result in colonization or infection with 
multi-resistant species, age (odds ratio[OR], 1,2 to 14.1); prolonged hospital 
stay (OR, 1,3 to 17,5); and exposure to broad-spectrum antimicrobial drugs 
(OR, 1,6 to 25,1).
Conclusions: Our data showed a high survival rate of THC in pts undergoing 
HD, with low incidence of catheter dysfunction and CRBI. Careful application 
of standard protocols and well educated dialysis staff contributed to achieve 
these results.
Oral SeSSiOn – eCMO, O103-O109
O103 
FLOW IN A CROSS LAYER FIBER OXYGENATOR: VALIDATION OF COM-
PUTATIONAL FLUID DYNAMICS USING PARTICLE IMAGE VELOCIMETRY
F. Hesselmann, P.C. Schlanstein, S.V. Jansen, T. Schmitz-Rode, U. Steinseifer, 
J. Arens
Institute of Applied Medical Engineering, RWTH-Aachen University, Aachen, 
Germany
Aim: Computational Fluid Dynamics (CFD) is routinely used for the investiga-
tions of the blood flow in fiber membrane oxygenators. For the experimental 
validation Particle Image Velocimetry (PIV) was applied on an up-scaled trans-
parent model of an oxygenator with cross layered fiber arrangement. 
Methods: The oxygenator is designated to be used as an artificial placenta 
with a flow range from 30 to 120 ml/min. Considering the similitude theory, a 
transparent and up-scaled model by a factor of 5.8 of the oxygenator was built 
that satisfies the requirements of the optical measurement method. 3C-PIV was 
performed to investigate the corresponding minimal and maximal flow rates. For 
the numerical approach the model was meshed unstructured in the original size 
and analyzed at the equivalent operating points. The fiber bundle was modeled 
as isotropic porous media. 
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Results: In comparison, the macroscopic flow field distribution, areas of high 
flow and stagnation show a good agreement. However, the view of the flow 
between the fibers differs in a microscopic level regarding the tortuosity that can 
be quantified by the path length of stream lines. 
Conclusions: These first PIV measurements of an up-scaled model of a cross 
layer oxygenator show promising results to be used as a validation methodol-
ogy for CFD of oxygenators in the future.
O104 
A NOVEL METHOD FOR IN-VITRO EVALUATION OF CO2 TRANSFER 
CAPACITY THROUGH MEMBRANE OXYGENATORS 
H. Tabesha,c, Gh. Amoabedinyb, A. Poorkhalilc, A. Kashefic, K. Mottaghyc
aFaculty of New Sciences and Technologies, bDepartment of Chemical 
Engineering, University of Tehran, Iran; cInstitute of Physiology, ECC Laboratory., 
RWTH University, Aachen, Germany
Aim: Membrane Oxygenators (MO) should have a sufficient physiological CO2 
Transfer Rate (CTR). This is crucially important especially during the long-term 
applications of artificial lungs, e.g. ECMO and AVCO2R. While CTR evaluation 
with native blood is complex and time consuming, an adaption of an analogous 
fluid instead of blood is still a challenging task for in-vitro investigations.
Methods: The proposed system is based on pH decrease as a result of CO2 
dissociation in distilled and deionized ultra-pure water. Having the pH of this 
liquid, the total CO2 content could be calculated through a cascade of equa-
tions. Subsequently, the CTR of a MO is achieved by measuring the liquid flow 
rate and pH-value difference between liquid inlet and outlet. Using a fitting curve 
analysis, a new equation is designed, representing the ratio of N2/CO2 used in 
the gas phase, considering the flow rate of the liquid phase, priming volume as 
well as membrane surface area of testing MO.
Results: In-vitro performance investigations of 2 different types of commercial 
adult and paediatric MOs up to their maximal liquid flow rates, show that the 
obtained results are in excellent accordance with those carried out with blood.
Conclusions: The presented method is suitable to predict the CO2 transfer ca-
pacity of MO in in-vitro studies as an easy handling and quick test, and can be 
considered a reliable alternative method to animal blood experiments.
O105 
THE EFFECT OF BLOOD CONTACT SURFACE AREA REDUCTION DURING 
CARDIOPULMONARY BYPASS IN A RAT MODEL
Y. Fujii, M. Shirai, Y. Takewa, E. Tatsumi
National Cerebral and Cardiovacular Center, Suita, Japan
Aim: Cardiopulmonary bypass (CPB), preserve patient’s life by providing ade-
quate oxygen supply and blood flow to vital organs. However, previous studies 
have suggested that the interaction of blood and large artificial surface contrib-
utes to inflammatory response during CPB. As a result of a series of chain reac-
tions, the numerous powerful inflammatory mediators are formed and released. 
We hypothesized that small CPB circuit which reduces priming volume and blood 
contact surface area attenuates the systemic inflammatory response with a re-
duction of inflammatory cytokine levels and organ tissue damage during CPB.
Methods: Rats were divided into the large surface area CPB (priming volume: 
15 ml, surface area: 0.044 m2) group and the small surface area CPB (priming 
volume: 7 ml, surface area: 0.036 m2) group. CPB pump flow was maintained 
at 80 ml/kg/min. Blood samples were collected before (baseline), and at 60 min 
and 120 min after initiation of CPB. We measured the serum cytokine levels 
(TNF-α, IL-6, IL-10) and biochemical markers (LDH, AST, ALT). 
Results: Pro-inflammatory markers (TNF-α, IL-6) and biochemical markers 
were significantly elevated in the high priming volume CPB group compared 
with the low priming volume CPB group at 60 min. At 120 min, however, none of 
the markers was statistically different between the 2 groups. 
Conclusions: These data suggested that in addition to the blood contact sur-
face area factor, the CPB exposure duration is also an important factor for caus-
ing the systemic inflammatory response.
O106 
COMPUTER TOMOGRAPHY OF AIRWAYS AND LUNGS DURING TOTAL 
LIQUID VENTILATION WITH PERFLUOROCARBONS
P. Bagnolia, M. Bonfantia, F. De Gaetanoa, M. Di Giancamillob, M. Ghiringhellib, 
C. Mocchib, G. Nicolinic, F. Acocellab
aPolitecnico di Milano, Milan, Italy; bUniversità degli Studi di Milano, Milan, Italy; 
cUniversità degli Studi di Milano Bicocca, Monza, Italy
Aim: The airway deformation and pulmonary distribution of liquid per-
fluorocarbons (PFC) were evaluated by computer tomography (CT) during 
Total Liquid Ventilation (TLV) performed with a new ventilator prototype 
(Pro-Li-Ve).
Methods: Spiral thorax CT scans (120 kV, 125 mA, ST 1.00 s, 3 mm thick-
ness/index, 1.00 pitch) were run during conventional gas ventilation and TLV 
with PFC (FC-770, 3M) on 2 anesthetised New Zealand juvenile rabbits (weight 
1.1 ± 0.08 kg). The time needed to fill the entire lungs at the beginning of TLV 
was evaluated. Series of 30 axial CT scans were also performed at the same 
section in 3 different airway regions (trachea, carina, first bronchi) to quantify 
airway deformation during normal breaths or expiration collapses. 
Results: About 15 min after TLV start the PFC is homogeneously distributed in 
the trachea, bronchi, and alveoli. The attenuation level is always positive (from 
269 to 509 Hounsfield Units (HU) in the independent and dependent pulmonary 
regions, respectively). Airway narrowing is induced by the negative expiratory 
pressure that can induce airway collapse (e.g. tracheal narrowing 20% during 
normal breaths, 48% during collapse).
Conclusions: This analysis proved PFC excellent properties as contrast medi-
um, having linear attenuation coefficient similar to the contrast agents common-
ly used in radiology. This property permitted good anatomic details, highlighting 
airway deformation during TLV and proving PFC to homogeneously fill the lungs.
O107 
PRACTICAL TECHNIQUE OF VENO-VENOUS EXTRACORPOREAL MEM-
BRANE OXYGENATION FOR EFFECTIVE OXYGENATION AND CARBON 
DIOXIDE REMOVAL
K. Togoa,b, Y. Takewaa, Y. Miyamotob, E. Tastumia
aNational Cerebral & Cardiovascular Center, Suita, Japan; bHyogo College of 
Medicine, Nishinomiya, Japan
Aim: Recently, the number of cases of veno-venous extracorporeal membrane 
oxygenation (VVECMO) for adult respiratory failure patients increases. However, 
oxygenated blood by ECMO may recirculate into ECMO circuit. This is known 
as recirculation. And it may induce ineffective gas exchange. Although some 
factors such as cannula position or bypass flow are related to recirculation, the 
details are not clarified. The aim of this study is to investigate practical tech-
nique of VVECMO for effective gas exchange.
Methods: VVECMO was performed in 5 goats (mean body weight, 58 kg). We 
varied the position of return cannula in the superior vena cava (SVC), the right 
atrium (RA) or the inferior vena cava (IVC), whereas the position of drainage 
cannula was fixed in the IVC. We changed bypass flows from 1-4 L/min in all 
positions, and compared the recirculation rate. We checked whether oxygen-
ation and carbon dioxide removal were enough by measuring the arterial oxygen 
saturation (SaO2), partial pressure of arterial oxygen (PaO2) and partial pressure 
of arterial carbon dioxide (PaCO2).
Results: In the SVC return cannula group, the recirculation rate was lowest, 
and SaO2 and PaO2 were highest. The bypass flow exceeded 2 L/min had 
SaO2 > 80% at SVC or RA position. PaCO2 approached the normal range when 
the bypass flow was more than 2 L/min.
Conclusions: Most desirable return cannula position is in the SVC, and both 
the cannula position and the bypass flow rate are important for effective oxy-
genation and carbon dioxide removal.
O108 
IMPACT OF AT3 INFUSION ON COAGULATION IN A PORCINE ECMO 
MODEL
P.D. Everson, E.C. Osborn
Tripler Army Medical Center, Honolulu, USA 
Background: Extracorporeal Membrane Oxygenation (ECMO) shows promise 
in supporting subjects with lung injury; however, the optimal method of antico-
agulation during ECMO remains unknown. A continuous antithrombin III (AT3) 
infusion, as opposed to traditional bolus administration, may result in attenua-
tion of hemorrhage and lung injury. 
Methods: Anticoagulation is analyzed through use of 14 pigs on mechani-
cal ventilation and ECMO using an oleic acid-induced acute lung injury ani-
mal model. An IRB approved protocol included cardiorespiratory monitoring 
for 32 hours of venovenous extracorporeal support. Experimental animals are 
randomly divided into two experimental groups (n = 6 per group): heparin + 
continuous AT3 and heparin, along with two control subjects. Serial laboratory 
analyses are obtained of bronchoalveolar lavage fluid and serum. 
Results: The group receiving continuous AT3 infusion demonstrates a trend 
towards decreased thrombus formation including intracardiac and oxygen-
ator clots (0% vs 40%). Analysis of lung histology suggests that a continuous 
AT3 may attenuate the inflammation and edema that attends acute lung injury. 
Subjects receiving AT3 received more crystalloid and colloid in response to 
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hypotension due to blood loss (2880 mL vs 1805 mL, p = 0.018) and a trend 
towards more blood transfusions (1906 mL vs 1015 mL, p = 0.086).
Conclusions: Use of a continuous AT3 infusion may allow for minimization of 
ECMO related thrombotic complications and decreased pulmonary inflamma-
tion, but due to hemorrhage, as well as increased required blood products and 
fluid resuscitation may cause more harm than benefit.
O109 
ABYLCAP AS PROMISING DEVICE TO TREAT PATIENTS WITH ACUTE 
RESPIRATORY DISTRESS SYNDROME (ARDS)
H. Peperstraete, F. De Somer, S. Claus, A. Dhondt, R. Vanholder, E. Hoste, 
S. Eloot
Ghent University Hospital, Gent, Belgium
Aim: In patients with ARDS, gas exchange is impaired and mechanical ventila-
tion is needed. The use of low tidal volumes is more lung protective but can 
be associated with hypercapnia and respiratory acidosis. Extracorporeal CO2 
removal (ECCO2-R) is a therapeutic option to correct pH. The aim of this study 
was to derive optimal working parameters for the ECCO2-R.
Methods: A 56-year-old man with ARDS was treated 7 days by Abylcap (Bellco, 
Italy). The system consists of a pediatric polymethyl- pentene hollow fiber mem-
brane oxygenator. The oxygenator and the incorporated heat exchanger are 
coated with a non-thrombogenic phosphorylcholine coating. Every 24 h dur-
ing 5 days, blood was sampled at the Abylcap inlet and outlet under different 
conditions of blood (QB: 200-400 mL/min) and 100% O2 flow (QG: 0.5-8 L/min). 
Blood samples were analysed for total CO2 content, partial O2 tension, O2 satu-
ration and hemoglobin concentration on a RapidLab1265 blood gas analyser 
(Siemens Healthcare). 
Results: Acidosis and oxygenation parameters gradually improved during the 
support period of 7 days. For a fixed QG, CO2 transfer linearly increased with QB 
(i.e. from 59 to 101 mL/min for QB 200-400 mL/min and QG7 L/min). For a fixed 
QB, CO2 transfer non-linearly increased with QG and flatted for QG≥6 L/min. Gas 
transfer remained constant over 5 days: for QB = 400 mL/min and QG = 6 L/min, 
CO2 transfer was 99 ± 6 mL/min and O2 transfer was 45.5 ± 0.3 mL/min. 
Conclusions: Using optimal operating parameters with QB at 400 mL/min and 
QG at least 6 L/min, the ECCO2-R is a promising device when treating patients 
with ARDS.
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PROTHROMBIN FRAGMENTS F1+2 AND FIBRINOGEN ARE HIGHLY EL-
EVATED IN PERITONEAL DIALYSIS PATIENTS, BUT ARE NOT ASSOCIAT-
ED WITH CARDIOVASCULAR COMPLICATIONS AND MORTALITY IN THE 
LONG-TERM FOLLOW-UP
N. Basic-Jukic, D. Coen-Herak, Z. Martinovic, M. Radic´-Antolic´, P. Kes
School of Medicine University of Zagreb, Zagreb, Croatia
Aim: Recognition of the role of coagulation system in the pathogenesis of car-
diovascular diseases has increased interest for investigations of the association 
of prothrombin fragments (F1+2) with cardio- and cerebrovascular complica-
tions which are the leading causes of death in the dialysis population. Few data 
exist about the coagulation parameters in dialysis population, with contradictory 
results. Aim of the present long-term follow-up prospective study was to investi-
gate the plasma levels of F1+2 and antithrombin III (AT) in dialysis patients, and 
to determine their role in development of different complications after 7 years 
of follow-up.
Methods and Results: Two groups were included in the investigation: 28 clini-
cally stable CAPD patients, (average age 45,33; range 18-75 years), who had 
not suffered from peritonitis during the last six months, and 18 patients (average 
age 53,7; range 18-74 years) on hemodialysis (HD) without signs of infection. 
The CAPD group had significantly elevated serum fibrinogen - 7.3 g/L; PV was 
1.34, APTV 27.9 s, and Trc 208.66 × 109/L. The HD group had fibrinogen 3.2, PV 
1.05, APTV 36.2, AT 82.91, and Trc 150. Antithrombin III (AT), a potent inhibitor 
of coagulation cascade, was higher in the CAPD (101.63%) vs. 82.91% in the 
HD group; however, both values were within the normal range of our laboratory 
(75-125%). A statistically significant elevation was found in the levels of F1+2 
in all patients, but significantly higher in the CAPD group, 3331,4 pmol/L, vs. 
514.38 pmol/L in the HD group (p<0.00001). Prothrombin F1+2 values refer-
ence range of our laboratory is 69-229 pmol/L. During the follow-up period of 
7 years 16 patients died (11 from the PD, and 5 from the CAPD group), 7 from 
the cardiovascular causes. However, there was no correlation between the 
coagulation parameters and occurrence of cardiovascular complications or 
mortality. 
Conclusions: Elevations of hemostasis activation markers may occur not only 
in the presence of overt thrombosis but also during the hypercoagulable state 
like is chronic kidney disease. Additionally, elevated F1+2 may reflect chronic 
inflammation in dialysis population. Further studies are urgently needed to pre-
cisely estimate role of coagulation cascade in development of cardiovascular 
disease in uremic patients.
O111 
TEMPORAL PATTERN OF AMYLASE-INDUCED DIGESTION OF GLUCOSE 
POLYMERS
J. Poleszczuka, E. Garcia-Lopezb, B. Lindholmb, J. Waniewskia
aInstitute of Biocybernetics and Biomedical Engineering, Warsaw, Poland; 
bKarolinska Institutet, Stockholm, Sweden
Aim: The enzymatic activity of amylase determines the rate at which glucose 
polymers (GP), such as icodextrin (Ico, a mixture of GP used as osmotic 
agent in peritoneal dialysis fluids,) are digested. We developed a mathemati-
cal model describing changes in the composition of Ico induced by amy-
lase at concentrations characteristic for biological fluids including peritoneal 
dialysate.
Methods: Solutions with Ico (75 mg/mL) were spiked with synthetic porcine 
pancreatic α-amylase (PPA) at 12.5 - 200 U/L. The concentrations of GP frac-
tions with molecular weight <1 to >66 kDa were during 240 min by HPLC. A 
mathematical model based on Michaelis-Menten kinetics for the temporal 
evolution of concentration of GP was proposed. The model parameters were 
estimated using experimental data.
Results: Whereas the concentration of GP 1-4, 4-9, and 9-21 kDa fractions 
decreased only marginally, GP fractions with molecular weight less than 
1 kDa increased substantially, from 5 mg/mL to 12.5 mg/mL when exposed 
to 200 U/L PPA, and the concentration of polymers >21 kDa also decreased 
substantially. The mathematical model reproduced the experimental data with 
high accuracy.
Conclusions: A mathematical model coupled with experimental data allowed 
accurate description of the temporal pattern of α-amylase-induced diges-
tion of glucose polymers. Whether the observed changes in the composition 
of Ico induced by α-amylase, resulting in increase of low molecular weight 
GP, influences the osmotically driven ultrafiltration flow needs to be further 
studied.
O112 
HEALTHCARE SYSTEM ORGANIZATION IS A FACTOR FOR DIFFERENT 
PD USAGE IN EUROPE?
A.M. Machowskaa,b, P. Rutherfordb
aKarolinska Institutet, Stockholm, Sweden; bBaxter Healthcare Corporation, 
Braine l’Alleud, Belgium and Zurich, Switzerland
Aim: The usage of peritoneal dialysis (PD) varies across Europe. The reimburse-
ment system for renal care has been suggested as an explanation for differ-
ences. However, PD usage differs within countries due to regional or centre level 
issues despite similar or identical reimbursement systems within the country. 
Therefore, other factors relating to the healthcare system organization may ex-
plain the PD variability within a country. 
Methods: The ERA-EDTA report was examined to show the differences in PD 
distribution across Europe. Published literature and country specific health sys-
tem data were examined to explore the variable PD utilization. 
Results: Published data from France show that overall 14% of patients start 
with PD, but this varies from 0% to 45% among 59 districts included in the 
study. Data from the UK Department of Health shows differences in distribution 
of PD usage in specific centres across the country with range from 2.74% to 
27.45%. Published data from Italy show that use of PD varies regionally and is 
strongly influenced by the number of private centres. In the seven regions with 
no private centres and in eight regions with <10% patients on dialysis in private 
centres the incident PD rate is 23.2% and 18.0% respectively. In the remaining 
regions with >10% of patients on dialysis in private centres the rate of PD usage 
declines to 9.5%. 
Conclusions: Within countries there are large differences in PD usage which 
cannot be explained solely on reimbursement issues. Centre specific dif-
ferences including individual nephrologists’ attitude, beliefs, PD knowl-
edge and practice organisation/infrastructure must influence the choice 
of PD.
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THE SELF-LOCATING CATHETER IS PREFERABLE TO A STRAIGHT 
TENCKHOFF FOR ACUTE ONSET OF PERITONEAL DIALYSIS
B.G. Stegmayra, W. Sperkera, C.H. Nilssona, C. Degermana, S.E. Perssonb, 
J. Stenbaekb, C. Arnerlövb
aDepartment of Public Health and Clinical Medicine, Umea University, Umea, 
Sweden; bDepartment of Surgical and Perioperative Science, Urology and An-
drology, Umea University, Umea, Sweden
Objectives: We are developing a technique for direct start of peritoneal dialysis 
after insertion of the dialysis catheter into the abdominal cavity without compli-
cations of obstruction or leakage. 
The aim of this study was to investigate if the use of a self-locating PD catheter 
with a wolfram weight at the tip (di Paolo catheter) would result in different out-
come than a straight Tenckhoff catheter. 
Material and Methods: The study included 106 operations. Three operations 
were excluded from analysis due to inability to insert a catheter due to extensive 
intra-abdominal adherences. Of the remaining 103 insertions, a straight Tenck-
hoff catheter was inserted in 60 and a self-locating catheter in 43 patients. In 
this clinical assessment study, in the first part we decided to start with insertion 
using a double cuffed straight Tenckhoff catheter. If reoperation was necessary, 
the first option was to change the catheter into a self-locating wolfram catheter. 
After the first 42 insertions we decided to randomize to insert either a straight 
Tenckhoff or a self-locating wolfram catheter. A previously described operation 
technique allows immediate postoperative start of dialysis in most patients.
Results: PD start was initiated the first postoperative day in 99% cases. We 
found that significantly less self-locating catheters had to be changed into stan-
dard straight Tenckhoff catheters due to less in- or outflow problems (p = 0.004). 
Long term patency was better with the self locating catheter.
Conclusions: The study showed that when using the self-locating wolfram 
catheter fewer outflow problems occurred. This type of catheter therefore 
can be recommended for acute start of peritoneal dialysis using an insertion 
technique tightening tissue in three layers.
O114 
PARICALCITOL THERAPY AND THE INFLAMMATORY MARKERS IN 
PERITONEAL DIALYSIS PATIENTS
D. Yonovaa, E. Vazelova A. Tcakovab, I. Trendafilova, M. Georgieva, V. Papazova, 
M. Lubiha, I. Georgievaa, T. Alexandrovaa
aDialysis Clinic, bCentral Clinical Laboratory, UMBAL “Alexandrovska”, Sofia, 
Bulgaria
Aim: A few links between chronic kidney disease (CKD) and cardiovascular dis-
ease (CVD) have been discovered, among them inflammation. In the last years, 
a growing interest has been given the pleiotropic effects of vitamin D in CKD. 
Paricalcitol, a selective vitamin D receptor activator (VDRA), has demonstrated 
in experimental studies a potential to modulate the inflammatory process. Aim 
of the study was to analyze the anti-inflammatory effects of oral paricalcitol. 
in peritoneal dialysis (PD) patients with secondary hyperparathyroidism (sHPT) 
and to compare the effect of paricalcitol to calcitriol.
Materials and Methods: 32 patients on CAPD were included in a 12 weeks 
study: 10 were on oral paricalcitol treatment (group P); 7 stopped oral pari-
calcitol (group NP); 7 were on oral calcitriol (group C) and 8 did not take any 
of the mentioned drugs (group N). Nobody of the patients had treatment with 
anti-inflammatory or immunosuppressant drugs 4 weeks before and during the 
investigation. Serum concentrations of intact parathyroid hormone (PTH), high-
sensitive C-reactive protein (CRP), interleukin (IL)-6, and tumor necrosis factor-
alpha (TNFa) were measured at the beginning and the end of the study. 
Results: At the end of the study, these parameters changed as follows: In the 
group P, treated with paricalcitol, mean levels of PTH, decreased significantly 
from 520.8 ± 53.3 to 276.33 ± 31.5 pg/ml (p<0.001), mean serum IL-6 levels 
fall from 11.58 ± 3.2 pg/ml to 5.12 ± 2.2 pg/ml (p<0.001); CRP experienced a 
significant decrease from 10.52 ± 2.5 to 7.68 ± 3.6 mg/l (p<0.01) and mean level 
of TNFa had a less significant fall – from 22.3 ± 2.7 to 21.2 ± 2.3 pg/ml (p<0.05). 
Interestingly after stop the treatment with paricalcitol (in group NP) IL-6 was sig-
nificantly higher in all patients at the end and mean TNFa was increased as well. 
In the rest of the patients (groups, C and N) the levels of CRP, IL-6 and TNFa did 
not change significantly. 
Conclusions: The present study shows that oral paricalcitol administration to 
PD patients (but not calcitriol) is associated with modulation of inflammatory 
process, specifically with a reduction of CRP and IL-6.
O115 
PHASE ANGLE AND LEAN TISSUE INDEX ARE SLIGHTLY HIGHER IN 
HEMODIALYSIS THAN IN PERITONEAL DIALYSIS GROUP OF PATIENTS
B. Knap, Z. Veceric Haler, J. Buturovic-Ponikvar, R. Ponikvar, A.F. Bren 
Department of Nephrology, Ljubljana, Slovenia
Background: Protein malnutrition is a common cause of morbidity and 
mortality in patients with renal replacement therapy. Determination of 
body mass composition with bioimpedance analysis is a useful tool for the 
evaluation of the nutritional status of patients on peritoneal dialysis and 
hemodialysis.
Methods: The aim of the study was to compare nutritional parameters in a 
group of dialysis patients using bioimpedance analyzing method. We analyzed 
12 patients on peritoneal dialysis and 17 hemodialysis patients. A negative se-
lection of patients on peritoneal dialysis in our study is present. Phase angle, 
lean tissue index, fat tissue index, body hydration status and routine biochemi-
cal blood analysis were evaluated. Average values of parameters with standard 
deviation, statistical significance (p<0.05) and Spearman`s correlation coeffi-
cients were calculated. 
Results: Phase angle was lower in the group of patients on peritoneal dialy-
sis (4.40 ± 1.06) than in the group of hemodialysis patients (5.025 ± 0.89), 
but non-significant. Out of the whole group, three patients had phase angle 
less than 3.5 and all of them suffered from heart failure. Phase angle was 
lower in women than in men, and had a negative correlation with age, lean 
tissue index, body composition mass, albumins, creatinine, haemoglobin 
values and physical capacity in both sexes. Patients on peritoneal dialysis 
had lower values of albumins than hemodialysis patients (36.33 ± 3.42 vs. 
39.05 ± 2.59 g/L, p = 0.019) and lower blood potassium values (4.42 ± 0.6 
vs. 5.21 ± 0.97 mmol/L, p = 0.021). Lean tissue index values were lower in 
patients on peritoneal dialysis (13.98 ± 3.57 vs. 14.13 ± 2.78 kg/m2, p = 0.89), 
but overhydration is more frequent in patients on peritoneal dialysis (2.68 ± 
2.53 vs. 1.92 ± 1.14 L). Values of iPTH is negatively correlated with lean tissue 
index (p = 0.026).
Conclusions: Bioimpedance body mass composition analysis showed a bet-
ter nutritional status in hemodialysis patients than in patients on peritoneal 
dialysis.
O116 
PLASMA PENTOSIDINE, MALNUTRITION AND ALL-CAUSE MORTALITY IN 
CKD STAGE 5 PATIENTS
A. Machowskaa,b, A.R. Qureshia, N. Isoyamaa, P. Leursa, B. Anderstama, 
O. Heimburgera, P. Baranya, P. Stenvinkela, B. Lindholma 
aKarolinska Institutet, Stockholm, Sweden; bBaxter Healthcare Corporation, 
Braine l’Alleud, Belgium
Aim: Chronic kidney disease (CKD) patients exhibit increased levels of ad-
vanced glycation end-products (AGEs) due to hyperglycemia, oxidative stress, 
and inflammation. Accumulation of AGE’s like pentosidine may represent a risk 
factor for cardiovascular disease (CVD) and other complications. We studied 
the association between pentosidine and nutritional status and its impact on 
clinical outcome.
Methods: Plasma pentosidine (by reversed-phase HPLC using fluorescence 
detection), biomarkers of inflammation, and nutritional status were measured 
in conjunction with initiation of dialysis therapy in 366 CKD stage 5 patients 
(53 ± 12 years; 61% males; 30% diabetics; 35% CVD; median glomerular filtra-
tion rate (GFR) 6.4 (range 3.7-9.1) ml/min/1.73 m2). Nutritional status was as-
sessed by subjective global assessment. We divided patients into four groups 
according to the median of plasma pentosidine and presence or not of malnu-
trition and analysed the relation between pentosidine, nutritional status, and 
all-cause mortality.
Results: The pentosidine levels associated positively with age (P<0.01), 
serum C-reactive protein (P<0.05), albumin (P<0.001), osteoprotegerin 
(P<0.001), vascular cell adhesion molecule-1 (P<0.001), homocyste-
ine (P<0.001) and 8OHdG (P<0.001) levels, and total lean body mass 
(P<0.001), and negatively with GFR (P<0.05). Malnourished patients with 
high pentosidine had the worst survival (Log rank test, Chi square = 33.7 
p<0.001).
Conclusions: Circulating pentosidine associates with markers of inflammation, 
oxidative stress, and nutritional status CKD stage 5 patients. Malnourished CKD 
stage 5 patients with elevated plasma pentosidine have an increased risk of 
death.
